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This work is an account of investigations into the chemistry of members of the Amaryllidaceae
and Hyacinthaceae families.
The plants of the family Amaryllidaceae are a large group comprising over sixty genera and
more than a thousand species. They are widely distributed, but are found more richly in the
tropics, with a particularly high density in South Africa, with smaller centers of diversity in
Andean South America and the Mediterranean. Amaryllidaceae plants have been extensively
used by local traditional healers and have been reported to have numerous pharmacological
uses. The alkaloids isolated from this family are a group of isoquinoline alkaloids found
exclusively in this family. Plants belonging to two Amaryllidaceae genera were investigated
phytochemically, one from each of the sub-tribes Crinineae and Amaryllidineae were
.. investigated phytochemically. Brunsvigia nata/ensis is used in local traditional medicine to
"straighten bones of children", treat barrenness in women and ease childbirth. This is the first
phytochemical investigation of Brunsvigia nata/ensis, and yielded two new alkaloids, a new
ceramide type compound and a known flavanoid. A comparative phytochemical investigation
was carried out on the bulbs and seeds of Crinum stuh/manni, which resulted in a number of
different alkaloids being isolated from the seeds and bulbs of this plant.
The southern African Hyacinthaceae is a large and chemically morphologically diverse group
of plants. This family comprises approximately sixty-seven genera and nine hundred species
worldwide, of which twenty-seven genera and three hundred and sixty - eight species are
found locally. There are five sub-families of which three occur in southern Africa. The
chemical constituents of this family can be divided into four classes, namely
homoisoflavanones, steroidal compounds, bufadienolides and miscellaneous compounds.
These plants are used in local traditional medicine for treating ailments such as hangovers,
rheumatic fever, sprains and even cancer. The phytochemistry of three Hyacinthaceae plants
was studied. The phytochemical investigation of Drimia macrocentra and Urginea riparia
yielded a novel bufadienolide glycoside. These glycosides are quite unusual with the glycone
attached to the aglycone at C-2 and C-3 and this has only been reported only once before in
this family. The phytochemical investigation of Ledebouria revo/uta yielded a number of
homoisoflavanones. These homoisoflavanones have been shown to have anti-inflammatory
activity and all of the compounds isolated in this work have been screened for this activity.
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Chapter 1: A Brief History of Alkaloids Used by Man
1.1 General
The use of alkaloid-containing plant extracts as potions, medicines and poisons can be traced
back to almost the start of civilisation.1 From the time Socrates drank the cup of hemlock
which contained the poisonous coniine, alkaloids have attracted enormous attention? other
famous examples include Cleopatra's use of atropine-containing extracts of Egyptian
henbane (Hyoscyamus muticus Unn.) to dilate her pupils and thereby make her appear more
alluring. Medieval European women utilized extracts of the deadly nightshade, Atropa
belladonna Unn., for the same purpose, hence the epithet belladonna meaning 'pretty lady'.1
In total, approximately 13,000 plant species are known to have been used medicinally
throughout the world.1 Approximately 25% of contemporary materia medica is derived from
plants and used either as pure compounds or models for synthetic drugs.1
Atropine (Figure 1. 1), which belongs to the group of tropane alkaloids, is the racemic form of
hyoscyamine, which comes from Atropa belladonna. It is used to dilate the pupils of the
eyes.
3
It is further used as a CNS stimulant and as a treatment for nerve gas poisoning.3 It
was the model for the synthetic drug tropicamide (Figure 1. 1), which is also used to dilate
the pupils and as a diagnostic tool in the detection of Alzheimer's disease.1
atropine
tropicamide
Figure 1. 1 Structures ofatropine and troplcamlde (right). Atropine was originally extracted from
Atropa belladonna (left), photographer: A1lce B. Russell, webslte:
http://www.ces.ncsU.eduldepts/hortlconsumer/poisonllmagesJAtrOpBe3.htm
QUinine (Figure 1. 2), isolated originally from Cinchona succirubra Pav. ex Klotzch, has been
the principal antimalarial drug for over two centuries. The beneficial effects of cinchona bark
were first discovered in South America in the 1630s.4 Without this antimalarial drug the
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exploration of Dutch and British explorers into Africa and India might have failed. Quinine has
been a model for a number of synthetic antimalarial drugs produced: chloroquine, primaquine
and mefloquine.3
quinine
Figure 1. 2 Structure of quinine (right), which was originally extracted from Cinchona succtrubra
(left), photographer not given, website: http://www.cocura.de/P328.hbnl
Another class of pharmacologically-important alkaloids are the ergot alkaloids. These
alkaloids are isolated from the dried sclerotium of the fungus Claviceps purpurea. 3,5 This
group of alkaloids is responsible for ergotism. Ergotism results in alimentary upsets (e.g.
diarrhoea, abdominal pains and vomiting), circulatory change (e.g. coldness of hands and feet
due to decrease in diameter of blood vessels) and neurological symptoms (e.g. headaches,
convulsions, psychotic disturbances and hallucinations).3 In 1926, at least 11,000 cases of
ergotism occurred in Russia.5 However, the alkaloids derived from ergot have now assumed
new importance for their pharmacological properties. Two examples of important ergot
alkaloids are ergonovine and methysergide (Figure 1. 3). Ergonovine has potent uterine
contraction activity and is used in treating postpartum haemorrhages.5 It is also used during
the final stages of labour.3 Methysergide is used as a cranial vasodilator in the treatment of
migraine headaches. 5 Other ergot alkaloids have been used to treat sexual disorders. The
most famous of this type of alkaloids, however, is lysergic acid diethylamide, LSD, which is a
derivative of lysergic acid. It is a powerful hallucinogen. Although it is not addictive, it can
. cause schizophrenia and there is danger of serious physical accidents to the patient.3
2
R1= H, R2= CH3, ergonovine
R1=CH3 R2= CH2CH3, methysergide
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lysergic acid diethylamide(LSD)
Figure 1. 3 Structures of some ergot alkaloids
Rauvolfia, a crude powered mixture of the dried rhizome and roots of Rauvolfia serpentina
(L.) Kurz (Figure 1. 4), is used in India as an antidote to snake-bite, fever, vomiting and to
treat insanity.3 Clinical tests in the late 1940s showed it to be effective for the control of
hypertension.3 It was employed in treating high blood pressure and to relieve anxiety and
restlessness and was thus important in initiating the tranquillizer era.3 This crude extract of
rauvolfia contained mainly the two alkaloids reserpine and deserpidine. Both these alkaloids
have been used as antihypertensives and mild tranquillizers in their pure form.3 However, the




Figure 1. 4 Structures of reserpine and deserpldlne (right), which are extracted mainly from
Rauvoltia serpentlna (left) photographer: Kazoo Yamasakl, website: http://pharm1.pharmazle.uni-
greifswald.delsystematlk/7_bilderlyamasakilRavolfia.jpg
Alkaloid-derived compounds that have aided in the fight against cancer are compounds such
as vincristine and vinblastine from Catharanthus roseus G.Don. (Madagascan Periwinkle)
(Figure 1. 5). Vinblastine is used for the treatment of Hodgkin's disease, breast cancer and
testicular carcinoma.
3
Vincristine, also from the same plant, shows a different spectrum of
3
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activity and toxicity.3 However. it has been found to be neurotoxic and is now used in






Figure 1. 5 Structures of vinblastine and vincristine (right), which are extracted from
Catharanthus roseus (left), photographer VICtory Cranberry, website:
http://www.ces.ncsu.eduldepts/hortlconsumerlfactsheets/annualslcatharanthusroseus.html
Another anticancer alkaloid is colchicine, a three ring membered amide, isolated from
Colchicum autumnale Unn. (Figure 1. 6). Colchicine is also used to reduce the inflammation
and pain of gout. It is used in the study of genetics due to its capacity to induce polyploidy.6
Pre-treatment of seeds with colchicine leads to various mutations of plants and it is therefore
used for selective purposes in agriculture.6
"'NHCOCH
colchicine
Figure 1. 6 Structure or colchicine (right), which was originally extracted from
Colchicum autumnale (Iert), photographer not given on webslte:
http://llbrary.thlnkqueslorg/COO797411_1aulhtm
Curare was used by the South American Indians as an arrow poison. Curare was made by
using the bark and stems of either Chondrodendron tomentosum Ruiz & Pav. or Strychnos
toxifera Schomb. ex Benth. The active ingredient in Chondrodendron tomentosum was found
to be the isoquinoline alkaloid tUbocurarine.3 Tubocurarine (Figure 1. 7) is used as a muscle
relaxant in surgical operations, reducing the need for anaesthesia.3 Furthermore, it has also
4
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been used to relax the heart muscles during open heart surgery and to treat spastic
paralysis. 3 However, due to its limited availability, a number of synthetic analogues are now
used.
d-tubocurarine
Figure 1. 7 Structure or 6-tubocurarine (right), and Strychnos toxifero (left) which Is
used In the preparation or curare, photographer: Thomas Schoepke, webslte:
http:/nlbrary.thlnkquestorg/COO797411_3stry.htm
A new p1ant-derived drug is galanthamine, which was first isolated from Galanthus nivalis Falk
(Figure 1. 8), but has now been found in many Amaryllidaceae species. It has recently been
approved (February 2001) by the FDA for the treatment of Alzheimer's disease. It is not a
cure for Alzheimer's but rather slows the rate of cognitive decline.
galanthamine
Figure 1. 8 Structure of galanthamine (right), which was originally extracted from the
bulbs of Galanthus nlvalls (left), photographer: John Worrall, website:
http://WWW.horlnetlgallerylviewlamy/galnl40/
Most spices, teas and other beverages such as coffee and cocoa owe their individual
properties (flavours and aromas) to the pharmacologically active plant metabolites that they
contain.? Most of them contain the purine alkaloids, caffeine, theobromine and theophylline.
These are found naturally in the leaves, seeds and fruits of more than sixty plants. They may
5
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also be produced synthetically. Caffeine (Figure 1. 9) is extracted mainly from tea leaves,
coffee beans and coca beans. Caffeine is used to stimulate the central nervous system,
cardiac muscles and respiratory system. It is mainly used to delay fatigue.
3
caffeine
Figure 1. 9 Structure of caffeine (right), which Is extracted mainly from camellia sinensls
(left) photographer not given, website: http://Www.pIantoftheweek.orgJweek046.shtml
Cocaine (Figure 1.10) is isolated from the leaves of the plant Erythroxylum coca T.Plowman
(coca plant). In the late 1800s cocaine was used for the treatment of a variety of illnesses
including alcohol and morphine addiction. However, many of the patients became addicted to
cocaine. Cocaine was also originally used in the Coca Cola soft drink; it was however
removed in 1906 because of its addictive properties. Cocaine is still used medically as an
anaesthetic for topical application.3 It is used as a constituent in Brompton's cocktail, which is
given to control pain in terminally ill patients. 3 It has been a model for several synthetic drugs.
An example is lignocaine (lidocaine), which is one of the mostly widely used anaesthetics.3
Another derivative of cocaine is crack, a highly addictive drug, which is processed from
cocaine hydrochloride to a free base for smoking. It is a central nervous stimulant that gives






Figure 1. 10 Structure of cocaine (right), which Is extracted mainly from Erythroxytum coca (left)
photographer Thomas SchOpke, website: http:Jnibrary.thinkquestorglCOO797411_2coc.htm '
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Another alkaloid stimulant is nicotine. Nicotine is produced by the plant Nicotiana tabacum
Unn. (Figure 1.11) that is cultivated widely for tobacco smoking. Nicotine in small doses can
act as a respiratory stimulant, however in large doses it causes respiratory depression.3
Despite the links between smoking and cancer the smoking habit continues worldwide.
Nicotine is toxic to man due to its effect on the nervous system. Studies suggest that nicotine
can improve memory by stimulating the transmission of nerve impulses and this finding may
account for the lower incidence of Alzheimer's disease in smokers. 3 However, any health
benefits of smoking are more than outweighed by the increased risk of heart, lung and
respiratory diseases. Nicotine is also used as an insecticide and fumigant. To date, no insect
has evolved resistance to nicotine.10
nicotine
Figure 1.11 Structure of nicotine (right), which is extracted mainly from
Nicotiana tabacum (left), photographer not given, website:
http://l1brary.thlnkqueslorg/C007974/1_1tob.htm
Ephedra, extracted mainly from Ephedra sinica Stapf (Figure 1. 12), is used worldwide as a
dietary supplement. It has been used for the treatment of asthma and also as a natural
decongestant and antihistamine. Ephedra contains mainly the two alkaloids ephedrine and
pseUdoephedrine. Ephedrine is a sympathomimetic amine with effects similar to adrenaline. 3
The effects have a longer duration than adrenaline. It is also used as a bronchodilator, giving
relief to asthma, and as a nasal decongestant. 3 PseUdoephedrine is used in cough and cold
preparations and as a decongestant.3
7





Figure 1. 12 Structures of ephedrine and pseudroephrlne (right), which are
extracted mainly from Ephedra sinica (left), photographer: Henrlette Kress,
website: http://iblblio.orglherbmedlpictureslp05lpageslephedra-sinica.htm
One plant that had a mixed effect on mankind is Papaver somniferum Unn. (Figure 1. 13),
the opium poppy. It is the oldest known intoxicating plant in human history.9 It was originally
used mainly in India and China where the desire for tranquility and sweet dreams led to
numerous poisonings.9 More than twenty alkaloids have been extracted from the opium
poppy.9 The most important ones are morphine, which is an important analgesic, codeine,
which is a common ingredient of cough medicines, and papaverine which is used as a pain
reliever.9 Morphine and codeine were also the model from which synthetic analgesic drugs
such as meperidine (Demerol), pentazocine (Talwin) and propoxyphene (Darvon) were
synthesized.9 Morphine has played another big, yet problematic part in recent human history:




Figure 1. 13 Structures of various alkaloids (right), lsoiated and derivatised from Papaver
somnlferum (left), no photographer given, webslte:
http://library.thlnkqueslorg/COO797411_1pop.htm
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Alkaloids have long been, and will continue to be, important sources and models for drugs,
insecticides and spices. Alkaloids, if used correctly, can be extremely beneficial to man; their
abuse may be fatal.
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Chapter 2: The Classification and Biosynthesis of
Alkaloids
2.1 Introduction
Alkaloids are a group of nitrogen-containing bases.1 They are natural products of non-peptide
origin.2 Their basic character is reflected in the name, alkaloid, derived from alkaline which
means basic. In the early eighteenth century Serturner isolated one of the first alkaloids,
morphine, from the opium poppy. He referred to it as " vegetable alkali" as he recognized it to
have basic properties. In 1818, however, W. Meisner proposed that such "vegetable alkalis"
should be called alkaloids and this became accepted and today the word generally denotes a
.basic, physiologically active nitrogen heterocycle of some complexity obtained from plant
sources.3
Despite the fact that all nitrogenous metabolites are classified as alkaloids, they can be
subdivided into three distinct groups according to their molecular structures and biosynthetic
origins. The true alkaloids are those compounds in which nitrogen forms part of a
heterocyclic ring system and are biosynthesized from amino acids. Pseudoalkaloids are
also characterized by nitrogenous heterocyclic ring systems but these are not biosynthetically
derived from amino acids. The third group contains physiologically active amines, which are
classified as protoalkaloids.4, 5
Due to the significant pharmacological activities and proven medicinal value of a large
number of alkaloids, the chemical investigation of these compounds has received a great deal
of attention and has been closely associated with the development of potential therapeutic
agents.4,
In this work, alkaloids from the Amaryllidaceae family have been investigated. This family
compromises over sixty genera and more than a thousand species worldwide.6-9 It is found
mainly in southern Africa and to a lesser extent in South America and the Mediterranean.5,9
Within southern Africa, the amaryllids are found throughout the three major areas of the
country, from the savannah in the north to the tropical environment of the east and the winter
rainfall areas in the south west.9 Of the nine tribes, two are present in South Africa, the
Amaryllideae and the Haemantheae. The Amaryllideae can be further subdivided into two
monophyletic sub-tribes: The Crinineae (Boophane, Crinum, Ammocharis and Cybistetes)
and the Amaryllidineae (Amaryllis, Nerine, Brunsvigia, Crossyne, Hessea, Strumaria and
Carpolyza). The Haemantheae contains six genera: Scadoxus, Cyrtanthus, Haemanthus,
Clivia, Gethyllis and Apodolirion.9
10
Chapter 2: The Classification and Biosynthesis ofAlkaloids
In this study, Crinum stuhlmannii Baker and Brunsvigia natalensis Baker were studied.
2.2 The Classification of Amaryllidaceae Alkaloids
The nomenclature of alkaloids has not been systematised. This is due mainly to the
complexity and variety of the compounds involved. Classification of alkaloids is therefore
problematic with some authors preferring a classification based on chemical structures (e.g.
pyridine, tropane, pyrrolizidine alkaloids), while others base theirs on plant genera. The
Amaryllidaceae alkaloids use both systems in their classification.
Some of the general characteristics of the Amaryllidaceae alkaloids are: 11
1. A fundamental ring system composed of a Ca-C1 and a N-C2_Ca building block, derived
from L-phenylalanine (L-Phe) and L-tyrosine (L-Tyr), respectively.
2. Weak bases (pKa 6-9).
3. Contain usually one nitrogen atom which is secondary, tertiary or even quaternary and
the carbon content varies from 16 to 20 atoms.
The alkaloids of this group can be classified into nine skeletal homogeneous subgroups:1o
Iycorine, homolycorine, crinine, haemanthamine, narciclasine, tazettine, montanine,
galanthamine and a miscellaneous subgroup. The alkaloids in all eight groups have a six
membered aromatic A ring. The Iycorine, homolycorine, crinine, narciclasine and
galanthamine type alkaloids also exhibit some degree of similarity in that they have identical
points of fusion for the A, Band C rings. The tazettine series also has six membered Band C
rings; however, the points of fusion between these rings are significantly different. Alkaloids
from the montanine series deviate from the above trend and typically display a seven
membered B ring and a six membered C ring. Those alkaloids grouped into the
miscellaneous class do not conform to any of the other classes and very little homogeneity is
observed.
2.2.1 The Lycorine Type Alkaloids
Figure 2. 1 Lycorine, an alkaloid of the Iycorine type
Lycorine is the most common alkaloid of this group.10 The Iycorine type alkaloids have an
additional five membered heterogeneous D ring together with the A, Band C rings and, in
11
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many cases, the C and / or D rings contain some degree of unsaturation and oxygenation.
The general characteristics of the 1H NMR spectra are:11
1. Two singlets for the para-oriented disubstituted aromatic protons, H-8 and H-11, in the
range CH 6.5-7.2 ppm.
2. A unique olefinic proton - CH 5.5 ppm (H-3).
3. Two doublets as an AB system corresponding to the benzylic protons at C-7.
4. The deshielding observed for thep protons at C-7 and C-5 in relation to their a-
homologues is due to the effect of the eis-lone pair of the nitrogen atom.
2.2.2 The Homolycorine Type Alkaloids
The homolycorine type alkaloids differ from the Iycorine type alkaloids in that the heteroatom
in ring B is oxygen instead of nitrogen. Ring B constitutes a lactone and the nitrogen atom in





Figure 2. 2 Masonine, an alkaloid of the homolycorine type
The general characteristics of the 1H NMR spectra are: 11
1. Two singlets for the para-aromatic protons, H-8 and H-11. In ring B lactone alkaloids,
one can differentiate between the H-8 and H-11 protons due to the deshielding of H-8
by the peri-carbonyl group (C-7).
2. In ring B hemiacetal alkaloids, the substituent at C-7 is always a and the benzylic
proton H-7 is p and appears as a singlet between OH 5-6 ppm, depending on the
substituent at C-7.
3. H-4 in the C ring is generally vinylic and is found around CH 5.5 ppm.
4. Between CH 2.0-2.2 ppm there is a singlet corresponding to the N-methyl group proton
resonance.
5. If a substituent occurs at C-5 it is always a.
6. The H-2a proton is more deshielded than H-2P due to the cis lone pair of the nitrogen
atom.
12
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2.2.3 Crinine • Haemanthamine Types
Both of these alkaloid types contain a 5,1 Ob-ethanophenanthridine bridge. These ring
systems are very common to Amaryllidaceae alkaloids with variations in position, type and
configuration of oxygenated substituents and the presence of alkaloids with enantiomeric
basic nuclei.10 In the crinine type alkaloids the 5,1 Ob-ethano bridge (ring D) is situated in a ~
orientation. This is the distinction between crinine alkaloids and haemanthamine alkaloids in







Figure 2. 3 Crinine and haemanthamine, alkaloids of the crinine and haemanthamine
types
The general characteristics of the l H NMR spectra are:ll
1. Two singlets for the para-oriented aromatic protons in the range OH 6.4-7.0 ppm.
2. When CDCls is used as a solvent, the magnitude of the coupling constant between
each olefinic proton (H-1 and H-2) and H-3 gives information about the configuration
of the substituent at C-3.
3. A large coupling constant between H-4o: and H-4a (J4a,4a-13 Hz) occurs due to their
trans-diaxial position and is characteristic of the haemanthamine series.
4. An AB system corresponding to the benzylic protons at C-6.
2.2.4 Pre-tazettine Type Alkaloids
This type of alkaloid has a [2]benzopyrano[3,4]indole skeleton. lo It contains four rings, an
aromatic A ring, a six membered B ring containing an oxygen atom, a unique six membered
ring C and a nitrogen-containing five-membered D ring with the nitrogen being methylated.
13
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OH
Figure 2. 4 An alkaloid of the pre·tazettine type
The general characteristics of the 1H NMR spectra: 11
1. A N-methyl group proton resonance at OH 2.4-2.5 ppm is used to distinguish this type
from the haemanthamine type alkaloids.
2. The methylenedioxy group (OH 5.9-6.0 ppm) is always present.
2.2.5 Galanlhamine Type Alkaloids
This class has a similar skeleton to crinine Ihaemanthamine types but has an open· Bring,
and a methyl group attached to the nitrogen atom. These alkaloids are unique in that the A
ring and the C ring are joined by an ether linkage. They contain an a-orientated ethane
nitrogen bridge.
OH
Figure 2. 5 Lycoramine, an alkaloid of the galanthamine type
The general characteristics of the 1H NMR spectra are: 11
1. Two doublets for the two ortho-oriented disubstituted aromatic protons, with a
coupling constant of J7,8-8 Hz.
2. The stereochemistry of the substituent at C-3 is determined by considering the




-5 Hz is observed the substituent is pseudoaxial while a coupling constant of -0 Hz
indicates the substituent at C-3 is pseudoequatorial.
3. A pair of doublets is observed for the AB system of the benzylic protons at C-6.
4. The H-1 proton resonance is deshielded by the presence of a 1,1 O-ether bridge.
14
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5. The presence of an N-methyl group is common but occasionally N-formyl or N-acetyl
derivatives have been reported.
2.2.6 Montanine Type Alkaloids
This class is characterized by having a seven membered nitrogen containing B ring with a
methylene bridge extending from the nitrogen atom to C-11 on the other side of the ring
forming a six membered and five membered ring.
Figure 2. 6 Coccinine, an alkaloid of the montanine type
The general characteristics of the 1H NMR spectra are:11
1. A pair of doublets for the para orientated protons (H-7 and H-10) with a coupling
constant of J-1 Hz.
2. The H-1 olefinic resonance at - OH 5.5 ppm.
3. The deshielded pair of doublets (J=16Hz) characteristic of the C-6 methylene protons.
4. Two triplets of doublets typical of the H-4 methylene protons at C-4.
2.2.7 Narciclasine Type Alkaloids
These contain only three rings, an aromatic A ring, an amide containing B ring and a C ring







Figure 2. 7 Narciclasine, an alkaloid of the narciclasine type
The general characteristics of the 1H NMR spectra are: 11
1. A pair of doublets (J-1 Hz) for the para orientated protons (H-7 and H-10).
2. The H-4a proton occurs at -OH 4.4 ppm.
3. The C-ring is normally highly oxygenated.
15
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2.3 The Biosynthesis of Amaryllidaceae Alkaloids
The Amaryllidaceae alkaloids are biosynthetically derived from two amino acids, making them
members of the true class of isoquinoline alkaloids.4,15 The amino acid, phenylalanine, gives
rise to the C6-C1 unit from which the aromatic ring A and the benzylic carbon are derived. The
second amino acid, tyrosine, gives rise to the C6-C2 unit from which the aliphatic C ring is
derived. It is also responsible for the provision of the nitrogen atom. Research has shown












Figure 2. 8 The origin of the A and C rings
The skeletal structures of all of the Amaryllidaceae alkaloids are related to an intermediate
known as norbelladine. This precursor, norbelladine, is formed by the condensation of
tyramine and protocatechualdehyde. Tyramine is derived from the decarboxylation of
tyrosine via a decarboxylation enzyme (Scheme 2. 1). Protocatechualdehyde is derived from
phenylalanine via cinnamic acid.4,5,12 The first step in the production of protocatechualdehyde
involves the deamination of phenylalanine by the enzyme phenylalanine ammonia lyase
(PAL), to give trans-cinnamic acid. Hydroxylation of cinnamic acid results in the formation of
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Scheme 2. 1 The biosynthesis of norbelladine4
The hypothesis of Barton and Cohen, that these alkaloids could arise from different modes of
phenol oxidative coupling of norbelladine and its derivatives, has been of central importance
in biosynthetic studies.4.5.13 This hypothesis has been proven true by tracer studies.10
Hydroxy groups ortho and/or para to sites of new bond formation between aromatic rings are
essential for biosynthetic schemes of this type.12 The precursor O-methylnorbelladine can be
twisted in different ways so that various modes of oxidative phenolic coupling are
possible.4.5.12.15
The biosynthetic pathway for Iycorine type alkaloids postulates that norbelladine is the
precursor.4,5,12.15 Norbelladine is first methylated to produce Q-methylnorbelladine. This is
followed by o-p' phenolic coupling and cyclisation onto nitrogen to produce norpluviine
(Scheme 2. 2).4,5 The hydroxy and methoxy groups on norpluviine combine to form a
methylenedioxy group. The final step in the formation of Iycorine is the hydroxylation of C-2.
It has been proven by tritium labeling that the configuration of the hydroxy group at C-2 is ~.11
17





















Scheme 2. 2 The biosynthesis of Iycorine type alkaloids 4,11,12,14,15
As in the biosynthesis of Iycorine, O-methylnorbelladine is the precursor for homolycorine
type alkaloids. The difference here is that there is a different mode of oxidative coupling:
instead of ortho-para you now have para-para (Scheme 2. 3).11 Norpluviine undergoes
18
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benzylic oxidation at position 7, which is followed by ring opening to produce an amino
aldehyde.14 Rotation about the C-11a-C-11b bond is then followed by hemiacetal formation,

















Scheme 2. 3 The biosynthesis of homolycorine type alkaloids 4,11,14,15
Crinane type alkaloids are also derived via phenol oxidative coupling, However the 0-
methylnorbelladine precursor is twisted in such a way that p-p' oxidative coupling between the
two aromatic rings takes place (Scheme 2. 4).4,5,15 The resulting molecule has an ethanoic
bridge between the nitrogen atom at position 5 and C-10b, hence the nomenclature 5,10b-
ethanophenanthridine alkaloids. The bridge formed can be a or p and this gives rise to the
two different series of alkaloids. The haemanthamine type alkaloids typically have an a
5,10b-ethanobridge and crinine type alkaloids, conversely, exhibit a p orientated bridge.
Tracer studies done to determine whether these two types of alkaloids can be interconverted
in vivo have shown that this is not possible.16 Haemanthamine, itself, has a hydroxy group at





























5,1 Ob-ethanophenathridine type alkaloid
• orientation of 5, 1Ob-ethano bridge and H-4a
depends on type of twisting of O-methylnorbelladine
precursor
Scheme 2. 4 The biosynthesis of crinane/5,10b-ethanophenanthridine type alkaloids 10,13
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The biosynthesis of pre-tazettine occurs by a process analogous to the conversion of
norpluviine into Iycorenine (Scheme 2. 5). In this case haemanthamine is converted via
haemanthidine into pre-tazettine. Under mildly basic conditions pre-tazettine is converted to
tazettine. Tazettine was for a long time considered to be a true alkaloid, however it has been
shown to be a artefact, arising from the true alkaloid pre-tazettine.17,21 This conversion is
thought to be an internal crossed Cannizzaro reaction. 17
21








Scheme 2. 5 The biosynthesis of tazettine type alkaloids 17
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The pathway to galanthamine involves para-ortho' oxidative coupling similar to that found in
other Amaryllidaceae type alkaloids. Initial tracer studies done on the King Daffodil showed
that methylation of norbelladine should occur before ortho-para' coupling, with narwedine the


















Scheme 2. 6 The biosynthesis of galanthamine type alkaloids 10,11,17
However, recent reports have postulated a new biosynthetic pathway to galanthamine
(Scheme 2. 7).20 Radioactive as well as 13C-labelled 4'-0-methylnorbelladine was fed to
LeuGojum aestivum Linn. and radioactive galanthamine and N-demethylgalanthamine were
produced. This biosynthesis is thought to proceed by phenolic coupling of 4'-0-
methlynorbelladine to yield an unstable dienone that spontaneously rearranges, without
enzyme catalysis, to form N-demethylnarwedine.20 This alkaloid is then enzymically and
stereoselectively reduced to galanthamine.20 According to this study, methylation of the
nitrogen atom occurs after the phenol coupling, narwedine is not the direct precursor to
galanthamine, and narwedine and galanthamine could possibly exist in equilibrium?O
23













Scheme 2. 7 Proposed biosynthesis of galanthamine 20
Montanine type alkaloids are biosynthetically derived via the para-para' oxidative coupling of
the norpluviine precursor. These alkaloids have a similar intermediate to the haemanthamine
type alkaloids but not haemanthamine itself, as tracer experiments have shown. 16,18 Tritium
labeled haemanthamine was fed into Haemanthus coccineus Linn., but no radioactive
montanine type alkaloids were produced indicating that haemanthamine is not a precursor.16
Researchers therefore speculated that the C-3 methoxy substituent is a point of interference
in the in vivo rearrangement to the montanine nucleus.16 However, tritium labeled vittatine
was incorporated into both montanine and haemanthamine type alkaloids from Rhodophiala
bifida Traub. which confirms the suggestion that a C-3 methoxy group hinders this
arrangement (Scheme 2. 8).16 The study also showed the specific radioactivity of vittatine-
derived haemanthamine was substantially higher than that of montanine.16 This indicates that
11-hydroxyvittatine is converted more efficiently to haemanthamine which requires only the
.methylation of the hydroxy group at C-3 while the formation of montanine involves a
rearrangement of the vittatine ring system in addition to the methylation of the oxygen at C-
2.16
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Scheme 2. 8 The biosynthetic relationship between haemanthamine, montanine and narciclasine
The biosynthesis of narciclasine type alkaloids is thought to proceed either via 0-
methylnorbelladine with para-para oxidative coupling of the D-methylnorbelladine.11 ,19 It has
an haemanthamine type intermediate. In feeding experiments on Pancratium maritimum
.Unn., tritium labeled vittatine was incorporated into narciclasine, demonstrating it to be an
intermediate in the biosynthesis. 19 In another feeding experiment on Narcissus
pseudonarcissus Unn., tritium labeled norpluviine was injected and radioactive labelled
narciclasine was produced, however the conversion was IOW. 14 It has been suggested,
therefore, that since narciclasine type alkaloids are structurally similar to both haemanthamine
and Iycorine, these compounds could be derived via both biosynthetic routes. Despite this,
the vittatine to narciclasine conversion is still significantly more efficient.14
25
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2.4 The Biological Activity of Amaryllidaceae Alkaloids
The wide occurrence and the structural diversity of Amaryllidaceae alkaloids has long
attracted attention for their biological activity. As early as the fourth century BC, oil from
Narcissus poeticus Huds. was used in cancer treatment by the Greek physician Hippocrates
of Cos (the "Father of Medicine")?2 A large number of Amaryllidaceae plants have been used
in folk medicine.
Bioassay-guided fractionation was employed on the alkaloids from Crinum amabile Donn. to











Figure 2. 9 Alkaloids isolated from Crinum amabile23
(-)Augustine (4) was found to be the most active alkaloid, showing a significant cytotoxic
response to human breast cancer, lung cancer, colon cancer, fibrosarcoma, melanoma, oral
epidermoid carcinoma, murine lymphoid neoplasma, epidermoid carcinoma, hormone-
dependent human prostatic cancer, hormone-dependent breast cancer and human
glioblastoma.23 Compounds 1 and 3 were not active. However, crinamine (5), differing in its
absolute configuration from 1 and 3, demonstrated strong cytotoxic results. Lycorine showed
good results in all the cancer lines tested. Crinamine (5), Iycorine (2) and (-) augustine all
showed moderate anti-malarial activity but Iycorine and augustine showed low selectivity
indices compared to the control compounds used.23 Lycorine has also shown further
biological activity including inhibition of growth and cell division in higher plants and algae,
inhibition of cyanide resistant respiration and of peroxidase enhancement.24,25,26 Further
studies have shown the A, Band methylenedioxy rings have little effect on the inhibitory effect
26
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of the Iycorine molecule. However electron donor groups on the C ring at C-1 and C-2 and a
~ configuration of the D ring result in increased inhibition?7
o
hippadine
Figure 2.10 Structure of hippadine
Hippadine, a phenanthridone type alkaloid, has been shown to reversibly inhibit fertility in
male rats?8 Rats treated with hippadine showed a 83.3 % fertility loss. However, 80% of the
rats regained fertility between 8 and 10 weeks while the remaining 20% remained sterile for
up to 12 weeks. Initially the onset of infertility was delayed with the loss of DNA and an
increase in concentration of protein. This together with the reversibility of the damage to the
germinal activity, suggestted that the alkaloid possibly acted on the germ cells in their earlier
stages of spermatocytogenesis?8 These observations suggest that hippadine exerts its












Figure 2. 11 Structures of different alkaloids tested on animal cell growth
The effects of eighteen alkaloids from various Amaryllidaceae bulbs were tested on (a) animal
cell growth (b) DNA, RNA, and protein synthesis by intact cells and (c) protein synthesis in
27
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cell-free systems.29 Six of the eighteen alkaloids halted HeLa cell growth at 10-1 mM or lower
concentrations. At their growth inhibitory concentration, these six compounds block protein
synthesis in ascites cells and stabilise HeLa cell polysomes in vivo. EMC RNA-directed cell
free polypeptide synthesis is also inhibited by these six compounds. It is therefore thought
that they halt protein synthesis in eukaryotic cells by inhibiting the peptide bond formation
step. Narciclasine was found to be the most potent of the six inhibitors and it is also known to
have antitumor and antimitotic effects.3o
It is due to these various pharmacological activities that this family has become the focus of
many pharmacological and phytochemical studies.
28
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Chapter 3: Extractives from Brunsvigia natalensis
3.1 Introduction
Brunsvigia natalensis Baker belongs to the Amaryllidaceae family. This family comprises nine
tribes worldwide, of which two are found in southern Africa, the Amaryllideae and Haemantheae.
The genus Brunsvigia Heist. has been placed in the Amaryllideae. 1
Brunsvigia natalensis is also known as the Natal Candelabra Flower, or Kanderlaarblom? It is
found in grassland and mainly marshy areas. The Zulu name for this plant is umbhola, a
reference to the rotten smell around the bUlbs.2 It is distributed in southern Africa mainly in the
mountainous highlands of KwaZulu-Natal, Mpumalanga and Swaziland.2 The subglobose bulbs
are approximately 5 cm in diameter.3 It is used in traditional medicine to 'straighten bones in
children,.2 .
Figure 3. 1 Brunsvigia natalensis, Photo: Erich van Wyk
This is the first reported phytochemical study of this plant. The dichloromethane and methanol
extracts of this plant were investigated. This led to the isolation of four compounds, three
alkaloids and a f1avanoid (Figure 3. 2). Of the four compounds isolated, three have not been
reported previously. The compounds isolated were nivanine A (compound I), nivanine B
(compound 11), 7-hydroxyflavan (compound ID) and brunsceramide (compound IV).
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Figure 3. 2 Compounds isolated from Brunsvigia natalensis
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3.2 Results and Discussion
3.2.1 Structural Elucidation of Compound I, 11-0ehydroxycrinamine (nivanine A)
(spectra 1.a-i)
Figure 3. 3 Structure of compound I, nivanine A
Compound I (Figure 3. 3), was isolated as an orange amorphous material. This compound was
found to have a molar mass of 285.13782 g. mor1 corresponding to a molecular formula of
C17H19N03. It was found to belong to the 5.1 Ob-ethanophenanthridine type of alkaloids. The
structure of this compound was identified using NMR spectroscopy together with the mass
spectrum.
The substitution pattern on the A ring was confirmed through the presence of two para orientated
aromatic protons (OH 6.45 and 6.77) and a two proton resonance at OH 5.87. which is typical of
protons of a methylenedioxy group, in the 1H NMR spectrum. Other characteristic features
observed in the 1H NMR spectrum included a doublet resonance (OH 5.78. 10.3 Hz) and double
.e::==.
doublet resonance (OH 6.40.2.2 and 10.3 Hz) in the olefinic region, assigned to H-£.and H-1 of a
.".-- . ~.
1. 2-double bond. and a methoxy group proton resonance at OH 3.38. Another typical alkaloid
-~~~ -
resonance was a double doublet at OH EO (dd. 3.7 and 13.2 Hz) assigned to the H-4a
resonance.4-6 The C-4a (oc 66.55), together With C-7 (oc 106.90) resonances showed a 3J HMBC
~-- _.~
correlation to the methylene protons at OH 3.75 (d. 16.9 Hz) and 4.36 (16.9 Hz), which were
, ..... ' ~ .-
assigned to 2H-6. The HMBC spectrum showed 3J correlations from C-6 (oc 61.95) and C-4a (oc
66.55) to the resonances at OH 2.88 (m) and 3.41 (m). which were seen to correspond in the
HSQC spectrum to a methylene carbon resonance at Oc 53.15. This was assigned to C-1'2. one
of the two bridging carbons. The COSY spectrum shows correlCltions between the 2H-12
resonances (at OH 2.88 (m) and 3.41 (m)) and the methylene proton resonances 8.t OH 2.07 (m)
and 2.11 (m) assigned to 2H-11, which were seen to correspond in the HSQC spectrum to the
methylene carbon resonance at Oc 44.62 ascribed to C-11.
Circular dichroism was used to determine the absolute configuration of the 5,10b-ethano bridge.
In this technique the shape, amplitude and sign of the CD spectrum can be used to determine
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configuration and conformational aspects of optically active compounds.7 The sign of the CD
peak generally relates to the configuration of the molecule. Consequently, comparison with
compounds of known stereochemistry can be used to determine the stereochemistry of unknown
compounds. This technique is useful in determining the stereochemistry of the ethanobridge in
crinane compounds since the configuration at the optically active benzylic carbon C-10b
determines the shape and sign of the CD spectrum. For the a-5,1 Ob-ethanophenanthridine
series, a minimum or a negative cotton effect is observed at between 245-250 nm and a
maximum or positive cotton effect at 285-290 nm in the CD spectrum. This is in direct contrast to
crinane alkaloids with a f3-5,1 Olrethano bridge where a maximum is generally observed between
245-250 nm and a minimum between 285-290 nm in the CD spectrum.4-6 A positive Cotton effect
for compound I was observed at 279 nm followed by a negative effect at 249 nm, which indicated
the bridge was of the a configuration. A 3J correlation seen in the HMBC spectrum from C-3 (Be
~,; ~ ,---
76.81) to the methoxy group proton resonance at 8H 3~38, indicated the methoxy substituent to be
......--....
present at C-3. This methoxy substituent at C-3 can be on the same side (cis) or on the opposite
<"--
side (tfans) of the 5,10lrethano bridge and this can be determined from the splitting pattern of the
H-2 resonance. The H-1 and H-2 atoms are the protons of a double bond and are planar (Figure \k'
3. 4) with~a dihedral angle of approximately 00 and they split each other into a doublet with
coupling constants of 10Hz. If the methoxy substituent at C-3 and 5,1 Olrethano bridge are on
the same side, then the dihedral angle between H-2 and H-3 is approximately 900 (giving a J2.3 of
approximately zero) and the H-2 resonance remains as a doublet. However, if the methoxy
substituent and the ethano bridge are on opposite sides, the dihedral angle is approximately 300 ,
which results in the~ resonance being split into-!I. double dou_blet with coupling constants of 10
(J1,2) and 5 (J2,3) Hz. Thus a H-2 resonance split into a doublet indicates a cis relationship
between the methoxy substituent and the bridge and if the H-2 resonance is split into a double
doublet, this indicates a !e...~s relationship between substituent and the ethano bridge.4-6 The H-2
resonance was found to be a doublet, indicating a cis relationship between the methoxy
substituent at C-3 and the 5,1 O-ethano bridge.
Fi~re 3. 4 Molecular model showing the different dihedral angles between B-2 and B-3. (a) shows a
dihedral angle of 90 degrees between B-2 and B-3; (b) shows a dihedral angle of approximately 30
degrees between B-2 and H-3.
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A proposed mass spectral fragmentation pattern is shown in Scheme 3. 1. The loss of a
fragment of 55 mass units from the parent ion can result from the loss of a CH2CHNCH2
fragment, leaving a fragment ion at m/z 230 as shown in the Scheme 3.1.8 This fragment ion at
m/z 230 can lose a methyl group (m/z 215) and, subsequently, can lose carbon monoxide to give
the fragment ion at m/z 187.8 Further fragmentation could involve the loss of formaldehyde from
the methylene dioxy group, which results in a fragment ion at m/z 157. The alternative
fragmentation route for the ion at m/z 230 is the successive loss of 2xCH20 fragments resulting in
























Scheme 3. 1 Fragmentation pattern of compound 18
~ .
\\ The infrared data supported the postulated alkaloid structure for compound I. Peaks were
" observed at 3384 cm-
1
(O-H stretching), 2922 cm-1 (aliphatic C-H stretching), 1492 cm-1 (aromatic
\ C=C stretching) and 1239 (C-N stretching). '---- - -
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A literature search indicated that this structure has not been reported previously. It was found to
be the epimeric of epibuphanisine which has previously been isolated from Ammocharis coranica
(Ker-Gawl.) Herb., Brunsvigia josephinae (Red.) Ker-Gawl and Boophane flava W.F.Barker ex
Snijman.6,9,1o However, it was different in the orientation of the 5,10b-ethano bridge and the
stereochemistry at C-3. In nivanine A the bridge and substituent were both in the a configuration
compared to epibuphanisine which has the bridge and stereochemistry at C-3 to be both in the ~
configuration.
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Table 3.1: 1H, 13C, HMBC, COSY and NOESY data for nivanine A (CDCI3)
lic'
HMBC
CARBON liH lic COSY NOESY
(C~H)
1 6.40 (dd. 10.3.2.2 Hz) 129.05 131.9 l1 exo 2 2,10
2 5.78 (d. 10.3) 128.81 125.8 4P 1 1;3;3-0CH3
3 3.97 (m) 76.81 72.2- 1;3-0CH3; 4a..P 4a.,P
2;4a;4p;3-
OCH3










60. 3.75 (d. 16.9 Hz) 6P 6P;7.12exo- 61.95 61.6 7;12exo. endo
6P. 4.36 (d, 16.9 ftz) 60. 4a;6a.;7
6a 125.62 124.3 6a..P;10.
7 6.46(s) 106.90 107.0 6a.,p; 10 6a.,p
8 146.19" 146.1 OCH20; 7;10
9 145.79" 146.5 OCH20 ;7;10
10 , 6.77d~) 102.77 103.1 7 1
10a 138.45 137.5 1;4a;6a.,p;7;11 exo ,endo
10b 44.800 44.6 2;4a.,p;1 0;11 exo. enOO




11 enoo 2.11 (m) 12exo. endo 11 exo;12enoo
12enoo 2.88 (m) 11 exo. enOO; 12exo 6a.;12exo
53.15 53.2 4a; 6a..P; 11 exo.endo
12exo 3.41 (m) 11 exo. endo; 12endo 11 exo;12enoo
-O~H20- 5.87 (d.d. 5.5,4.4 Hz) 100.76 101.0
3-0CH3
,
3.38 ($) 55.91 56.7 2;3;4q13
* Literature spectra of epibuphanisine run in CDCI3.
6
a 13C NMR resonance values interchangeable.
b 13C NMR resonance values interchangeable.
C 13C NMR resonance values interchangeable.
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3.2.2 Structural Elucidation of Compound 11, 4g-acetyl-2-deacetyl-1~





Figure 3. 5 Structure of compound 11, nivanine B
Compound II (Figure 3. 5) was isolated as a white amorphous material. This compound was
found to have a molar mass of 361 g. morH suggesting a molecular formula of C19H23N06 and
also belongs to the 5,10b-ethanophenanthridine group of alkaloids. The structure was
determined using NMR spectroscopy and was found to be a new alkaloid named nivanine B.
The substitution pattern on the A ring was the same as the previous compound with two para
orientated aromatic protons (OH 7.24 and 6.53) and a two proton resonance at approximately OH
5.86, in the 1H NMR spectrum, which is typical of protons of a methylenedioxy group (2H). Other
features observed in the 1H NMR spectrum included a methoxy group proton resonance at OH
3.95 and an acetoxy group proton resonance at OH 2.09. A typical resonance for the 5,10b-.....---
ethanophenanthridine alkaloids is the AB splitting pattern for the H-6 methylene protons which
were observed as a pair of doublets (d, 16.9 Hz) at OH 3.76 and OH 3.93.4-6 The C-6 resonance
showed a 3J HMBC correlation to the resonance at OH 4.46 (d, 10.2 Hz) assigned to H-4a.
The COSY spectrum was used to assign the protons of ring C. The H-4a (OH 4.46) resonance
showed a correlation in the COSY spectrum to a resonance at OH 4.98, which was assigned to H-
4. This resonance showed a corresponding carbon resonance in the HSQC spectrum at Oc 75.86
indicating an oxygenated methine carbon to be present. The carbonyl carbon resonance of the
acetate group (oc 170.99) showed a 3J HMBC correlation also to this resonance at OH 4.98. This
implied that C-4 had an acetate group attached to it. The resonance at OH 4.98, in turn, showed a
correlation in the COSY spectrum to two protons of a methylene group (OH 1.88 and 2.01) which
were assigned to 2H-3. These resonances, in turn, showed correlations to the protons of another
methylene group (OH 1.70 and 1.99) which were assigned as 2H-2. The carbon resonances for
ring A and B were assigned by comparison to the previous compound together with the HMBC
T HRMS is currently being done.
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and COSY spectra. This left the acetal carbon resonance at Oc 93.84 to be assigned and the only
position unassigned was C-1. This resonance showed a 3J HMBC correlation to the H-3
resonance at OH 2.01 and was thus confirmed to be C-1. The methoxy proton group resonance
(OH 3.95) showed a correlation in the NOESY spectrum to the H-10 resonance and was thus
assigned the ~ orientation. The other substituent on C-1 was assigned to be a hydroxy group by
mass difference from the mass spectrum, and also because of the chemical shift of the Oc of
93.48 ppm. Circular dichroism spectroscopy was used to determine the absolute configuration of
the 5, 10b-ethano bridge. A positive Cotton effect was observed at 284 nm followed by a further
positive effect at 247 nm, which indicated the bridge was of the ~ configuration since negative
Cotton effects are typically observed at 243 nm for the Cl orientated series.7, 15
The infrared data supported the postulated alkaloid structure for compound 11. Peaks were
observed at 3437 cm,1 (O-H stretching), 2949 cm'1 (aliphatic C-H stretching), 1727 (C=O
stretching), 1472 cm'1 (aromatic C=C stretching) and 1262 cm'1 (C-N stretching).
A literature search for the compound showed that it has not been described previously and was
named nivanine B. Table 3.2 shows the 1H and 13C NMR resonances together with the HMBC,
COSY and NOESY NMR data.
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2a 1.70 (m) 3a,~ 2~
27.63
2~ 1.99 (m) 3a.~ 2a;313
3a 1.88 (m) 4;2a,~ 3~;4a
26.07 2
3~ 2.01(m) 4;2a,~ 3a;4
4 4.98 (m) 74.7,7 4a 4a, 3a.~ 3~;4a
4a 4.46 (d, 10.2 Hz) 75.86 4 4 3a;4
6a 3.76 (d, 16.9 Hz) 6(3 6~;12endo
52.03 4a;7
6~ 3.93 (d, 16.9 Hz)* 6a 6a
6a 139.62 6a,~;10
7 7.53 (5) 102.45 4;4a
8 148.77 OCH20; 7;10
9 133.59 OCH20 ;7;10




11 exo 2.41 (m) 12exo, endo
OCOCt!.338.46 4a
11 endo










- OCH2O- 5.86 (5) 100.67
3-0CH3 3.95 (5) 59.11 10
4-0COCH3 2.09 (5) 21.33 11 exo
4-0.Q.OCH3 170.99 4;4-0COCt!.3
* Coupling constant could not be determined as resonances overlap each other. However it was
assumed to have the same coupling constant as 6 a.
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Figure 3. 6 Structure of compound llI, 7-hydroxyflavan
Compound ill (Figure 3. 6) was isolated as an orange amorphous material. It was found to have
a molar mass of 226 g. mor1, corresponding to a molecular formula of C1sH1402.t The structure
of this compound was deduced based on the NMR data as being a f1avanoid type of compound.
The 1H NMR spectrum together with the COSY spectrum showed coupled proton resonances at
OH 5.04 (dd 2.5, 10.0 Hz), OH 2.16 (m) and 2.12 (m)) and OH 2.71 (m) and 2.89 (m) assigned to H-
2, 2H-3 and 2H-4 of a chromane moiety. The presence of resonances at OH 7.41 (2H) (m), OH
7.38 (2H) (m) and OH 7.33 (m) was indicative of a monosubstituted benzene ring, linked to the
chromane moiety at C-2. This linkage of the benzene ring at C-2 was confirmed on the basis of a
3J HMBC correlation from C-2 (oc 77.80) to the H-2' and H-6' (OH 7.41) resonances.
Circular dichroism spectroscopy was used to determine the absolute configuration of the
stereogenic centre at C-2. A negative Cotton effect was observed at 282 nm and 242 nm, which
indicated the stereogenic centre to have the 2R absolute configuration. 16,17
The structure of ring A remained to be determined. The presence of an aromatic AB system in
the 1H NMR spectrum, with resonances at OH 6,93 (d, 7.9 Hz), OH 6.32 (dd, 7.9, 2.5 Hz) and OH
6.28 (d, 2.5 Hz) was indicative of the presence of three non-equivalent protons on the A ring and
that the A ring was tri-substituted. Two of the three substituents were linkages between the
chromane ring C to the aromatic ring A. That the remaining substituent was an hydroxyl group
was determined both from the molecular formula and the disappearance of the broad resonance
at OH 5.41 ascribed to the free hydroxyl group proton resonance.a The position of this substituent
was determined using the HMBC, COSY and NOESY spectra. The C-4 resonance showed a 3J
HMBC correlation to the aromatic resonance at OH 6.93 (d, 7.9 Hz) which was assigned to H-5.
The COSY spectrum showed a correlation between H-5 and the aromatic proton resonance at OH
t HRMS experiments were not done on known compounds due to financial restraints.
a The 1H NMR spectrum was reacquired after adding CD30D.
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6.32 (dd, 7.9, 2.5 Hz) this was assigned to H-6. The H-6 resonance showed a correlation in the
NOESY spectrum to the broad resonance at OH 5.41. This, in turn, showed a correlation in the
NOESY spectrum to the remaining aromatic resonance at OH 6.28 (d, 2.5 Hz) assigned to H-8.
This implied that the hydroxyl group was present at C-7.
A literature search for the compound indicated that it was similar to 7~hydroxyflavan, previously
isolated from the bulbs of Narcissus pseudonarcissus L (Amaryllidaceae) and is an anti-fungal
agent.11 It was different from the known compound from literature at the chiral centre in
compound ill it was found to be 2R instead of 2S found .in literature. The 13C NMR data are not
provided in the literature. Table 4.3 shows the 1H, 13C, HMBC, COSY and NOESY data for 7-
hydroxyflavan.
yfId fdN
Coupling constant could not be determined as resonances overlap each other.
a Carbon value interchangeable.




2 5.04 (dd,2.4,10.0 Hz ) 77.80 3a,~;4a,~;2'/6' 3a,~ 3a,~;4~;2';6'
3a 2.12 (m) 2;3,8,4a;2';6'
29.96 2;4a,~ 2;4a,~
3~ 2.16 (m) 2;3a;4a,~;2';6'
4a 2.71 (m) 3a,~;4~;5
24.27 2;3a,~;5 3a,~
4,8 2.89 (m) 2;3a,~;4a;5
5 6.93 (d, 7.9 Hz) 130.49 4a,~ 6 4a,~;6
6 6.32 (dd, 2.5, 7.9 Hz) 103.12 4~;5;8 5 5;7-0H
7 - 155.67a




2' 7.41 (m)* 125.95 2;4';6' 3' 2;3a,~
3' 7.38 (m)* 128.46 5' 2';4'
4' 7.33 (m)* 127.80 2';6' 3';5'
5' 7.38 (m)* 128.40 3' 4';6'
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3.2.4 Structural Elucidation of Compound IV, (2S,3S,4E,7C)-1,3-dihydroxy-2-[(2'R)-2'-
hydroxyhexadecanoylamino]-4,7-octadediene (brunsceramide) (spectra 4.a-j)
QH
HO
Figure 3. 7 Structure of compound IV, brunsceramide
Compound IV (Figure 3. 7) was isolated as an orange amorphous material. The highest peak in
the mass spectrum occurred at m/z 533 and the odd number suggested the presence of a
nitrogen atom. The presence of a carbonyl group carbon resonance at Oc 175.1 in the 13C NMR
spectrum and peaks at 3363 and 1643 cm·1 in the IR spectrum, indicated the possible presence
of an amide. The presence of a secondary amide was further suggested by a correlation in the
HMBC spectrum between the carbonyl resonance and a one proton doublet resonance at OH 7.19
(d, 7.7 Hz) which disappeared on re-running the 1H NMR spectrum in deuterated methanol,
indicating a NH group.
The COSY spectrum was useful in determining the type of compound present. The N-t!
resonance showed coupling in the COSY spectrum to a one proton multiplet at OH 3.93 (H-2)
which was seen to be coupled to two non - equivalent oxymethylene protons at OH 3.88 (m) and
3.72 (brd, 7.9 Hz, 2H-1) and an oxymethine proton resonance at OH 4.27 (m, H-3). The
oxymethine proton resonance showed further coupling to an alkene proton resonance at OH
5.51(dd, 6.3, 15.4 Hz, H-4) which was further coupled to a second alkene proton at 5.78 (brd,
15.4 Hz, H-5). This proton of the second alkene group proton was seen to be coupled to protons
of a methylene group at OH 2.10 (brs, 2H-6). In turn these methylene group protons were seen to
be coupled to the proton of a second double bond at OH 5.32 (m) (H-7). The large coupling
constants of 15.4 Hz between the olefinic protons of H-4 and H-5 and the coupling constant of
approximately 13 Hz between H-7 andH-8 (although this was difficult to determine accurately due
to the H-7/H-8 resonances being very close to each other) indicated that both double bonds were
of the E configuration..This led to the following partial structure being suggested from the NMR
data (Figure 3.8).
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HO
Figure 3. 8 Partial structure of compound IV based on NMR data
A literature search based on the above partial structure (Figure 3.8) indicated the compound to
be a ceramide type. Ceramides contain a C-18 sphingosine chain base and hence the following
partial structure could be tentatively deduced (Figure 3.9).
HO
A (m/z 298)
Figure 3. 9 Partial structure of compound IV including sphingosine chain base
Lee et al. have undertaken extensive investigations on the fragmentation patterns in the mass
spectra of ceramides.2o Their studies indicate the presence of two major peaks in the mass
spectrum of ceramides. The fragments are shown as A and B on the structure below (Figure
3.10). These two fragments must differ in mass by 17 mass units.
Figure 3.10 Typical fragmentation pattern of a ceramide 20,21
Peaks differing in 17 mass units were found at m/z 314 and m/z 297 in the mass spectrum of
compound IV. If one takes off the mass of 70 required for the fragment below (Figure 3.11) from
297 a mass of 227 remains.
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Figure 3. 11 Showing the known partial structure of compound IV
This corresponds to a molecular formula of C1sH31 0 indicating one of the carbons of the lower
chain to have a hydroxy group attached. The presence of a hydroxy group on this chain was
further indicated by a unassigned double doublet at OH 4.10 (dd, 3.8, 8.1 Hz) in the 1H NMR
spectrum which showed coupling to only one methylene group in the COSY spectrum, so it was
placed at C-2'. Thus the overall proposed structure is shown below (Figure 3.12).
OH
HO
Figure 3. 12 Proposed structure of compound IV
In order to confirm the proposed structure the mass spectrum was re-examined again. The
proposed structure requires a molecular ion peak at m/z 551. The highest peak in the mass
spectrum occurred at m/z 533, indicating the loss of a unit of water.
A literature search for these type of compounds showed that three related compounds, two with a
C-2' hydroxy group, have been found previously in higher plants, from Physalis philadelphica
(Solanaceae) (Figure 3.13).22
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Figure 3. 13 Ceramides isolated from Physalis philadelphica 22
In the ElMS of the three compounds, the molecular ion peak is very small, occurring at a relative
abundance of 2% (A), 3% (B) and 0.8% (C) respectively. It is therefore likely that the molecular
ion was not detected in the ElMS of compound IV.
The stereochemistry of the three chiral centres, C-2, C-3 and C-3', could not be determined due
to insufficient amounts of the compound remaining for the preparation of Mosher esters.
However, from literature studies, compounds isolated previously all had the 25, 35, 2'R
stereochemistry. 22,26. Re-isolation of brunsceramide is required to confirm the stereochemistry.
Ceramides have been isolated previously from sponges, 23-25 sea stars, 26-27 gorgonians, 21 and
green algae.26 To the best of our knowledge this is the first report of the isolation of ceramides
from a plant of the genus Brunsvigia or the family Amaryllidaceae. The HMBC, COSY and
NOESY data are shown for the key functional groups in Table 3.4
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1 13Table 3.4: H, C, HMBC, COSY and NOESY data for brunsceramide (CDCI3)
CARBON aH ac HMBC COSY NOESY
(C-+H)
1a 3.88 (m) 1b;2 1b;2
62.1 3
1b 3.72 (brd, 7.9) 1a;2 1a;2
2 3.93 (m) 54.3 3 1a,b;N-.!::!.;3 1a,b;2
3 4.27 (m) 74.2 1;4;5 2;4 2;4;5
4 5.51 (dd,6.3,15.4) 128.9 6 3;5 3;6
5 5.78 (d, 15,4) 133.7 6 4;6 3;6
6 2.10 (brs) 26.7 7;8 5;7 4;6;7
7 5.32 (m)* 128.4 6;9 6 6
8 5.38 (dd, 6.3,15.1)* 130.9 6;9 9 9
9 2.00 27.3 7;8 8;10 8
1' 175.1 N-.!::!.
2' 4.10 (3.8,8.1,4.3) 72.4 3'
3'a 1.54 (m) 2';3'b 3'b
34.74
3'b 1.64 (m) 2';3'a 3'a
N-H 7.19 (d, 7.7 Hz) 2
* Difficult to determine J due to peak overlapping.
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3.3 Foreword to Experimental
3.3.1 Nuclear Magnetic Resonance Spectroscopy (NMR Spectroscopy)
Nuclear magnetic resonance spectroscopy was carried out on either a 400 MHz Varian UNITY-
INOVA spectrophotometer or a 300 MHz Gemini spectrophotometer. All spectra were recorded
at room temperature in either deuterated chloroform (CDCI3), deuterated methanol (CD30D), or
deuterated pyridine (CsDsN). The chemical shifts were all recorded in ppm relative to TMS.
3.3.2 Infrared Spectroscopy (I.R. Spectroscopy)
The infra-red spectra were recorded using a Nicolet Impact 400D Fourier-Transform Infra-Red
(Ft-IR) spectrometer. The crystalline compounds were analysed using KBr discs and the non-
crystalline samples were dissolved in dichloromethane and analysed on a sodium chloride
window. The spectra were calibrated against an air background.
3.3.3 Ultraviolet Absorption Spectroscopy (U.V. Spectroscopy)
The ultra-violet absorption spectra were obtained on a Varian DMS 300 UV-visible spectrometer.
The solvent in which the spectra were recorded was methanol. The NaOAc and AICI3 solutions
used for bathochromic shifts were prepared by dissolVing 0.5 g of each salt (anhydrous) in 100 ml
volumetric flasks with methanol.
3.3.4 Melting Points
Melting points for crystalline compounds isolated were determined on an Emst Leitz Weltzlar
melting point apparatus and are uncorrected.
3.3.5 Mass Spectrometry
All low-resolution mass spectra were recorded on an Agilent MS 5973 instrument connected to a
GC 6890 by Mr B. Parel or myself. High-resolution mass spectra were recorded on a Micromass
VG 70 SEQ operated at 8kV in Cl mode by Mr T. van der Merwe.
3.3.6 Optical Rotations
Optical rotations were recorded at room temperature in methanol on a Perkin Elmer polarimeter
(Model 341).
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3.3.7 Circular dichroism
CD spectra were recorded using a Jasco J700 spectro-polarimeter at the Department de
Products Naturals, Facultat de Pharmacia, at the University of Barcelona, Spain and at the
Department of Chemistry at the University of the Free State.
3.3.8 General Chromatography
The isolation process involved column and thin layer chromatographic techniques. In column
chromatography, different sized columns were used ranging from 2-8 cm in diameter, depending
on the amount of sample available and the purification stage. Separation of crude extracts was
generally carried out on a column using Merck Art. 9385 silica gel. Final purifications were found
to be most successful when use was made of open 0.75 cm diameter Pasteur pipettes as
columns for the alkaloids and Sephadex for the glycosides. All separations were carried out
under gravity. Both the column and thin layer techniques made use of varying ratios of
dichloromethane, ethyl acetate, hexane and methanol. Sephadex columns were eluted using
methanol as the solvent. Thin layer chromatography was carried out on 0.2 mm silica gel,
aluminium-backed plates (Merck Art. 5554). The plates were first viewed under UV and then
developed using an anisaldehyde: cone. H2S04: methanol [1 :2:97] spray reagent. The plates
were first analysed underUV light (366 nm) and then heated. The alkaloid compounds were
sprayed with Dragendorff reagent: basic bismuth nitrate (1.7 g) dissolved in a mixture of acetic
acid (20 ml) and water (80 ml) (solution a); potassium iodide (16 g) in water (40 ml) (solution b); a
and b are mixed 1: 1 (v/v) (stock solution - may be kept for several months in a refrigerator); for
spraying: stock solution (1 ml) is mixed with acetic acid (2 ml) and water (10 ml). Colour reaction:
orange-brown spots on a yellow background for alkaloids.
3.3.9 Preparative Thin Layer Chromatography (PTLC)
Compounds, which were visible under UV light, were isolated using this technique. The
aluminium-backed plates (Merck Art. 5554) were lined with the extract sample 1 cm from the
bottom of the plate. The plates were loaded by dipping a capillary tube in the extract solution and
allowing it to run onto the silica gel by touching it to the plates. The plates were then developed
in a chromatography tank and the compound of interest was detected using UV light. The
marked portion was cut out, boiled in methanol and dichloromethane and filtered to remove the
silica gel from the filtrate containing the compound of interest.
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Pyridine (1 ml) and acetic anhydride (1 ml) were added to the sample (20 mg) in a round-
bottomed flask. The sample was left to stand for 48 hours. Methanol (5 ml) was then added to
the sample to react with the excess acetic anhydride, and toluene (4x10 ml) was added
successively to remove pyridine. After each addition. the solvent was evaporated off under
reduced pressure. Thereafter, methanol (5x10 ml) was added to remove the toluene. The
sample was then spotted on a TLC plate to see whether the reaction had gone to completion or
needed to be purified.
3.3.11 Anti-Cancer Screening
CSIR Biochemtek in Pretoria carried out this screening under the supervision of Dr V. Maharaj.
The three cell lines utilised were MCF7 (breast), TK10 (renal) and UACC62 (melanoma). The
method employed was obtained from the National Cancer Institute webpage. 12
The cell lines are grown in RPMI 1640 medium containing 5% fetal bovine serum and 2 mM L-
glutamine. Cells are inoculated into 96-well flat bottom, polystyrene plates in 180 IJL at plating
densities ranging from 5,000 to 40,000 cells/well depending on the doubling time of individual cell
lines. 1 Each cell line is plated on duplicate plates. After cell inoculation, the microtiter plates are
incubated at 37°C, 5% C02, 95% air and 100% relative humidity for 24 h prior to addition of
experimental drugs.12
After 24 hours, the plates of each cell line are fixed in situ with time course assay (TCA), to
represent a measurement of the cell population for each cell line at the time of drug addition.
Experimental drugs are solubilized in dimethyl sulfoxide at 400-fold the desired final maximum
test concentration and stored frozen prior to use. Compounds are diluted in complete media with
0.1 % Gentamicin sulfate and dispensed into wells in a volume of 20 fJl to yield a test
concentration of 100 fJg/ml. NSC 123127 (Adriamycin) is used as the standard and is included
into each plate.12
Cells are fixed in situ by the addition of cold TCA (final concentration 10 % TCA) and incubated
for 60 minutes at 4°C. The supernatant is discarded, plates washed five times with tap water and
air-dried. SRB at a 0.4 % (w/v) in 1 % acetic acid is added to each well and the plates are
incubated for 10 minutes at room temperature.12 Unbound dye is removed by washing six times
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with 1 % acetic acid and the plates are air-dried. Bound sulforhodamine B (SRB) is solubilized
with 10 mM trizma base and the absorbance is measured at a wavelength of 515 mm.1
3.3.12 Inflammatory and Microsomal Screening
Anti-inflammatory screening was carried out by a fellow member of the group, Karen du Toit, in
Prof. J. Van Staden's laboratory at the University of Kwa-Zulu Natal in Pietermaritzburg. The
method used was extracted from Jager et al. 13 The procedure was carried out at 4°C. Sheep
seminal vesicles were homogenised in 150 ml 0.1 M K-Pi, pH 7.4, containing 1 mM
ethylenediaminetetraacetic acid (EDTA). The homogenate was centrifuged at 4000 x 9 for 15
min; the supematant was further centrifuged at 17000 x g for 10 min. The microsomes were
isolated by centrifugation at 100 000 x 9 for 1 hour. The microsomal pellet was resuspended in
0.1 M K-Pi, pH 7.4 and adjusted to 10 mg protein/ml. Aliquots were stored at -70°C. Protein
determinations were performed with the Bio-Rad Protein assay kit.
The bioassays were performed according to the method of White and Glassman.14 Ten
. microlitres (0.3 pg protein) of sheep seminal vesicle microsomes and 50 pi f co-factor solution (L-
adrenalin and reduced glutathione, 0.3 mglml each in 0.1 M Tris buffer, pH 8.2) were
preincubated in an ice bath for 15 min. Twenty microlitres of solvent, test solution or standard
solution (20 pi of aqueous solutions; 2.5 pi of ethanolic solutions + 17.5 pi water; 2.5 pi of a 8 x
10-4 M ethanolic indomethacin solution + 17.5 pi water) and 20 pi C4C]arachidonic acid (16
Ci/mole, 30 mM) were added and the assay mixture incubated at 37°C for 10 min. the reaction
was terminated by adding 10 pi 2 N HCI. A blank was kept in the ice bath. After incubation 5 pi
of a 0.2 mg/ml carrier solution of unlabelled prostaglandins (PGE2: PGF2 1:1) was added. The
prostaglandins were separated from unmetabolised arachidonic acid by column chromatography
into scintillation vials. After mixing with scintillation solution the radioactivity was counted. The
experiments were carried out in duplicate.
3.4 Experimental
Brunsvigia natalensis Baker was collected near Belfast, Mpumalanga, South Africa and a voucher
specimen retained (N. Crouch 865, NH).
The bulbs (4.2 kg) were dried, chopped into smaller pieces, and extracted successively with
dichloromethane and methanol by agitation on a Labcon Mechanical shaker at 140 rpm. The
extracts obtained were then filtered and the solvent removed under reduced pressure. A
dichloromethane extract (32.71 g) and methanol extract (100.9 g) were thus obtained. 1H NMR
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analysis of the crude methanol extracts revealed nothing of interest and the extract was not
investigated further.
The dichloromethane extract was loaded onto a 5 cm diameter column and eluted with a step
gradient solvent system collecting 50 ml fractions at a time (100% dichloromethane fractions 1-
27; 10% ethyl acetate in dichloromethane fractions 28-51; 20% ethyl acetate in dichloromethane
fractions 52-80; 40% ethyl acetate in dichloromethane fractions 81-91; 80% ethyl acetate in
dichloromethane fractions 92-110; 100% ethyl acetate fractions 117-139, 1% methanol in
dichloromethane fractions 140-165; 2% methanol in dichloromethane fractions 166-242; 5%
methanol in dichloromethane fractions 243-269; 10% methanol in dichloromethane fractions 270-
293; 20% methanol in dichloromethane fractions 294-321). Purification of fractions 215-232
using a 2% methanol in dichloromethane solvent system afforded compound I at a yield of 0.8%
(39.0 mg) and compound II, at a yield of 0.2% (10.3 mg). Purification of fraction 11-16 using a
5% ethyl acetate in dichloromethane solvent system afforded a partially pure compound Ill.
Preparative TLC using a 10% ethyl acetate afforded pure compound Ill, at a yield of 1.3% (67.2
mg). Purification of fractions 166-186 using a 5% methanol in dichloromethane solvent system
afforded compound IV at a yield of 0.4% (20 mg).
3.4.1 Physical data for Compound I
Name: nivanine A, 11-Dehydroxycrinamine
Yield: 39.0 mg
Physical description: orange amorphous material
Optical rotation: +68.91 (c, 0.534 in methanol)
Mass spectrum: HRMS: [M+] at rnIz 285.13782, C17H19N03requires 285.136494 g. mor
1
ElMS rnIz: 285,270,230,215,198,128,115,68
CDnm:486,467,441,418, 388, 372, 346,323,303,279,250,213
Infrared: v~I cm'1: 3384 (O-H stretching), 2922 (C-H stretching), 1492 (aromatic C=C
stretching), 1239 (C-N stretching) and 1039 (C-O stretching)
1H NMR: OH (ppm) CDCI3: Table 3.1
13C NMR: Oc (ppm) CDCI3: Table 3.1
3.4.2 Physical data for Compound IT
Name: nivanine B, 4a-acetyl-2-deacetyl-1 J3-methoxyjosephinine
Yield: 10.3 mg
Physical description: white amorphous material
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Optical rotation: +19.84 (c, 0.126 in methanol)
Mass spectrum: GC-MS: [M+] at m/z 361, C16H140S requires 361.152538 g. mor1
ElMS m/z: 361,331,317,288,234,204,191,133,115,43,103,89,77,43
CD nm: 470, 460, 450, 441, 428, 411, 387, 343, 308,285,248
Infrared: v;;::1 cm-I: 3437 (O-H stretching), 2949 (C-H stretching), 1727 (C=O stretching), 1472
(aromatic C=C stretching) and 1262 (C-N stretching)
1H NMR: OH (ppm) CDCI3: Table 3.2
13C NMR: Oc (ppm) CDCI3: Table 3.2
3.4.3 Physical data for Compound III
Name: 7-hydroxyflavan
Yield: 67.2 mg
Physical description: orange-brown amorphous material
Mass spectrum: GC-MS: [M+] at 226 g. mor1requires a mass of 226.099380 g. mor1
ElMS m/z: 226,197,165,135,104,71,51
CDnm:293,286,282,274,265.261,255,251,242,238,234,227,223
Infrared: v;;::1 cm-1: 3380 (O-H stretching), 2926 (C-H stretching), 1627 (C=O stretching), 1503,
1414 (aromatic C=C stretching), 1305 (C-N stretching) and 1155 (C-O stretching)
l H NMR: OH (ppm) CDCI3: Table 3.3
13C NMR: Oc (ppm) CDCI3: Table 3.3




Physical description: brownish-yellow amorphous material
Optical rotation: -1.95 (c, 0.128 in methanol)
Mass spectrum: [M+] not found, C34H6SN04 requires 551.491360 g. mor1
ElMS m/z: 533 [M+-H20l, 336, 314, 297, 266, 149, 109,83,60 .
Infrared: v;;::1 cm-I: 3362 (O-H stretching), 2921, 2854 (C-H stretching)
l H NMR: OH (ppm) CDCI3: Table 3.4
13C NMR: Oc (ppm) CDCI3: Table 3.4
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Crinum stuhlmannii
4.1 Introduction
Crinum stuhlmannii Baker (syn. C. delagoense I.Verd.) belongs to the Amaryllidaceae family.
This family has nine tribes of which two, the Amaryllideae and Haemantheae, occur in southern
Africa. The genus Crinum L., with its twenty-three regional species, has been placed in the
Amaryllideae. 1
Crinum stuhlmannii (Figure 4. 1) is known in Zulu as umnduze, and in English as the Candy-
striped Crinum?,3 The original name 'delagoense' comes from Delagoa Bay which was thought
to be the closest civilized point to the site of its discovery.4 It is distributed in southern Africa from
northern KwaZulu-Natal through to coastal Mozambique.3 It usually occurs in grassland,
bushveld and on sandy soils. The bulbs may reach 220 mm in diameter.3 It is used in traditional
medicine to treat urinary tract problems.2 Unspecified parts are used medicinally for the
treatment of cattle.2 All members of the Crinum genus are considered capable of causing
dermatitis?
Figure 4. 1 Crinum stuhlnumnii, Photo: Neil Crouch
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This present study was undertaken as a previous one by Nair et a/.5 reported on the constituents
of plants collected from a region (Natal Midlands) not likely to accomodate Crinum delagoense.
As the botanical voucher proved untraceable, an attempt was made to verify the earlier report.
Six alkaloids were isolated in the previous study as shown in Figure 4.2.5
OH












Figure 4.2 Compounds isolated previously from Crinum stuhlmannU s
Secondly, a comparative study of the bulbs and seeds was carried out to identify organ-specific
production of chemical constituents. This led to the isolation of eleven alkaloids (Figure 4. 3).
The compounds isolated were Iycorine (compound V), 8,9-methylenedioxophenanthridine
(compound VI), 6-hydroxycrinamine (compound VII), 6-ethoxycrinamine (compound VIll),
haemanthamine (compound IX), hamayne (compound X), stuhlmanine A (compound XI),
stuhlmanine Band C (compound XllA and XllB), N-methyldelagoenine (compound XIII), and
stuhlmanine 0 (compound XIV).
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Figure 4. 3 Compounds isolated, in this study, from Crinum stuhlmannii
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4.2 Results and Discussion
4.2.1 Structural Elucidation of Compound V, Lycorine (spectra 5.a-h)
OH
Figure 4. 4 Structure of compound V, Iycorine
Compound V (Figure 4. 4) was isolated as a white crystalline material with a melting point of 244-
247°C. This compound was found to have a molar mass of 287 g. mor1 corresponding to a
molecular formula of C16H17N04'
Compound V was identified based on its NMR data as .Iycorine. It is insoluble in most organic
solvents, which makes it difficult when one compares NMR data, as the NMR data tends to be
reported in the literature in different solvent mixtures. The substitution pattern on the A ring was
confirmed in the 1H NMR spectrum by the presence of two para orientated aromatic protons and-_ .. -- _.,
a two proton resonance at OH 5.75, which is typical of protons of a methylenedioxy group. Other
characteristic features observed in the 1H NMR spectrum included a broad singlet in the olefinic
region assigned to H-3 (OH 5.80), the pair of doublets for the 2H-7 methylene protons (OH7a 3.30,
OH7P 3.98, 14.0 Hz). The multiplet at OH 3.11 and the double doublet at OH 2.08 (dd, 8.4, 17.6 Hz)
were attributed to the two H-5 proton resonances. The resonance for the 2H-4 protons appeared
at OH 2.41, superimposed as a multiplet. The resonances ascribed to H-1 and H-2 were found at
OH 5.09 and 4.82 respectively, with corresponding carbon resonances at oe 73.43 and 72.22
respectively indicating the presence of oxygen substituents which were determined to be hydroxy
substituents from the molecular formula. The H-11b resonance was found to occur as a doublet
at OH 3.23 (d, 10.6 Hz). The resonance ascribed to H-11 c appeared as a multiplet at OH 3.19.
The H-11 b resonance has a p configuration on biosynthetic grounds and it showed a correlation
in the NOESY spectrum with the H-1 resonance indicating the orientation of the H-1 atom to be p.
The HMBC, COSY and NOESY data are provided in Table 4.1.
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The infrared data supported the postulated alkaloid structure for compound V. Peaks were
observed at 3333 cm-1 (O-H stretching), 2957 cm-1 (aliphatic C-H stretching), 1056 cm-1 (C-O
stretching).
A literature search for the compound indicated that it was Iycorine, a common alkaloid previously
isolated from Crinum augustum, Crinum amabile and Crinum stuhlmannii and numerous other
members of the Amaryllidaceae family.5-8 Comparison of the 13C NMR spectra (Table 4.1)
proved to be quite difficult as they are often run in different solvents.
Figure 4. 5 Structure of Iycorine di-acetate (VA)
Acetylation of Iycorine (V) afforded the di-acetate (VA). The 1H NMR spectrum of the dj-acetate
showed the downfield shift of H-1 from OH 5.09 to 5.72. The H-2 resonance also shifted downfield
from OH 4.82 to 5.23. This confirmed that acetylation occurred at both positions 1 and 2 of ring C.
Further evidence of the formation of the dj-acetate was the two singlet methyl resonances at OH
1.93 and OH 2.06. Comparison of the 13C NMR data of the acetate to that of 1,2-di-O-
acetyllycorine (Table 4.2) however did show discrepancies. 16
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Table 4.1: 1H, 13C, HMBC, COSY and NOESY data for Iycorine (CsDsN)
OH &: &: HMBC
Carbon COSY NOESY
(ppm) (ppm) (ppm) (C~H)
1 5.09 (s) 73.43 70.21 2;11b 2;11;11b
2 4.82 (brs) 72.22 71.72 1 3 1;3
3 5.80 (brs) 119.56 118.48 1 2;4a.,~ 2;4a.,~
3a 143.01 141.68 4a.,~;5~,11b;11 C
4a,p 2.41 (m) 28.99 28.13 5a. 3;5a.,~ 3
Sa 2.08 (dd, 8.4,17.6 Hz) 4a.,~;5~ 4a.,~;5~;7a.
·54.15 53.31 7a.
Sp 3.11 (m)l; 4a.,~;5a. 4a.,~;5a.;7~
70. 3.30 (d, 14.0 Hz) 7~ 5a.;7~;11c
57.62 56.73 5a.,8
7P 3.98 (d, 14.0 Hz) 7a. 7a.;8
la 130.72° 129.69 8;11
8 6.52 (s) 107.55 107.01 7a.,f3;11 7~
9 146.673 145.20 8;11
10 146.193 145.65 8;11
11 7.10 (s) 106.07 105.06 8 1
11a 130.54° 129.57 8;11
11b 3.23 (d, 10.6 Hz) 41.91 40.18 1;11 1 1
11c 3.19 (m)L; 62.03 60.83 1;5f3;7f3;11b 7a.
OCH20 5.75 (dd, 7.3, 1.3 Hz) 101.13 100.57
3 13C NMR resonance values interchangeable.
b 13C NMR resonance values interchangeable.
C Resonance obscured; J values could not be determined.
* Literature spectra run in DMSO-d6.
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313C NMR resonance values interchangeable.
b 13C NMR resonance values interchangeable.
c 13C NMR resonance values interchangeable.
* Literature spectra run in CDC13.
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Figure 4. 6 Structure of compound VI, trisphaeridine
This compound (Figure 4.5) was isolated as fine yellow needle-like crystals with a melting point
of 138-140°C. Compound VI was found to have a molar mass of 223 g. mor1corresponding to a
molecular formula of C14H9N02• This compound was identified using the mass and NMR spectra.
The NMR spectra of compound VI proved to be quite interesting with peaks observed only
downfield of 6 ppm. The substitution pattern on the A ring was confirmed through the presence of
two para orientated aromatic protons (OH 7.34, H-7; OH 7.92, H-10) and a resonance at OH 6.17
(2H), for protons of the methylenedioxy group, in the l H NMR spectrum. Other features observed
in the 1H NMR spectrum were four coupled aromatic proton signals, which included a pair of
double doublets for H-1 (OH 8.38, dd, 1.3, 8.0 Hz) and H-4 (OH 8.18, dd, 1.5, 8.2 Hz) and multiplets
for the H-2 (OH 7.63) and H-3 (OH 7.68) aromatic ring C protons. The remaining signal at OH 9.09 in
the proton NMR spectrum was found to a be an iminic proton singlet which corresponded to a
peak at Oc 151.25 in the 13C NMR spectrum this was assigned to H-6 and hence a double bond
was placed between C-6 and the nitrogen atom. The HMBC, COSY and NOESY data are
provided in Table 4.2.
A literature search for the compound indicated that it was 8,9-methylenedioxophenanthridine (VI)
(trisphaeridine), previously isolated from Lapierdra martinezii (Amaryllidaceae).9 The 13C NMR
data is not provided in the literature, however, the 1H NMR data was given and is shown in Table
4.3. The 1H NMR data obtained proved to be close to literature values.
63
Chapter 4: A Comparative Study ofthe Bulbs and
Seeds ofCrinum stuhlmannii
Table 4.3: 1H, 13C, HMBC, COSY and NOESY data for, 8,9-methylenedioxophenanthridine
(CDCI3)
liH liH- lie HMBC
Carbon COSY NOESY
(ppm) (ppm) (ppm) (C~H)
1 8.38 (dd, 1.3, 8.0 Hz) 8.36 122.04 3 2 2;10
2 7.63 (m) 7.61 126.94 4 1;3 3;1
3 7.68 (m) 7.67 128.27 1 2;4 2,4
4 8.18 (dd, 1.5, 8.2) 8.11 129.48 2 3 3
4a -130a 1
6 9.09 (s) 9.06 151.25 7 7
6a 122.88 6,10
7 7.34 (s) 7.32 105.65 6 6
8 -152a,u 7;10;OCH2O
9 148.37° 7;10;OCH2O
10 7.92 (s) 7.89 100.02 1
10a - 130.63 6;7
10b - 124.30 10
OCH2O 6.17(s) 6.15 102.05
a Exact carbon values could not be determined as resonances were very weak and could only be
detected through HMBC correlations to these peaks.
b 13C NMR resonance values interchangeable.
* Literature spectra run in CDCI3.
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4.2.3 Structural Elucidation of Compound VII, 6-Hydroxycrinamine (spectra 7.a-j)
Figure 4. 7 Structure of compound VII, 6-hydroxycrinamine
Compound VII (Figure 4. 7), was isolated as white crystals with a melting point of 142-144°C.
This compound was found to have a molar mass of 317 g. mor1 corresponding to a molecular
formula of C17H19NOs. It was identified on the basis of the NMR data and found to be a 5,1 Ob-
ethanophenanthridine type of alkaloid, which was isolated as an inseparable mixture of the two C-
6 epimers. This was indicated by the pairing of some of the peaks in the 13C NMR spectrum.
Assignment of resonances for the major epimer has been done only, as the minor epimer was
present in very low amounts and resonances were very hard to assign. With the aid of the
NOESY spectrum it was determined that the major epimer contained the 6~-OH group and the
minor, the 6a-OH group.
Resonances in the 1H NMR spectrum due to two para orientated aromatic protons (OH 6.75 (s), H-
7), OH 6.84 (s), H-10) and a two proton resonance at OH 5.89, which is typical of protons of a
methylenedioxy group, confirmed the A ring to have only two unsubstituted positions. Other
characteristic features observed in the 1H NMR spectrum included a double doublet resonance
(OH 6.28, 2.2 and 10.3 Hz) and doublet resonance (OH 6.09, 10.3 Hz) in the olefinic region
assigned to H-1 and H-2 respectively of a 1,2-double bond and a methoxy group singlet proton
resonance at OH 3.39. The absence of an AB splitting pattern for the methylene proton at about 4
ppm, which is seen for all C-6 unsaturated crinane alkaloids confirmed the substituted nature of
C_6. 10 The HMBC spectrum showed 3J correlations from C-7 and C-10a to a resonance at OH
4.96, which was seen in the HSQC spectrum to correspond to a carbon resonance at Oc 88.94
and, hence, a hydroxy group was placed at C-6. Another typical resonance was a double doublet
at OH 3.56 (dd, 4.0 and 13.6 Hz) which was assigned to the H-4a resonance.10 The HMBC
spectrum showed 3J correlations from C-6 and C-4a to the resonances at OH 3.15 (dd, 3.6, 14.3
Hz) and 3.43 (dd, 3.3, 6.2 Hz), which corresponded to a methylene carbon resonance of Oc
58.92, in the HSQC spectrum. This resonance was assigned to C-12, one of the two carbons of
the bridge. The downfield shift in the resonance can be attributed to the adjacent nitrogen atom.
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The second bridging carbon was identified through a correlation in the COSY spectrum between
the H-11 (OH 3.85) and 2H-12 (OH 3.15 and 3.43) resonances. The corresponding oxymethine C-
11 carbon resonance at Oc 79.42, was assigned to C-11.
Circular dichroism was used to determine the absolute configuration of the 5,10b-ethano bridge.
A positive Cotton effect was observed at 276 nm followed by a negative Cotton effect at 251 nm,
which indicated the bridge was of the a configuration since negative Cotton effects are typically
observed at 250 nm for the a orientated series.1Q..12,17-18 An HMBC 3J correlation from C-3, which
occurred at Oc 77.87, to the methoxy group proton resonance at OH 3.39 indicated the methoxy
substituent to be present at C-3. The orientation of the methoxy group was determined to be a,
since the H-2 resonance was split into a doublet (see section 3.2.1 for explanation).1Q..12
The orientation of the bridge substituents was determined using the NOESY spectrum. A
correlation between the H-10 resonance and the H-11 resonances indicated H-11 to be endo and
the hydroxy substituent on C-11 to be exo. A further correlation in the NOESY spectrum from the
H-11 endo resonance to the H-12 resonance at OH 3.43 indicated it to be endo. The H-12 endo
resonance showed a correlation in the NOESY spectrum to the H-6 resonance and this could
only have been H-6a with the hydroxy group at C-6~. This implied the major epimer isolated
contained the hydroxy group at C-6~.
The infra-red data supported the alkaloid structure for compound vn. Peaks were observed at
3411 cm-1 (O-H stretching), 2893 cm-1 and 2821 (aliphatic C-H stretching), 1488 cm-1 (aromatic
C=C stretching), 1248 (C-N stretching) and 1042 cm-1(C-O stretching). These assignments were
confirmed by the HMBC, NOESY and COSY spectra and are listed in Table 4.4.
A literature search for the compound identified it as 6-hydroxycrinamine previously isolated from
Brunsvigia orientalis and also the from the bulbs of Crinum delagoense as reported by Nair et
al.
5
,13 However there was one major discrepancy in current assignments compared to literature.
The resonances earlier assigned to H-1, C-1 and H-2, C-2 13 are opposite to what is here
assigned to compound VII. The assignment of H-1, in compound vn, was confirmed through an
HMBC correlation to C-3 and a correlation in the NOESY spectrum to H-10. The assignment of
H-2 was confirmed through a correlation in the NOESY spectrum to the H-3 resonance and
methoxy group proton resonance. The literature assignment requires correction.
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Table 4.4: 1H, 13C, HMBC, COSY and NOESY data for 6.hydroxycrinamine (CD30D)
5H ()c ()c* ()c.. HMBC
Carbon COSY NOESY
(ppm) (ppm) (ppm) (ppm) (C~H)
1 6.28 (dd, 2.2, 10.3 Hz) 125.75 136.4 136.2 2;3 2 2;10
2 6.09 (d, 10.3 Hz) 134.37 123.0 123.2 1;3;4~ 1 1;3;3-0CH3
3 4.07 (m) 77.87 75.9 75.6 1;3-0CH3;4a,~ 4a,~ 2;4~;4a
4a 2.12 (m) 3;4a,~;4a 4~
30.41 29.4 29.4 2;4a
413 2.00 (m) 3;4a;4a 3;4a;4a, 12exo
4a 3.56 (dd, 4.0,13.6 Hz) 61.80 59.5 64.8 1;4a,~;6;12endo 4a,~ 3;4~
6 4.96 (5) 88.94 88.0 85.5 4a;7;12exo.endo 7;12endo
6a 129.22 127.3 128.8 6;10
7 6.75 (5) 110.29 109.5 108.3 6;10 6
8a 149.24 146.5 146.7 7;10;OCH2O
9a 147.69 147.8 147.5 7;10;OCH2O
10 6.84 (5) 103.77 102.8 102.7 1;11
10a 138.52 135.8 134.6 4a;6;7;11
10b 51.81 50.4 50.8 2;4a,~;10;12endo
11 endo 3.85 (m) 79.61 78.1 79.0 4a;12exo 12exo,endo 10;12endo------
12exo 3.15 (dd, 3.6, 14.3 Hz) 11 ;12endo 12exo,endo
58.92 57.7 51.8 4a;6
12endo 3.43 (3.3, 6.2 Hz) 11;12exo 6;11;12exo
OCH20 5.89 (5) 102.43 101.1 101.1
3-0CH3 3.39 (5) 55.81 55.9 55.9 3 2
* Literature spectra run in CDCI3with H_6a.
13
** Literature spectra run in CDCI3with H_6~.13
a 13C NMR resonance values interchangeable.
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4.2.4 Structural Elucidation of Compound VUI, 6~·Ethoxycrinamine(spectra 8.a-j)
Figure 4. 8 Structure of compound VID, 6j3-ethoxycrinamine
Compound VUI (Figure 4. 8), was isolated as a brownish amorphous material. The Cl mass
spectrum showed a [M+Hr peak at rn/z 346 g. mor1. Chemical ionisation mass spectra show
peaks at one mass unit higher than those expected in electron impact. It was identified on the
basis of the NMR data and found to be a 5,1 Ob-ethanophenanthridine type of alkaloid. This
compound was found to be closely related to 6-hydroxycrinamine with the presence of an ethoxy
group at C-6 instead of an hydroxyl group as found in 6-hydroxycrinamine.
The absence of an AB splitting pattern for the methylene proton at about 4 ppm, which is seen for
all C-6 unsaturated crinane alkaloids confirmed the substituted nature of C_6.10 The HMBC
I
spectrum showed a 3J correlations from C-7 and C-10a to a resonance at OH 4.51 (s), which
corresponded to a carbon resonance of Oc 94.27, in the HSQC spectrum, and indicated the
presence of an oxygen-containing substituent at C-6. The HMBC spectrum showed a 3J HMBC
correlation from the methylene carbon at Oc 64.H to H-6 (OH 4.51). This carbon resonance
corresponds to a pair of coupled proton resonances at 6H3.65 (dd, 2.4, 7.1) and 4.01 (m) in the,
HSQC spectrum. The COSY spectrum shows correlation from the, two methylene proton
resonances at OH 3.65 and 4.01 to the methyl group proton resonance at OH 1.24 (t, 7.1), implying
the presence of an ethoxy group at C-6.
The HMBC spectrum showed 3J correlations from C-6 and C-4a to a 2 proton resonance at OH
. --------3.27 (d, 5.9 Hz), which corresponded to a methylene carbon resonance of Oc 58.47, in the HSQC
spectrum. This resonance was assigned to C-12, one of the two carbons of the bridge. The
downfield shift in the resonance can be attributed to the adjacent nitrogen atom. The second
bridging carbon was identified through a correlation in the COSY spectrum between the H-12 (OH
3.27) and H-11 (OH 3.85, t, 4.8) resonances. The corresponding oxymethine resonance was
found to occur at Oc 78.45, and was assigned to C-11.
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Circular dichroism was used to determine the absolute configuration of the 5,1 Ob-ethano bridge.
A positive Cotton effect was observed at 289 nm, which indicated the bridge was of the a.
configuration since positive Cotton effects are typically observed at 280 nm for the a. orientated
series. lO,12,17-18 An HMBC 3J correlation from C-3, which occurred at Oc 76.10 to the methoxy
group proton resonance at OH 3.39 indicated the methoxy substituent to be present at C-3. The
H-1 and H-2 proton resonances overlapped. From literature, if H-2 is split into a doublet we
should have a coupling constant of 10 Hz and if is split into a double doublet the coupling
constants are 10 and 5 Hz the assumption was made that if it was a double doublet we would
have seen the larger coupling constant however this was not the case and we assumed that H-2
was split into a doublet only.10-12 The orientation of the methoxy group was therefore determined
to be 0.. 10,12
The remaining assignments were completed by comparison to the previous compound (6-
hydroxycrinamine (compound VII)). The compound isolated is believed to be an artefact of the
extraction process, and could have possible formed when ethanol (a standard solvent used for
the extraction of alkaloids) was used during the extraction procedure.
The orientation of the bridge substituents was determined using the NOESY spectrum. A
correlation between the H-10 resonance and the H-11 resonance indicated H-11 to be endo and
the hydroxy substituent on C-11 to be exo. The H-12 resonance showed a correlation in the
NOESY spectrum to the H-6 resonance as this can only be H-60., the ethoxygroup is at C-6~.
This is very similar to compound VII. The major epimer of compound VII has the H-6 also in the
a. orientation. This suggests that the ~-OH form is the more stable form of 6-hydroxycrinamine.
The infra-red data [spectrum] supported the alkaloid structure for compound VIII. Peaks were
observed at 3361 cm'l (O-H stretching), 2925 cm'l (aliphatic C-H stretching), 1479 cm'l (aromatic
C=C stretching), 1248 cm-1(C-N stretching) and 1033 cm'l (C-O stretching).
A literature search for the compound confirmed it not to have been isolated previously and it was
named 6~-ethoxycrinamine. The 1H• 13C, HMBC, NOESY and COSY data are listed in Table 4.5.
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1 6.20 (m)3 123.43 3;4;11 10,11
2 6.21 (m)3 136.43 3,3-0CH3
1;2;3-
3 4.03(m) 76.10 4a,~ 4a;3-0CH3; 4a,~
OCH3;4a,~
2.03 ddd 3;3-0CH3;4a;
4a,~ 29.67 2 2;3;4a
(1.8,9.2,8.8) 12a,~
4a 3.52 (t, 8.8, 9.2) 59.95 1';4a,~;6,12 4 3;4a,~
7; 6a,b-
6 4.51 (s) 94.27 7;12
OCH2CH3;12
6a 126.97 10
7 6.70 (s) 109.51 6 6
8 147.823 OCH2O;7;10
9 146.313 OCH2O;7;10
10 6.72 (s) 102.69 - 1;11
10a 136.43 6;71
10b 50.35 10;1;2
11 3.85 (t, 4.8) 78.45 12 1;10;12
"("-_.-..-
12 3.27 (d,5.9) 58.47 6;11 11 6;11; 4a,~;
-OCH2O- 5188 (dd, 12.8) 101.04









6-0CH2CH3 1.24 (7.1) 15.45 6-0CH2CH3 6-0CH2CH3
3Resonance superimposed J values could not be determined, 2nd order spectrum.
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4.2.5 Structural Elucidation of Compound IX, Haemanthamine (spectra 9.a-i)
o
<o
Figure 4. 9 Structure of compound IX, haemanthamine
Compound IX (Figure 4. 9) was isolated as a yellow amorphous material and identified through
comparison with literature NMR data to be haemanthamine. It was found to have a molar mass
of 301 g. mor1 corresponding to a molecular formula of C17H19N04 and was also a 5,10b-ethano
bridge type of alkaloid.
The substitution pattern on the A ring was similar to the previous compounds isolated with the
presence of only two para orientated aromatic protons (OH 6.52 and 6.89) and a resonance at OH
5.86 (2H), which is typical of a methylenedioxy group, in the 1H NMR spectrum. Other
characteristic features observed in the 1H NMR spectrum included: the AB splitting of the
methylene protons of H-6 at OH 3.76 (d, 16.7Hz) and 4.28 (d, 16.7 HZ),1O th~H-4a resonance at
OH 3.30 (m) and a doublet at OH 6.44 (d, 10.1 Hz) and a double doublet at 6.23 (dd, 4.9, 10.1 Hz)
in the olefinic region assigned to H-1 and H-2 of a 1, 2-double bond. The double doublet
resonance for H-2 implied a trans relationship between the 5,10b-ethano bridge and the
substituent at C_3. 10-12 The G~- resonance (oc 72.98) showed a 3J HMBC correlation to the
methoxy proton group resonance at OH 3.33 and this indicated the methoxy group was attached at
C-3.
Circular dichroism was used to determine the absolute configuration of the 5,10b-ethano bridge.
A positive Cotton effect was observed at 271 nm followed by a negative Cotton effect at 254 nm,
which indicated the bridge was of the a configuration since negative Cotton effects are typically
observed at 250 nm for the a orientated series. 10-12,17-18 Due to a trans relationship between the
bridge and the methoxy group proton, the orientation of the methoxy group attached at C-3 is
13. 10-12
The C-6 resonance showed a 3J HMBC correlation to the methylene protons at OH :h1~ (dd, 3.2,
13.9 Hz) and 3.44 (dd, 7.0, 13.9 Hz) assigned to 2H-12. The 2H-12 proton resonances showed a-_....... ,.
correlation in the COSY spectrum to the resonance at OH 3.94 (m), which had a corresponding
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carbon, seen in the HSQC spectrum at Oc 79.72 indicating the presence of an oxygen substituent
on C-11 and this was deduced to be an hydroxyl substituent from the molecular formula. A
correlation in the NOESY spectrum between the H-10 resonance and the H-11 resonance
indicated H-11 to be endo and the hydroxy substituent on C-11 to be exo. A further correlation in
the NOESY spectrum from the H-11 endo resonance to the H-12 resonance at OH 3.44 indicated
it to be H-12 endo.
The IR data supported the postulated structure with peaks observed at 2928 cm-1 (aliphatic C-H
stretching), 1438 cm-1 (aromatic C=C stretching), 1239 cm-1 (C-N stretching) and 1037 cm-1 (C~O
stretching).
A literature search for the compound identified it as haemanthamine isolated from Scadoxus
puniceus (Haemanthus puniceus L.) and numerous other Amaryllidaceae taxa.8,14 The 1H, 13C,
HMBC, COSY and NOESY data are shown in Table 4.6.
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Table 4.6: 1H, 13C, HMBC, COSY and NOESY data for hamaenthamine (CD30D)
. HMBC
Carbon ~ Bc Bc COSY NOESY
(C-.H)
1 6.44 (d, 10.1 Hz) 127.98 127.3 2;3 2 2;10;11
2 6.23 (dd, 4.9,10.1 Hz) 129.39 131.6 1;3;4p 1;3 1;3;3-0CH3
3 3.85 (m) 72.98 72.7 1;2;4a,p;4a;3-0CH3 2;4a,p 2;4a,p;3-0CH3
4a 2.14 (ddd, 4.2, 9.2,13.5 Hz) 3;4a;4p 3;4P;12exo
27.78 28.1 2;4a;3;3-0CH3
4P 1.97 (ddd, 4.4, 9.0, 13.4 Hz) 3;4a;4a 3;4a;4a
4a 3.30 (m) 67.90 62.6 1;3;4a,p;12endo 4a,p 4P;6P
6a 3.76 (d, 16.7 Hz) 6P;7. 6p,7;12endO
60.36 61.2 4a;7; 12exo, endo
6P 4.28 (d, 16.7 Hz) 00;7 4a;6a;7
6a 125.21 126.5 6a,p;10
7 6.52 (5) 106.66 106.7 6a,p;10 6a,p 6a,p
8 147.00· 146.3 .6a,p;7;10;OCH20
.9 146.52D 146.0 7;10;OCH20
10 6.89 (5) 103.11 103.2 6a,p;7 1;11




11 3.94 (m) 79.72 80.0 4a;6a,p;12exo 12exo, end 1;10;12enoo
12enoo 3.44 (dd, 7.0, 13.9 Hz)
11 ;
6a;11 ;12exo
62.57 63.5 4a;6a,p 12endo
12exo 3.14 (dd.3.2, 13.9 Hz) 11 ;12exo 4a;12exo
-OCH20- 5.86 (5) 55.61 100.7
3-0CH3 3.33 (5) 55.61 56.5 3;4a 2
* Literature spectra run in CDC13 •
14
a 13C NMR resonance values interchangeable.
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4.2.6 Structural Elucidation of Compound X, Hamayne (spectra 10.a-i)
Figure 4. 10 Structure of compound X, hamayne
Compound X (Figure 4. 10) was isolated as a brownish amorphous material and identified by
comparison against literature data to be hamayne, a compound previously isolated from the bulbs
of Crinum delagoense. 5
The substitution pattern on the A ring was similar to the previous compounds isolated with the
'" '--
presence of only two para orientated aromatic protons (OH ~.61 and 6.05) and a resonance at OH
! 5.91 (2H), which is typical of protons of a methylenedioxy group, in the 1H NMR spectrum. Other
. \.
characteristic features observed in the 1H NMR spectrum included resonances in the olefenic\
region (OH, 6.22, dd, 10.3,2.2 Hz; 6.05 d, 10.3 Hz assigned to H-1 and H-2 of a 1,2-do_lJ..~te bond.
-' -
The doublet resonance for H-2 implied a cis relationship between the 5,1 Ob-ethano briage and- .
the hydroxy substituent at C_3.10-12: 17-18
Circular dichroism was used to determine the absolute configuration of the 5,10b-ethano bridge.
A positive Cotton effect was observed at 294 nm followed by a negative Cotton effect at 253 nm,
which indicated the bridge was of the a configuration since negative Cotton effects are typically
observed at 250 nm for the a orientated series. 10-12,17-18. Due to a cis relationship between bridge
and the hydroxy group the orientation of the hydroxy group attached at C-3 is a. 10-12,17-18
, The C-6 reson:-~::e showed a 3J HMBC correlation to the methYle~P!~tons at OH~~'§J<!g, 3.3,
13.9 Hz) and/3.73'\(dd, 6.2, 13.9 Hz)assigned to 2H-12. The 2H-12 protons showed a correlation
in the COS~"SJ:>~ct;~~ to the resonance at .QH 4.g3'1(~)~,;!~~iCh had a corresponding carbon
resonance, seen in the HSQC spectrum, at Oc 79.74 indicating the presence of an oxygen
~.
substituent at C-11 and this was deduced to be an hydroxyl substituent from the moiecular
-..--......
formula. A correlation in the NOESY spectrum .___between the H-10 resonance and the _H-11
~.~ i - ' .
resonance Indicated H-11 to be endo and the hydroxy substituent on C-11 to be eXQ. A further
correlation in the NOESY spectrum from the H-11 endo resonance to the H-12 resonance at OH
3.45 indicated it to be H-12 endo.
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The infrared spectrum supported the postulated structure with peaks at 3349 cm-1 (O-H
stretching), 2922 cm-1 and 2853 (C-H stretching), 1610 cm-\ 1465 cm-1(aromatic C=C stretching)
and 1265 cm-1(C-N stretching).
A literature search for the compound identified it as hamayne, first isolated from Crinum
bulbispermum (Burm.f) Milne-Redh. & Schweick. in 1984.15 It has more recently been isolated
from Ammocharis coranica and Crinum stuhlmannii.5•16 The l H, 13C, HMBC, COSY and NOESY
data are shown in Table 4.7.
Table 4.7: 1H, 13C, HMBC, COSY and NOESY data for hamayne (CD30D)
. HMBC
Carbon ~ &: &: COSY NOESY
(C~H)
1 6.22 (dd, 10.3,2.2 Hz) 123.58 124.0 2 2;10
2 6.05 (d, 10.3 Hz) 137.50 137.4 1 1;3
3 4.36 (m) 67.858 .J3..7-7 1;4a 4a,~ 2;4a;4~-.--.............---
4a 2.23 (m) 3;4a;4~ 4~;12exo
33.26 33.5
4~ 2.11 (m) 3;4a;4a 3;4a;4a
4a 3.58 (dd, 3.7,13.6 Hz) 67.248 65.6 1;4a,p;6a;11 4a,p 3;4P;6~
6a 4.01 (d, 16.1 Hz) 6P 6P,7
60.27 60.7 7;12exo. endo
6P 4.49 (d, 16.1 Hz) 6a 4a;6a;7
6a 123.58 124.7 6a,p;10
7 6.61 (5) 107.95 107.9 6a 6a,p
8 148.86° 148.1 7;OCH2O
9 148.29u 148.6 10;OCH20
10 6.92 (5) 104.55 104.4 1
10a 135.77 136.4 6u,p;7
10b 51.64 51.6 4a,p;10
11 4.03 (m) 79.74 80.2 12exo• ooOO 120000
12enoo 3.45 (dd, 3.3,13.6 Hz) 11;120000 4a;12endo
62.19 63.2 6a;p
12exo 3.73 (dd,6.2,13.9 Hz) 11 ;12exo 11 ;12exo
-OCH20- 5.91 102.62 102.5
a 13C NMR resonance values interchangeable.
b 13C NMR resonance values interchangeable.
* Literature spectra run in CD30D. 16
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4.2.7 Structural Elucidation of Compound XI, N-methyl-3-epi-crin-6-amide (stuhlmanine A)
(spectra 11.a-j)
Figure 4. 11 Structure of compound XI, stuhlmanine A
Compound XI (Figure 4. 11) was isolated as a brownish amorphous material. The mass
spectrum showed a molecular ion peak at 330.13415g. mor1 which corresponded to a molecular
formula"f C18H20NOs. It was found to be a new alkaloid that belongs to the 5,1 Ob-ethano bridge
type of alkaloids.
The substitution pattern on the A ring was similar to the previous compounds isolated with the
presence of only two para orientated aromatic protons (OH 7.42 and 6.84) and a two proton broad
singlet resonance at OH 6.05, which is typical of a methylenedioxy group in the 1H NMR spectrum.
However, in comparison with the H-7 resonance in previous alkaloids of this type that have been
isolated, these resonances are much further downfield.
Other characteristic features observed in the 1H NMR spectrum included resonances OH 5.70, 1.3,
10.3 Hz, H-1, (OH 6.09, H-2) in the olefinic region assigned to protons of a 1,2-double bond and a
methoxy group proton resonance at OH 3.42. The COSY spectrum showed correlations between
the H-2 resonance and a resonance at OH 3.91 (m), assigned to H-3. The H-3 resonance, in turn,
showed correlations to the 2H-4 resonances (OH4a 2.36, m, OH4~ 2.44, brd 16.0 Hz) which, in turn,
showed correlations to the H-4a resonance (OH 3.33, m). The resonance assigned to H-3 showed
a corresponding carbon resonance at Oc 72.12 in the HSQC spectrum, which showed a 3J HMBC
correlation to the methoxy group proton resonance (OH 3.42) implying the methoxy group to be
present at C-3. The orientation of the methoxy group was determined with the aid of CD spectra
and the H-2 resonance. Circular dichroism was used to determine the absolute configuration of
the 5,1 Ob-ethano bridge. A positive Cotton effect was observed at 279 nm followed by a negative
Cotton effect at 258 nm, which indicated the bridge was of the a configuration. 10-12,18-19 The
resonance for H-2 was obscured by the methylenedioxy group proton resonance. However, on
expanding this region, a doublet with a coupling constant of 5 Hz was measured. From literature,
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if H-2 is split into a doublet only a coupling constant of 10 Hz would be observed; if split into a
double doublet the coupling constants are 10 and 5 Hz the assumption was made that part of the
H-2 resonance was obscured. 10-12 This double doublet indicates a trans relationship to the bridge
and hence the methoxy group is p.10-12.
The methylene group carbon resonance at Dc 53.83 was assigned to C-12, the first of the two
bridging carbons. The second bridging carbon was identified through a correlation in the COSY
spectrum between the H-11 and the 2H-12 proton resonances. The H-11 resonance occurred at
DH 4.73 (dd, 3.4, 7.7 Hz), and corresponded to a oxymethine carbon resonance at DC 81.25,
ascribed to C-11 from the molecular fonnula. The absence of an AB splitting pattern for the
methylene proton at about 4 ppm, which is seen for all C-6 unsaturated crinane alkaloids,
confirmed the substituted nature of C_6. 1O The signal in the 13C NMR spectrum at Dc 167.17
indicating the presence of a carbonyl group, showed a 3J HMBC correlation in the HMBC
spectrum to the H-7 resonance. This implied the presence of a carbonyl group at C-6. The IR
confinned the presence of an amide carbonyl group with a peak at 1724 cm-1. The remaining
signal in the 13C NMR spectrum was a methyl carbon resonance at DC 42.64. This resonance
showed a HMBC correlation to the H-12 resonance and the only possible position it could be
placed was attached to the nitrogen atom. This implied that a N-methyl group was present and
could explain why the C-4a resonance was a short broad peak and the methyl group was so far
downfield in the 1H NMR spectrum. Other IR resonances were 3373 cm-1 (O-H stretching), 2925
and 2854 cm-1(C-H stretching) and 1274 cm-1(C-N stretching).
A literature search confirmed the novelty of the compound as a natural product and it was named
stuhlmanine A. The HMBC, COSY and NOESY data are shown in Table 4.8.
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Table 4,8: 1H, 13C, HMBC, COSY and NOESY data for stuhlmanine A (CD30D)
HMBC
Carbon BH Bc COSY NOESY
(C-+H)
1 5.70 (dd, 10.3, 1.3 Hz) 128.30 3 2 2;10
2 6.09 (mt 129.54 3 1;3 1;3; 3-0CH3
3 3.91(m) 72.12 3-0CH3 2;4a..~ 2;4a.;3-0CH3
4a. 2.36 (m) 3;4a 3;4~;10
28.78 2
4~ 2.44 (brd, 16.0 Hz) 3,4a 4a.
4a 3.33 (m)D 64.27 N-CH3 4a.,~ N-CH3
6 167.17 7;10
6a 119.51 10
7 7.42 (s) 111.36 10
8 154.40a 7;10;OCH2O
9 148.94a 7;10; OCH2O
10 6.84 (s) 104.89 1;4a;4a.
10a 142.86 7
10b 46.88 10
11 4.73 (dd, 3.4, 7.7 Hz) 81.25 4a 12a,b 12a
12a 2.91 (m) 11 ;12b 11;12b;N-CH3
53.83 N-CH3
12b 3.22 (m) 11 ;12a 12a
-OCH2O- 6.05 (m) 103.94
3-0CH3 3.42 (s) 56.98 3 2;3
N-CH3 2.58 (s) 42.64 12b 4a;12a
a 13C NMR resonance values interchangeable.
b resonances obscured-could not determine coupling constant.
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4.2.8 Structural Elucidation of Compound XIIA and B, 4a-hydroxy-1,2-di-epi-bowdensine










Figure 4. 12 Structure of compound XIIA andXIIB, stuhlmanine Band C
Compound XII (Figure 4. 12) was isolated as a yellow amorphous material. It showed one spot
on tic analysis. The mass spectrum showed a molecular ion peak at m/z 419.15897
corresponding to a molecular formula of C21H2SN08. However the, 1H and 13C NMR spectra
showed distinctive doubling of some resonances and it was found to be a mixture of two
inseparable epimers at C-1. Both epimers were found to be new alkaloids of the 5,1 Ob-ethano
bridge type of alkaloids and were named stuhlmanines Band C.
The structural determination of one epimer is discussed first. By similar arguments, the signals
for the second epimer were assigned. The signals due to each epimer were distinguished on the
basis of size of the resonances and the integration. The appearance of only one singlet at OH
6.72 and the methylenedioxy group proton resonance at OH 5.88 indicated only one unsubstituted
position on the A ring thus differentiating this compound from compounds previously isolated from
this species. The presence of the AB splitting pattern for the 2H-6 methylene protons at OH 3.83
and 4.08 indicated H-6 was unsubstituted.10 The C-6 (oc 52.76) resonance showed a 3J HMBC
correlation to the methylene protons at OH 2.72 (m) and 3.54 (m) ascribable to 2H-12. The 2H-12
resonances showed correlations in the COSY spectrum to the methlyene protons at OH 1.69 (m)
and 2.16 (m), which were assigned to 2H-11.
The proton NMR spectrum also showed the presence of two acetate group proton signals and
one methoxy group proton signal belonging to this compound. The H-6 resonance at OH 3.83 (m)
showed a correlation in the NOESY spectrum to the methoxy group proton resonance at OH 3.99
(s) indicating its presence at C-7 and identifying H-10 as the unsubstituted position on ring A.
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The quaternary carbon resonance at Oc 91.93 pm showed 3J HMBC correlations to H-6 (OH 3.83)
and H-12 (OH 1.69) and was assigned to C-4a. By mass difference C-4a was determined to have
a hydroxy group attached. Further HMBC correlations was seen from C-4a, together with the
carbonyl resonance, of one which of the two acetates, to a resonance at OH 6.23, which can be
either to H-3 or H-1. The NOESY spectrum showed a correlation from H-10 (OH 6.72) to the
resonance at OH 6.23 enabling this resonance to be assigned to H-1. This resonance, in turn,
showed a correlation in the COSY spectrum to the resonance at OH 4.99 enabling this resonance
to be assigned to H-2. Similarly, the carbonyl carbon resonance of the remaining acetate group
showed a 3J HMBC correlation to thus H-2 resonance, placing the second acetate group at C-2.
The stereochemistry of the acetate at C-2 was assigned to be in the axial position due to a very
small coupling constant. The COSY spectrum was used to complete the assignment of the C
ring. The H-2 resonance (OH 4.99) showed correlations to the methylene protons at OH 1.72 (m)
and 2.14 (m) which were assigned to 2H-3. The 2H-3 resonances, in turn, showed correlations to
resonances at OH 1.98 (m) and 2.18 (m), which were assigned to 2H-4.
Circular dichroism spectroscopy was used to determine the absolute configuration of the 5, 10b-
ethano bridge. A positive Cotton effect was observed at 275 nm followed by a further positive
effect at 253 nm, which indicated the bridge was of the ~ configuration since positive Cotton
effects are typically observed at approximately 250 nm for the ~ orientated series. 1D-12,17,18
A similar set of reasoning lead to the assignment of the structure of the second epimer. The only
difference noted was in the NOESY spectrum. The H-10 resonance showed a correlation to the
acetoxy group proton resonance attached to C-1, which was absent in the assignment of
stuhlmanine B. With the aid of a molecular model it could be seen that the acetoxy group
orientation was ~.
A literature search for the compounds indicated that they have both been isolated for the first time
and they were named stuhlmanine Band stuhlmanine C. The HMBC, COSY and NOESY data
are shown in Table 4.9 and 4.10 for both epimers.
80
Chapter 4: A Comparative Study ofthe Bulbs and
Seeds ofCrinum stuhlmannii
Table 4.9: 1H, 13C, HMBC, COSY and NOESY data for stuhlmanine B (CDCh)
HMBC
Carbon liH lie COSY NOESY
(C-+H)
1 6.23 (d. 2.7 Hz) 71.33 2 2;10
c
1;30:;40:;10; 2-
2 4.99 (m) 69.65 1.40:.P 1;30:,P
COCH3
3a 1.72 (m) 2;4a.p 2;4a
22.34 1
3P 2.14 (m) 2;4a.p 313; 2-COCH3
4a 1.98 (m) 30:.13 2;3a;413
26.09
413 2.18 (m) 3a.13 4a;2-COCH3, 11 exo
4a 91.93 1;60
6a 4.08 (d. 17.9 Hz) 613 4a;6p;2-COCH3
52.76 12exo
6P 3.83 (d. 17.9 Hz) 6a 60;12exo;7-0CH3
6a 115.97 6a.I3;10
7 140.11 OCH3; 10;60:,13
8 149.63 OCH2O;10
9 134.0 OCH2O;10
10 6.72 (5) 98.05 1;2
10a 134.45 60:,p;11 P
10b 49.60 1;4;10


















-OCH2O-* 5.88 (5) 101.02
OCH3* 3.99 (5) 59.148 6P
1-0COCH3 2.09 (5) 21.18 2-COCH3
2-0COCH3* 1.97 (5) 20.88
2;3 P ;11 exo;60;1-
COCH3
1-0COCH3* 169.84 1;1- OCOCH3
2- OCOCH3 170.32 2- OCOCH3
* Proton and carbon values mterchangeable WIth correspondmg resonances between eplmers.
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Table 4.10: 1H, 13C, HMBC, COSY and NOESY data for stuhlmanine C (CDCI3)
HMBC
Carbon SH Se COSY NOESY
(C~H)
1 5.32 (d, 4.5 Hz) 72.46 2 2;10;1- OCOCH 3
2 5.60 (brs) 68.22 1 1;3a;2-0COCH3
1.87 (m) 2;4 3~;2
3 24.55
2.16 (m) 2;4
4a;~ 1.95 (m) 27.50 3~ 3a,p
4a 93.12 6a
6a 4.42 (d, 17.9 Hz) 6a 6P
52.33





10 6.16 (s) 98,87 1; 1-0COCH3
10a 135.30 6a,p;1
10b 48.85 1;10
11 exo 2.06 (m) 11 p; 12exo.enOO
35.51 1
11 oodo 2.99 (m) 11a;12a,p 1-0COCH3
12exo 2.92 (m) 11 exo. endo;12enoo 12endo
49.88 6a,p;10
120000 3.52 (m) 11 exo. endo 12exo 12exo
-OCH2Q-* 5.84 (s) 100.85
OCH3* 3.97 (s) 59.186 6P
1-0COCH3 2.07 (s) 21.15 1;10;11 endo
2-0COGH3* 2.20 (s) 21.05 1;2;3a,p
1-0COCH3* 170.08 1;1-0COCH3
2- OCOCH3 169.78 2-0COCH3
*Proton and carbon values interchangeable with corresponding resonances between epimers
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4.2.9 Structural Elucidation of Compound for XIll, N-Methyldelagoenine (spectra 13.a-i)
Figure 4. 13 Structure of compound XIII, N-methyldelagoenine
Compound XIII (Figure 4. 13) was isolated as an orange amorphous material. The mass
spectrum showed a molecular ion peak at m/z 362.20451 g. mor1corresponding to a molecular
formula of C20H28NOs. It was found to be a new alkaloid that belonged to the 5,1 Ob-ethano bridge
type of alkaloids and was found to the N-methyl derivative of delagoenine.
The substitution pattem on the A ring was similar to the previous compounds isolated with the
presence of only two para orientated aromatic protons (OH 6.63 and 6.64). However, the
methylenedioxy group at C-8 and C-9 was absent. The C-8 and C-9 resonances showed 3J
HMBC correlations to two methoxy group proton resonances and these were placed at C-8 and
C-9. A characteristic feature in the 1H NMR spectrum of the 5,10b-ethano bridge type alkaloid is
the AB splitting pattern of the H-6 protons which occurred at OH 4.59, (d, 15.6 Hz) and OH 4.71 (d,
15.6 Hz) 10 and the H-4a resonance at OH 3.65 (dd, 5.2, 12.4 Hz). The C-4a and C-6 resOnances
showed a 3J HMBC correlation to the methyl group proton resonance at OH 3.08 (s). This methyl
group was therefore assigned to be a N-methyl group. Further correlations from C-6 were seen
to a resonance at OH 5.98 (brd, 5.9 Hz) assigned to H-12. The H-12 resonance showed a
correlation in the COSY spectrum to the methylene protons at OH 2.55 (dd, 6.7, 13.5 Hz) and 2.19
(brs) which were assigned to 2H-11.
Assignment of the ring C protons was done with the aid of the COSY spectrum. The methylene
group proton resonances at OH 2.29 (brd, 13.5 Hz) and 1.92 (m) showed correlations to H-4a (OH
3.65) and were assigned to 2H-4. The methylene group proton resonances showed further
correlations to the resonance at OH 5.18 (brs), assigned to H-3, which, in turn, showed
correlations to the two H-2 methylene protons (OH 1.78 (brd, 14.1 Hz) and 1.92 (m». which
showed further correlations to the 2H-1 (OH 2.21 (m» resonance. The acetoxy group was placed
at C-3.
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Circular dichroism spectroscopy was used to determine the absolute configuration of the 5, 10b-
ethano bridge. A positive Cotton effect was observed at 259 nm and a negative Cotton effect at
280 nm, which indicated the bridge was of the ~ configuration since negative Cotton effects are
typically observed at 280 nm for the ~ orientated series.10-12,17,18
The infrared spectrum showed a carbonyl group with a peak at 1734 cm-1• Other IR resonances
occurred at 2956 cm-1 and 2848 cm·1 (C-H stretching), 1515 cm·1 (aromatic C=C stretching) and
1262 cm-1 (C-N stretching).
A literature search for the compound identified it has being the N-methyl derivative of the known
delagoenine which was previous isolated from C. stuhlmannii.5 The HMBC, COSY and NOESY
data are Shown in Table 4.11 together with the 13C NMR data of N-methyldelagoenine.
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Table 4.11: 1H, 13C, HMBC, COSY and NOESY data for N-methyldelagoenine (CDCI3) .
Bc Bc HMBC
Carbon 5H COSY NOESY
(C-4H)
1 2.21 (m)8 23.86° 23.3 2a.j3;11a,j3 2a,j3 10




2b 1.92 (m)8 1;3 2a;3
3 5.18 (br5) 67.48 69.8 2;4a,j3 2a,b;4j3
4a 2.29 (brd, 1~;5 Hz) 3;4a 3;4a;4j3
26.65 30.3 4a
4j3 1.92 (m)8 3.4a 3;4j3
4a 3.65 (dd, 5.2, 12,4 Hz) 68.17 62.5 4a.j3;6a,j3;N-CH3 4a.13 3;4a
6a 4.59 (d, 15.6 Hz) 613 4a;6j3;7
64.11 56.9 4a;7;N-CH3
6j3 4.71 (d, 15.6 Hz) 6a 6a;7
6a 118.38 121.4 6a, j3; 10;N-CH3
7 6.64 (5)0 108.660 108.9 6a,13 6a,j3;8-0CH3
8 148.78c 148.2 6a;8-0CH3;10





10a --- 134.45 139.0 4a;6a.j3;7;11a.13
10b 42.28 44.3 4a.j3; 4a; 10
11 exo 2.55 (dd,6.7,13.5 Hz) 11 endo;12 11 endo
44.10 46.2 4a;6a;12
11 endo 2.19(m) 11 exo;12 10;11 exo
12 5.98 (d, 5.9 Hz) -109 93.8 11a,4a;N-CH3 11 exo,endo
8-0CH3* 3.75 (5)e 56.00
e 56.0 7
9-0CH3* 3.79 (5)e 55.90e 56.0 10
3-COCH3 1.93 (5) 21.07 21.2
3-COCH3 170.07 170.2 3-COCH3
N-CH3 3.08 (5) 41.66 6a
• Carbon value for delagoenine in CDCI3.
5
8 Resonances obscured. Accordingly, coupling constants could not be determined.
b,c,d,e 1H and 13C NMR resonance values interchangeable.
f Exact value could not be determined as resonance was weak.
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4.2.10 Structural Elucidation of Compound for XIV, Stuhlmanine 0 (spectra 14.a-j)
Figure 4.14 Structure of compound XIV, stuhlmanine D
Compound XIV (Figure 4. 14) was isolated as an orange amorphous compound and was found
to be a novel structure. It was found to have a 5,1 Ob-methano bridge instead of the 5,1 Ob-ethano
bridge, and this is the first reported occurrence of this type of bridge in the crinamine and
haemanthamine type alkaloids. The GC-LC-MS gave a highest peak at 332 g. mor1• However,
the expected [M+] peak at m/z 332.186184 for C19H26N03 (suggested by the NMR spectra) could
not be observed in the Cl HRMS, which did, however show the [M-CH21+ peak at m/z 318.17176
(calc. for [ClsH24N04t 318.170533).
The substitution pattern on the A ring was the same as the previous compound (compound XIll)
isolated with only two para orientated aromatic protons (OH 6.52 and 6.77) and methoxy groups at
C-8 and C-9. The characteristic AB splitting pattern resonances of the 2H-6 protons which
occurred at OH 3.84 (m) and OH 4.02 (d, 15.1 Hz) 10 and the H-4a resonance at OH 2.88 (dd, 4.2,
13.2 Hz) were present in this molecule. This compound also had an N-methyl group (OH 2.45 (s).
The C-4a and C-6 resonances showed a 3J HMBC correlation to the methyl group proton
resonance at OH 2.45 (s) confirming its presence.
Assignment of ring C was done with the aid of the COSY spectrum. The H-4a (OH 2.88)
resonance showed correlations to the methylene group proton resonances at OH 1.75 (d, 2.2,12.2
Hz) and 2.09 (m) ascribable to 2H-4. These methylene group proton resonances showed further
correlations to the resonance at OH 5.22 (brs) assigned to H-3, which, in turn, showed correlations
to the methylene group protons of H-2 (OH 1.81 (m) and 1.93 (dd, 1.7, 9.6 Hz)), which further
showed correlations to 2H-1 (OH 1.81 (m) and 2.13 (m)). The acetoxy group was placed at C-3.
The carbon resonances for rings A, BandC were assigned using the HMBC, COSY and NOESY
spectra and this left one unassigned carbon resonance at Oc 47.78. The C-10a resonance
showed a 3J HMBC correlation to the methylene protons of this unassigned carbon, at OH 2.18
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(dd, 2.2, 14.1 Hz) and bH 2.74 (dd, 6.3, 14.1 Hz), and were thus assigned to 2H-11. The
appearance of a double doublet resonance for H-11 could be explained by it undergoing W
coupling to both H-1 and N-C!:::b. The protons corresponded to the carbon resonance at be 47.78
in the HSQC spectrum. This resonance, in turn, showed a 3J HMBC correlation to the
resonances at 2H-1 confirming the assignment.
The mass spectrum supported the proposed structure. The base peak at mlz 258 could result
from the loss of a CH2 fragment (Scheme 4. 1) and subsequent loss of a unit of acetic acid (60
mass units)
m/z 318
Scheme 4. 1 Fragmentation pattern of compound XIV
Circular dichroism spectroscopy was used to determine the absolute configuration of the 5, 10b-
ethano bridge. A positive Cotton effect was observed at 292 nm and a negative cotton effect at
247 nm, which indicated the bridge was of the Cl configuration since negative Cotton effects are
typically observed at approximately 250 nm for the Cl orientated series. 10-12,17.18 Although the
bridge was not an ethano bridge the stereochemistry of the bridge was still assigned by
comparison, in a manner similar to that used in the haemanthamine and crinane series.10-12 The
stereochemistry of H-4a was therefore assigned to be (3. This H-4a resonance showed a
correlation in the NOESY spectrum to the H-3 proton resonance, implying H-3 to be (3. Therefore
the acetoxy group substituent on C-3 was ex.
The infra-red spectrum showed a carbonyl group with a peak at 1724 cm'1. Other IR resonances
were 3373 cm·
1
(O-H stretching), 2925 and 2854 cm"1 (C-H stretching) and 1274 cm'1(C-N
stretching).
A literature search for the compound indicated that it was isolated for the first time and it was
named stulhmanine D. The HMBC, COSY and NOESY data are shown in Table 4.12.
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Table 4.12: 1H, 13C, HMBC, COSY and NOESY data for stulhmanine 0 (CDCI3)
CARBON BH Bc HMBC COSY NOESY
(C~H)
10. 2.13 (m)a 27.63 1~;2o.,~ 10.;10
1~ 1.81 (mt 1o.;2o.,~ 1~;2o.;4a;4p
20. 1.81 (m)a 24.77 1o.,~;3 2P;3
2~ 1.93 (dd, 1.7,9.6 Hz) 1o.,~;3 1p;2a
3 5.22 (brs) 68.48 1a 2o.,~;4o.,~ 1P;2~;4~
---
40. 1.75 (dd, 2.2, 12.2 Hz) 28.00° 3;4a 3;4P;11 exo
4~ 2.09 (m) 3;4a 1p;3;4a;4a;N-CH3
4a 2.88 (dd, 4.2, 13.2 Hz) -61 0 1a;11 exo;N-CH3 4cx.,p 1o.;6P;4P
60. 4.02 (d, 15.1 Hz) 6P 6P;7
60.98 7;N-CH3 .
6P 3.84 (d, 15.1 Hz) 60. 4a;6a
6a -124° 10
7 6.52 (s) 108.46 - 6a;8-0CH3
8 148.38 10;8-0CH3
9 148.24 7; 9-0CH3
10 6.77 (s) 107.02 - 1a; 11 exo ;9-0CH3
10a 134.11 7,11 exo, endo
10b 42.86 10;1o.,~;11exo,
endo
11 endo 2.18 (dd,2.2, 14.1 Hz) 47.78 1P 11P 10
11 exo 2.74 (dd, 6.3,14.1 Hz) 110. 4a
N-CH3 2.45 (s) 39.50 4P
8-0CH3 3.84 (s) 56.05° 7
9-0CH3 3.84 (s) 55.92° 10
3-COCH3 1.99 (s) 21.29
3-COCH3 170.16 3-COCH3
a Obscured.
b 13C NMR resonance values interchangeable.
c Resonances overlap.
d Exact carbon values could not be determined as resonances were of low intensity/broadened.
88
Chapter 4: A Comparative Study ofthe Bulbs and
Seeds ofCrinum stuhlmannii
4.3 Comparison of Bulbs and Seed Chemistry of Crinum stuhlmannii
The different compounds isolated from the bulbs and seeds of Crinum stuhlmannii during this and
the previous study (under the name Crinum delagoense)5 are shown in Table 4.13.
Table 4.13: The different chemical constituents isolated from the seeds and bulbs of
Crinum stuhlmannii
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6-HYdroxycrinamine was the only common chemical constituent isolated from the seeds, and
both studies of the bulbs. Lycorine was the only other common constituent found in both bulbs
studied. However, Nair et al.5 isolated a novel alkaloid named delagoenine in their study of the
bulbs whilst in the current study the N-methyl derivative of delagoenine (Compound XIII) was
found. This indicates that the bulbs studied previously were possibly C. stuhlmannii although the
production of delagoenine and its derivatives may yet prove not to be restricted to the genus
Crinum. Hamayne which was isolated in the previous study by Nair et al.5 was isolated from the
seeds of C. stuhlmannii. The only common constituent isolated in current studies of the bulbs
and seeds of C. stuhlmannii was 6-hydroxy crinamine and this was isolated in fairly large yields
from both bulbs and seeds. None of the novel alkaloids (stuhlmanine A, B, e, 0 or N-
methyldelagoenine) were isolated from both seeds and bulbs which indicate that these chemical
constituents may be organ-specific.
4.4 Experimental
The plant material of Crinum stuhlmannii Baker was collected in Maputaland near Kosi Bay and a
voucher specimen was retained (N. Crouch 953, NH). The parts of the plant investigated were
the bulbs and seeds. General chromatographic techniques were employed (Chapter 3).
The seeds (1.1 kg) were dried, chopped into smaller pieces and extracted with ethanol by
agitation on a Labcon Mechanical shaker at 140 rpm. The extract obtained was then filtered and
the solvent was removed under reduced pressure 8.2 g of ethanol extract was obtained. The
extract was dissolved in water and lowered to a pH of 2 where it was extracted with 3 x 200ml
with chloroform. This was called the acidic extract (4.6 g). The pH of the original extract was
raised to a pH of 10 and again extracted with 3 x 200 mL chloroform. This was called the basic
extract (1.2 g). Both the acidic and basic extracts were investigated.
The acidic extract of the seeds was loaded onto a 5 cm diameter column and eluted with a step
gradient solvent system collecting 50 ml fractions at a time (100% dichloromethane fractions 1-
34; 1% methanol in dichloromethane fractions 35-61; 2% methanol in dichloromethane fractions
61-74; 5% methanol in dichloromethane fractions 75-99; 10% methanol in dichloromethane
fractions 100-116; 20% methanol in dichloromethane fractions 117-129). Purification of fraction
39 using a 100% dichloromethane solvent system afforded compound VII at a yield of 0.6% (23
mg). Purification of fractions 82-83 using a 2% methanol in dichloromethane solvent system
afforded compound IX at a yield of 0.2% (12.3 mg). Purification of fractions 75-79 using 2%
methanol in dichloromethane afforded compound X at a yield of 0.1 % (7.3 mg).
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The basic extract of the seeds was loaded onto a 2 cm diameter column and eluted with a step
gradient solvent system collecting 50 ml fractions at a time (100% dichloromethane fractions 1-
18; 1% methanol in dichloromethane fractions 19-31; 5% methanol in dichloromethane fractions
32-53; 10% methanol in dichloromethane fractions 54-73; 20% methanol in dichloromethane
fractions 74-91). Although TLC analysis indicated interesting spots, the constituents present
were in very low amounts and no further work could be done.
The bulbs (3.5 kg) were dried, chopped into smaller pieces and extracted with ethanol by
agitation on a Labcon Mechanical shaker at 140 rpm. The extract obtained was then filtered and
the solvent was removed under reduced pressure. 37.27 g of ethanol extract was obtained. The
extract was dissolved in water and lowered to a pH of 2 where it was extracted with 3 x 200ml
with chloroform. This was called the acidic extract (mass = 4.5 g). The pH of the original extract
was raised to a pH of 10 and again extracted with 3 x 200 mL chloroform. This was called the
basic extract (3.3 g). Both the acidic and basic extracts were investigated.
The acidic extract of the bulbs was loaded onto a 5 cm diameter column and eluted with a step
gradient solvent system collecting 50 ml fractions at a time (100% dichloromethane fractions 1-
50; 1% methanol in dichloromethane fractions 51-70; 2% methanol in dichloromethane fractions
71-97; 5% methanol in dichloromethane fractions 98~127; 10% methanol in dichloromethane
fractions 128-160; 20% methanol in dichloromethane fractions 161-174). The acidic extract was
dissolved in chloroform and filtered. This afforded compound V at a yield of 3% (120.7 mg).
Fractions 22-27 were combined and loaded onto a 1 cm column and eluted with a 100%
dichloromethane solvent system to afford compound VI at a yield of 0.2% (10.3 mg). Fractions
83-84 were combined and purified using a 2% methanol in dichloromethane solvent system. This
afforded compound VIII, at a yield of 0.3% (12.3 mg). Purification of fractions 100-110 using 2%
methanol in dichloromethane afforded compound XII at a yield of 0.2% (10.7 mg). Purification of
fractions 120-127 using a 5% methanol in dichloromethane solvent system afforded compound
XIII at a yield of 0.4% (15.6 mg).
The basic extract of the bulbs was loaded onto a 2 cm diameter column and eluted with a step
gradient solvent system collecting 50 ml fractions at a time (100% dichloromethane fractions 1-
23; 1% methanol in dichloromethane fractions 24-43; 2% methanol in dichloromethane fractions
44-66; 5% methanol in dichloromethane fractions 67-110; 10% methanol in dichloromethane
fractions 111-140; 20% methanol in dichloromethane fractions 141-179). Compound VII was
obtained in pure form from fractions 74-75 at a yield of 1% (44 mg). Purification of fraction 119-
121 using a 10% methanol in dichloromethane solvent system afforded compound XI, at a yield
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of 0.2% (12.2 mg). Purification of fraction 98 using a 5% methanol in dichloromethane solvent
system afforded compound XIV, at a yield of 0.4% (20 mg).
4.4.1 Physical data for Compound V
Name: Iycorine
Yield: 120.7 mg
Physical description: white crystalline
Melting Point: 244-247°C (lit. 251-254oC)12
Optical rotation: -60.32 (0.202 g in 100 ml methanol) (lit. -62° (methanol, 0.1))7
Mass: GC-MS: [M+] at 287, C16H17N04requires 287.115758 g. mor
1
ElMS: 287,268,250,227,226, 147
Infrared: v:;1 cm-1: 3350 (O-H stretching), 2926 (C-H stretching), 2852 (C-H stretching), 1603
and 1480 (aromatic methylenedioxy)
1H NMR: OH (ppm) CsDsN: Table 4.1
13C NMR: Oc (ppm) CsDsN: Table 4.1
4.4.2 Physical data for Compound VI
Name: 8,g-methylenedioxophenanthridine
Yield: 10.3 mg
Physical description: yellow needle-like crystals
Melting Point: 138-140°C (Lit. 138-139oC)9
Optical rotation: +6.25 (c, 0.104 methanol) (value not given in lit.)9
Mass spectrum: GC-MS: [M+] at 223, C14H9N02requires 223.63329 g. mor
1
ElMS m/z: 223,222,164,138,137,111
Infrared: v:;1 cm-1: 1477 (aromatic C=C stretching) and 1262 (C-N stretching)
1H NMR: OH (ppm) CDC!J: Table 4.3
13C NMR: Oc (ppm) CDCI3: Table 4.3
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4.4.3 Physical data for Compound VII
Name: 6-hydroxycrinamine
Yield: 67 mg (44 mg from bulbs and 23 mg from seeds)
Physical description: white crystals
Melting Point: 142-144°C (lit. 150-152oC)10
Optical Rotation: +94.50 (c, 0.300 in methanol) (lit. 40° (c, 0.5 in methanol»10
Mass spectrum: GC-MS: [M+] 317, at C17H19NOs requires 317.126323 g. mor
1
ElMS m/z: 317, 271, 270, 211,181,153
CD nm: 492,477,447,430, 410, 372,360,345,329,302,277,252,230,217
Infrared: v:;1 cm-1: 3410 (O-H stretching), 2893 and 2821 (C-H stretching), 1488
(aromatic C=C stretching), 1248 (C-N stretching) and 1042 (C-O stretching).
1H NMR: OH (ppm) CD30D: Table 4.4
13C NMR: Oc (ppm) CD30D: Table 4.4
4.4.4 Physical data for Compound VIII
Name: 6(3-ethoxycrinamine
Yield: 12.3 mg
Physical description: brown amorphous material
Optical rotation: +16.89 (c, 0.074 g in methanol)
Mass spectrum: CIMS: [MJ not seen, C19H23NOs requires 345.15623 g. mor
1
ElMS m/z: 346 [M+Ht, 328, 314, 300, 268, 254, 240, 224,149,123,109,97,83.
CD nm: 489, 467, 456, 443, 409,375,330,290,224
Infrared: v ~:;I cm-1: 3380 (O-H stretching), 2922 (C-H stretching), 1637 (C=O
stretching) and 1522 (C=C stretching).
1H NMR: OH (ppm) CDCh: Table 4.5
13C NMR: Qc (ppm) CDCI3: Table 4.5
4.4.5 Physical data for Compound IX
Name: hamaenthamine
Yield: 12.3 mg
Physical description: yellow amorphous material
Optical rotation: +48.00 (c, 0.06 methanol)
Mass spectrum: GC-MS: [MJ at m/z 301, C17H19N04 requires 301.131408 g. mor1
ElMS: 272,240,181,153,128,115
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CD nm: 469, 453, 431, 388, 359, 343, 326, 308, 291, 272, 254, 236, 212
Infrared: v ~~I cm-1: 2928 (C-H stretching), 1438 (aromatic C=C stretching), 1239
(C-N stretching)
1H NMR: OH (ppm) CD30D: Table 4.6
13C NMR: Oc (ppm) CD30D: Table 4.6
4.4.6 Physical data for Compound X
Name: hamayne
Yield: 7.3 mg
Physical description: brown amorphous material
Optical rotation: the yield of sample was too low to obtain a stable reading
Mass spectrum: GC-MS: [M+] at m/z 287, C16H17N04 requires 287.115758 g. mor
1
ElMS m/z: 287,215,185,149,115
CD nm: 491, 462, 443, 429, 405,374,337,294,264,239,217
Infrared: v~l cm,l; 3349 cm-1 (O-H stretching), 2922 cm-1 (C-H stretching), 1565 cm,l (C=C
stretching) and 1265 cm-1(C-N stretching).
lH NMR: OH (ppm) CD30D: Table 4.7
13C NMR: Oc (ppm) CD30D: Table 4.7
4.4.7 Physical data for Compound XI
Name: stuhlmanine A, N-methyl-3-epi-crin-6-amide
Yield: 12.2 mg
Physical description: brown amorphous gum
Optical rotation: -7.80 (c, 0.186 in methanol)
Mass spectrum: HRMS: [M+] at m/z 330.13415, C1sH2oNOsrequires 330.134148 g. mor1
ElMS m/z: 330,329,299,279,256,216,149,129,107
CD:476,454,414,350,319,279,258,234,217
Infrared: v~I cm,1: 3373 (O-H stretching), 2923 and 2855 (C-H stretching), 1727
(C=O stretching), 1479 (aromatic C=C stretching) and 1281 (C-N stretching).
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1H NMR: OH (ppm) CD30D: Table 4.8
13C NMR: oe (ppm) CD30D: Table 4.8
4.4.8 Physical data for Compound XIIA and XIIB
Name: stuhlmanines B, 4a-hydroxy-1,2-di-epi-bowdensine; stuhlmanine C, 4a-hydroxy-2-
epi-bowdensine
Yield: 10.7 mg
Physical description: yellow amorphous material
Optical rotation: +36.36 (c, 0.11 g in methanol)
Mass spectrum: HRMS: [M+] at m/z 419.15897, C21H2sNOsrequires 419.158017 g. mor1
ElMS m/z: 419, 359, 316, 291, 273, 216, 204
CD nm: 447, 432, 400, 374, 342, 303, 276, 254,235, 225
Infrared: v;::1 cm,1: 3380 (O-H stretching), 2941 (C-H stretching), 1740 (C=O
stretching), 1482 (aromatic C=C stretching) and 1260 (C-N stretching)
1H NMR: OH (ppm) CDCI3: Tables 4.9 and 4.10
13C NMR: oe (ppm) CDCI3: Tables 4.9 and 4.10
4.4.9 Physical data for Compound XIII
Name: N-Methyldelagoenine
Yield: 15.6 mg
Physical description: orange amorphous material
Optical rotation: +93.09 (c, 0.362 in methanol)
Mass spectrum: HRMS: [M+] at m/z 362.20451, C2oH2SNOs requires 362.196748 g. mor1
ElMS rn/z. 362,333,318,308,274,258,242,218,179,130.129.68,35.
CD nm: 488, 456, 405, 372, 338, 319, 299, 280, 259
Infrared: v:;1 cm,1: 2956 and 2848 (C-H stretching), 1734 (C=O stretching), 1515
(C=C stretching) and 1262 (C-N stretching).
1H NMR: OH (ppm) CDCI3: Table 4.11
13C NMR: oe (ppm) CDCI3: Table 4.11
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4.4.10 Physical data for Compound XIV
Name: stuhlmanine D
Yield: 15.6 mg
Physical description: orange amorphous material
Optical rotation: -55.51 (c, 0.118 in methanol)
Mass spectrum: HRMS: [MJ not found, C19H26N04 requires 332.186184 g. mor
1
ElMS m/z: 318 [M-CH2r ,258,218,179,43
CD nm: 479, 286, 451, 404, 373, 336, 319, 292, 269, 248, 227
Infrared: v:;1 cm-1: 2946 (C-H stretching), 1729 (C=O stretching), 1516 (C=C stretching) and
1255 (C-N stretching).
1H NMR: OH (ppm) CDCI3: Table 4.12
13C NMR: oe (ppm) CDCh: Table 4.12
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Chapter 5: The Classification and Biosynthesis of
Homoisoflavanones and Bufadienolides
5.1 Introduction
The family Hyacinthaceae, formerly part of the Liliaceae sensu lato, is richly represented in
southern Africa. It comprises approximately sixty-seven genera and nine hundred species
worldwide, of which twenty-seven genera and three hundred and sixty-eight taxa are located
in southern Africa.1•2 The other major region of Hyacinthaceae diversity stretches from the
Mediterranean to South West Asia.3
Within southern Africa, the Hyacinthaceae are widespread and well adapted to the fluctuating
moist-arid climate, often withering down to bulbs during seasonal dry periods. In this study
the phytochemistry of the bulbs of the plants was studied.
Although great difficulties in phylogenetically systematizing the genera have been
acknowledged, a recent arrangement has been proposed.1-3 Of the five sub-families delimited
by Speta, three occur in southern Africa. These are the Hyacinthoideae, Urgineoideae and
the Ornithogaloideae. In this study Ledebouria revo/uta (L.t.) Jessop and Drimia macrocentra
(Baker) Jessop (Urgineoideae) were studied.
The two major classes of compounds isolated from this family during this work were
homoisoflavanones and bufadienolides. The biosynthesis of these compounds will be
discussed in this chapter.
5.2 The Classification of Homoisoflavanones
The numbering of the basic homoisoflavanone skeleton is similar to that of all simple
flavonoid compounds and is shown below (Figure 5.1) using a 3-benzyl-4-chromanone type
(1) and a scillascillin type (2) as examples.
99






Figure 5. 1 The numbering system for homoisoflavanones
Homoisoflavanones belong to a small family of natural products whose first member was
isolated from the bulbs of Eueomis bie%r Bak.4 They are restricted in their distribution,
having been previously reported to occur mainly in taxa of the Hyacinthaceae.5-13 However,
these homoisoflavanones have also been reported to occur outside this family. Intricatin and
intricatinol are two homoisoflavanones isolated from the Fabaceae family (Section 5.6). Until
recently homoisoflavanones were thought to be present in only the Hyacinthoideae of the
Hyacinthaceae.5-8 However, they have very recently been reported from the
Ornithogaloideae.50
Homoisoflavanones, which are more commonly referred to as homoisoflavonoids, belong to a
. class of naturally occurring oxygen heterocycles.14 The term homoisoflavonoid is actually
incorrect since these compounds do not undergo the characteristic 2,3-aryl migration of the
C6-C3-C6 moiety that is common in the biosynthesis of isoflavonoids.
13 Also, they have a
sixteen-carbon skeleton instead of a fifteen-carbon skeleton characteristic of isoflavonoids.15
The correct systematic name is 3-benzyl-4-chromanones. The spectroscopic behavior of the
homoisoflavanones resembles very closely that of f1avonoids. 16 This sixteen carbon skeleton
bears either a chromanone, chromone or chromane moiety to which is attached, in most
cases, a benzyl or benzylidene group at the 3-position.18 The homoisoflavanones can
generally be classified into three types based on structural features:14.16.18
5.2.1 The 3-benzyl-4-chromanone or dihydroeucomin type
HO 7
OH 0
Figure 5. 2 A homoisoflavanone of the 3-benzyl-4-chromanone type
This type of homoisoflavanone (Figure 5. 2) shows a very characteristic-coupling pattern in
the 1H NMR spectrum due to the 2H-2, H-3, 2H-9 proton coupled system. A pair of double
doublets within the chemical shift range OH 4.1-4.3 ppm [AB of ABX, 2H-2], one multiplet in the
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range SH 2.7-2.9 ppm [H-3]t and two double doublets in the range SH 2.6-2.7 ppm and SH 3.1-
3.3 ppm [2H-9] are indicative of this arrangement.




Figure 5. 3 A homoisoflavanone of the 3-benzyl-3-hydroxy-4-chromanone type
These compounds (Figure 5. 3) typically possess a hydroxy substituent at C-3. The
characteristic feature in the 1H NMR spectrum of this type of homoisoflavanone is the
presence of two AB systems, one for the C-2 protons at SH 4.20-4.4 ppm and SH 4.1-4.2 ppm
15and another at SH 3.1-3.2 ppm and SH 2.7-2.8 ppm for the protons at C-9.









Figure 5. 4 A homoisoflavanone of the 3-benzylidene-4-chromanone type
These compounds (Figure 5. 4) are characterized by a 3,9-double bond and can be in the
(Z)- or the (E)-configuration. The characteristic features in the 1H NMR spectrum are the
presence of an AB-system for the 2H-2 resonances and a singlet for the H-9 resonance. The
pair of doublets for 2H-2 are found to resonate at approximately SH 5.2-5.5 ppm while the
position of the H-9 resonance depends on the configuration. The (Z)-configuration places the
proton at C-g away from the. anisotropic region of the carbonyl group and causes the vinyl
group proton to resonate at approximately SH 5.5 ppm. In the (E)-configuration the proton at
C-9 is in the anisotropic region of the carbonyl group and causes it to resonate at SH 7.6-7.9
ppm. 15
t The absolute stereochemistry can be determined using CD spectra and is discussed in Chapter 6
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Besides these three basic structural types, a number of unusual compounds which contain a
fourth ring (Figure 5. 5), have been isolated.14,18 These compounds are thought to be
biogenetically related to homoisoflavanones and are classified with this group.13,14,16
Scillascillin type compounds possess a unique 3-spiro-cyclobutane ring sytem.16,18 The C-4
carbonyl group is retained in scillascillin-type compounds but is absent in brazilin and
hematoxylin where a cyclopentane C-ring is observed. The biosynthetic origin of these more
complex compounds has been investigated and it has been postulated that they are derived








Figure 5. 5 Homoisoflavanones of the scillascillin, brazilin and hematoxylin types
The l H NMR spectra of homoisoflavanones also show a number of characteristic features
besides the splitting pattern of the H-2, H-9 and H-3 protons, which are important in the
structural elucidation of these compounds. The signals between OH 6.50-7.20 ppm generally
indicate the substitution pattern on the B-ring. This is usually either an ABX or an AA'BB'
system. The substituents present are attached to C-4' (AA'BB' system) giving a pair of
doublets, each integrating to two protons, or C-3' and C-4'(ABX system) where the proton
resonances of C-1', C-5' and C-6' all appear as double doublets.
The region between OH 5.80-6.30 ppm indicates the substitution pattern on the A-ring. There
are usually only one or two proton resonances in this region which are due to H-6 and/or H-8.
The position of the protons is normally assigned by using the NOESY spectrum.
The uv spectrum is another tool one can use in determining the substitution pattern of the A
ring. When AICI3 is added to a homoisoflavanone containing a hydroxy group at C-5, one
observes a bathochromic shift in the UV spectrum.5,7 Similarly if NaOAc is added to a
homoisoflavanone containing a hydroxy group at C-7, there is a bathochromic shift in the UV
spectrum.5,7
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The mass spectrum is another important tool used in the determination of the structure of the
compound. The first step is cleavage of the C-3, C-9 bond in what is known as an A-4 type
cleavage.16 In dihydroeucomin this leads to fragment ions at m/z 180 and m/z 121 as shown
in Scheme 5. 1. In most cases the tropylium ion gives rise to the base peak of the spectrum.
One of the fragments formed may then undergo a retro-Diels Alder (RDA) reaction.16 In
dihydroeucomin the chromanone fragment ion at mlz 180 may eliminate water, CO or
undergo a RDA cleavage to give a fragment ion at m/z 152 or due to a hydrogen shift, m/z
153.16 The major pathway is the RDA cleavage and H-shift.16 The minor pathway is usually






mlz 152 mlz 153
Scheme 5. 1 Fragmentation pattern of homoisoflavanones16
5.3 The Biosynthesis of Homoisoflavanones
Phenolic compounds can be biosynthesized via the shikimate pathway or polyketide
pathway. 19 Often compounds like flavonoids and homoisoflavanones are of mixed
biosynthetic origin. In homoisoflavanones, the A-ring is polyketide derived while the B-ring is














Figure 5. 6 The origin of the A and Brings
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The first step in the biosynthetic pathway leading to homoisoflavanones involves the
formation of a chalcone. Since chalcones are known to be direct precursors of
homoisoflavanones, the biosynthesis of chalcones is essentially a part of the biogenetic route
to homoisoflavanones.13,15,16 The precursors to chalcones are three malonyl CoA units and p-
I C A 20-22coumaroy o.
Malonyl-CoA is synthesized from acetyl-CoA and carbon dioxide.20-22 The reaction, which is
shown below is catalysed by acetyl-CoA carboxylase in the presence of adenosine 5'-
triphosphate (ATP) and Mg2+.20-22
----;~~ HOOC-CH2-CO-SCoA + ADP + Pi
p-Coumaroyl CoA, the second precursor in chalcone formation, is derived from the shikimate
pathway. This pathway is responsible for the production of the hydroxy cinnamic ester, from
which the B-ring is derived.20-22 The precursors of the shikimic acid pathway, erythrose-4-
phosphate and phosphoenolpyruvate, are primary metabolites of carbohydrate metabolism.20-
22
The first step in the formation of the precursor is the deamination of phenylalanine (Scheme
5. 2), which is catalyzed by the enzyme phenylalanine ammonia lyase (PAL).20-22 PAL
catalyses the anti-elimination of ammonia and the (pro-3s)-proton from L-phenylalanine to
yield trans-cinnamic acid.2°-22 Cinnamate-4-hydroxylase (C4H) catalyses the introduction of a
hydroxy group at position 4 of the trans-cinnamic acid.20-22 This reaction requires NADPH and
molecular oxygen and exhibits properties characteristic of those catalysed by plant P450
enzymes.20-22 This reaction mechanism involves a H-shift. The proton at the 4-position is
oxidised to a hydroxy group, being moved itself to the 3-position. This shift was established
by trituim-Iabelling experiments performed at the National Institute of Health at Bethesda,









Figure 5. 7 The NIH shift for the hydroxylation of cinnamic acid2D-22
The p-coumaric acid is activated by the formation of a CoA ester, which is catalysed by 4-
coumarate: CoA ligase.
20
-22 This reaction which requires ATP and Mg2+ as cofactors,
proceeds via an acyl-AMP intermediate, characterizing the enzyme as a synthase.2o-22
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HCOH shikimic acid pathway HOI + 2cdB ~
HCOH I












p-coumaroyl-eoA p-coumaric acid cinnamic acid
'PAL= phenylalanine ammonia-lyase. C4H= cinnamate-4-hydroxylase
Scheme 5. 2 The biosynthesis of the intermediate p-coumaroyl CoA20•22
The formation of the chalcone is common to all classes of f1avonoids and is thought to be the
most important step in flavonoid biosynthesis.2O-22 The formation ofthe chalcone is catalysed
by the enzyme chalcone synthase.21 ,22 Since the chalcone is the central intermediate for all
f1avonoids, chalcone synthase can be regarded as the key enzyme in flavonoid
biosynthesis.2G-22 The overall reaction consists of three successive condensation steps with
"acetate units" being derived from malonyl_CoA.20-22 The result is the elongation of the
aliphatic side chain of 4-coumarate by six carbon atoms (Scheme 5. 3).20 The enzyme
chalcone synthase then catalyzes the cyclization to give the aromatic ring A.20
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Scheme 5. 3 The biosynthesis of the 2',4',6',4-tetrahydroxychalcone2o•22
In many biosynthetic pathways, S-substituted methionine is often the source of an additional
carbon atom. 2',4',6',4-Tetrahydroxychalcone is methylated with S-adenosylmethionine and
is converted to the 2'-methoxy-4',6',4-trihydroxychalcone. This reaction is catalyzed by a









2',4' ,6',4-tetrahydroxychalcone 'Z -methoxy-4' ,6',4-trihydroxychalcone
Figure 5. 8 The formation of 2'-methoxy-4',6',4-trihydroxychalcone2o•22
A scheme for the conversion of chalcones to homoisoflavanones has been proposed by
Dewick12 whereby the 2'-methoxy group is oxidised and then undergoes a subsequent
cyclisation, which produces the three basic types of homoisoflavanones. The addition of a
hydride ion produces the 3-benzyl-4-chromanone type while the loss of a proton leads to the
formation of the 3-benzylidene-4-chromanones.12 Hydration or oxidation at the C-3 position of
a 3-benzyl-4-chromanone leads to a 3-benzyl-3-hydroxy-4-chromanone. These proposals are
illustrated in Scheme 5. 4.
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Scheme 5. 4 The proposed biosynthetic routes to basic homoisoflavanones12
Scillascillin-type compounds which have a 3-spirocyclobutenyl ring are derived from a more
complex mechanism. The precursor to scillascillin-type homoisoflavanones is thought to be
the 3-benzyl-3-hydroxy-4-chromanone homoisoflavanones (Scheme 5. 5).
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Scheme 5. 5 The proposed biosynthetic route to scillascillin type homoisoflavanones12
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5.4 The Classification of Bufadienolides
The numbering system used for bufadienolides is shown below (Figure 5. 9).
4 H 6
bufadienolide
Figure 5. 9 The numbering system for bufadienolides
Bufadienolides are one of the two types of cardiac glycosides found in the Hyacinthaceae,
with the other being the cardenolides. The group at C-17 defines the class of cardiac
glycoside (Figure 5. 10). The cardenolides have a butyrolactone ring while the






Figure 5.10 The structural difference between a cardenolide and bufadienolide
Bufadienolides were first isolated from the skin of the toad (Bufa spp.), from which they
derived their name. In the Hyacinthaceae, bufadienolides have been shown to occur
predominantly in the sUbfamily Urgineoideae.
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Some of the characteristic features of cardiac glycosides are:
1. The presence of predominantly eis-fusion of the AlB and CID ringst.
2. The presence of a 14~-hydroxy group.
3. The presence of an unsaturated lactone at C-17~.
4. A sugar moiety often occurs at C-3~.
The 1H NMR spectrum of a bufadienolide is very characteristic with the lactone ring proton
resonances of H-21, H-22 and H-23 occurring at OH 7.35-7.45, OH 7.90-8.05 and OH 6.20-6.30
ppm respectively and only two methyl group proton resonances present. If a sugar molecule
is attached to the steroidal structure one usually finds the anomeric proton resonance
between OH 4.4-5.1 ppm.
5.5 The Biosynthesis of Bufadienolides
Bufadienolides are thought to arise from the manipulation of cholesterol in animals. In plants
and algae, cycloartenol is the precursor.23
The first step in the conversion of cycloartenol to cholesterol is the opening· of the
cyclopropane ring (Scheme 5. 6) and the formation of a lanosterol derivative. It has been
suggested that a nucleophilic group from an enzyme attacks C-9, thereby opening the ring,
with a proton incorporated from water into the methylene group of the cyclopropane ring.23
The stereochemistry at C-8 (H-~) is unfavorable for a concerted mechanism involving loss of
H-8 with cyclopropane ring opening. The double bond between C-8 and C-9 is formed by a
trans-elimination to form a lanosterol derivative.23
t Physodine C and D isolated from Drimia physodes (Jacq.) Jessop have frans fused NB and Cl D
rings43
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Scheme 5. 6 The opening of the cyclopropane ring23
The C-14 methyl group is lost next as formic acid (Scheme 5. 7).23 This reaction is catalysed
by a cytochrome P-450 mono-oxygenase. Two oxidation reactions give the 14a.-formyl
derivatives, with the loss of the formyl group thought to occur via a Baeyer-Villiger type














O2 !peroxy adduct formation
NADPH via nucleophilic attack
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Scheme 5. 7 ShOWing loss of the methyl group of C-14 23
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The next step is the sequential loss of the two methyl groups (Scheme 5. 8) at C-4· via a
decarboxylation mechanism. This occurs by the sequential oxidation of the 4a-methyl group
to a carboxyl group and the 3-hydroxyl group to a ketone, thereby generating a l3-keto acid.23
This is followed by the decarboxylation of the l3-keto acid. Keto-enol tautomerism occurs with
the remaining methyl group taking up the more favoured equatorial configuration. The ketone













decarboxylation 0V 10. p -keto acid / - CO2 (}..(H
reduction of ketonel
back to 3p-alcohol NADPH
HO
repeat of whole process
---3." •
HO
Scheme 5. 8 Showing loss of the two methyl groups of C-4 23
A NADPH-dependent reductase reduces the 1124 double bond (Scheme 5. 9). The hydride
from the coenzyme is added at C-25, and the H-24 is derived from water.23
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eH
Scheme 5. 9 Loss of C-24 double bond 23
The final step in the formation of cholesterol involves the migration of the A8 double bond to A5
via A7 and the A5,7 diene (Scheme 5. 10).23 This sequence involves an allylic isomerization






reduction of double bond..
NADPH
H
Scheme 5. 10 AJlylic isomerization of double bond 23
+
The side chain of cholesterol is cleaved to form a two-carbon acetyl group. This shortening is
achieved by successive oxidation, hydration and cleavage of the C-20/22 bond to give
pregnenolone which is, in turn, oxidized to give progesterone. Reduction of the A4 double
bond gives the cis fused AlB system, 5~-pregnan-3,20-dione,z3 Further reduction of the C-3
ketone gives a ~-hydroxy group (Scheme 5.11). Hydroxylation occurs at C-14 with inversion
of the stereochemistry,z3 This is very peculiar as normally hydroxylation by mono-oxygenase
occurs with retention of configuration.23 This is followed by hydroxylation of the side chain at
C_21.23
In bufadienolides, the formation of the lactone ring (Scheme 5. 12) then occurs. This ring is
created by the incorporation of the three carbons from oxaloacetate via an aldol addition
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process, with the fourth carbon being lost by decarboxylation.23 The last step is the ketone

































Scheme 5. 11 Conversion of pregnenolone to 3P-hydroxy-5P-pregnan.20.one 23
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Scheme 5. 12 Proposed formation of bufadienolide lactone ring 23
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5.6 The Biological Activity of Homoisoflavanones
Homoisoflavanones are known to be concentrated in the waxy, scale-like layers of bulbs.16 In
this work, the homoisoflavanones were isolated from bulb extracts. Homoisoflavanones are
known to possess anti-inflammatory, anti-mutagenic, anti-bacterial and analgesic properties.24
Two well known homoisoflavanones, intracatin and intricatinol (Figure 5. 11), isolated from
the roots of Hoffmanseggia intricata T. S. Brandeg. (Fabaceae), have shown antimutagenic
properties, with both showing varying inhibition of mutagenicity in Salmonella typhimurium of
the carcinogens 2-amino - anthracene, acetylaminofluorine and ethyl methanesulphonate.25t
It was also shown that intricatinol, which possesses two hydroxy groups, was more broadly
active than intricatin, which possesses one hydroxy group.25 This led to the postulation that










The anti-inflammatory properties of bulbs within the Hyacinthaceae have been widely
investigated.26 The crude extracts of the bulbs of Muscari comosum Mill. (Hyacinthaceae)
were tested for anti-inflammatory properties, by using the inhibition of croton oil-induced
dermatitis in the mouse ear.26 Homoisoflavanone-rich fractions were shown to inhibit mouse
dermatitis.
26
The inhibitory effect obtained was comparable to that of the potent anti-
inflammatory drug, indomethacin.26
Two homoisoflavanones isolated from Veltheimia bracteata Harv. ex Baker (syn. V. viridifolia




chromanone was reported to possess a weak selective profile for PDE IV and PDE V.27 The
study also investigated the in vitro activity of this homoisoflavanone on leukotriene
synthesis.
27
A weak activity was reported for this system. The study also investigated the
bronchiospasmolytic in vivo activity of the homoisoflavanone on the respiration and on the
t Note that these homoisoflavanones from the Fabaceae have different ring A oxidation patterns to the
homoisoflavanones isolated from the Hyacinthaceae
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cardiac system of guinea pigs.27 The results obtained indicated that the compound induced a
slight increase in the expiratory flow and a pronounced increase in the respiratory rate in the
test subjects.z7 In addition, a moderated bronchiospasmolysis was detected in conjunction
with a decrease in heart rate.Z7 The conclusions were that the homoisoflavanone had a weak
and especially short biological activity in the in vivo test systems.27
5.7 The Biological Activity of Bufadienolides
The cardiac glycosides are an important class of naturally occurring drugs with actions that
are both beneficial and toxic. Bufadienolides act as a blood pressure stimulant and also show
antineoplastic and respiratory activity.53
Pharmacological studies have shown that the bufadienolides' activity lies with the aglycone
part of the molecule.53 However the sugar moiety plays an important role in the kinetics of
action. In general, cardiac glycosides with more lipophilic character are absorbed faster and
have longer duration of action and this is determined by sugar residues and the number of
hydroxyl groups on the aglycone part of the glycoside.53 The stereochemistry of the steroidal
nucleus also plays an important role. Structures with an AlB cis ring fusion have been shown
to be more active than those that contain an AlB trans system and a similar sort of effect is
observed for the CID ring system.53 The lactone ring alone, when not attached to the steroid
structure, is not active; therefore one is led to believe that the activity lies in the steroid
skeleton. However the lactone plays an important role in receptor binding as saturation of the
lactone ring dramatically reduces the biological activity.53
hellebrigenin 3-acetate: R1= Ac, Rz= H
hellebrigenin 3,5-diacetate R1=Rz=Ac
Figure 5.12 Two bufadienolides isolated from Bersama abyssinica28
Hellebrigenin 3-acetate and hellebrigenin 3,5-diacetate (Figure 5. 12) isolated from the stem
bark of Bersama abyssinica Fresen. (Melianthaceae) were shown to exhibit inhibitory activity
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against human carcinoma of the nasopharynx in cell culture (KB}.28 Both compounds were
also tested for in vivo activity against the Walker intramuscular carcinoma 256 in rats.
Hellebriginin 3-actetate showed significant activity and was the first cardiotonic steroid to
show activity against an in vivo tumour system.28 Further studies on the fruit of Bersama
abyssinica, yielded three novel bufadienolides, all of which have shown in vitro inhibitory
activity against cells derived from human carcinoma of the nasopharynx.29
Work done on the eggs of the toad, Bufa marinus, yielded five novel bufadienolides. All five
compounds showed inhibitory Na+, K+ and ATPase enzymatic activity.3o
Drimia maritima (L.) W.T.Stearn, from Europe, contains principally the bufadienolide scillaren
A and proscillaridin A, although is not used as a cardiac glycoside, it is used for its
expectorant action in preparations such as Gee's linctus.23 This species is also known to
contain bufadienolides such as glucoscilliroside and scilliroside, which have been used as a
rodenticide.23 Its no longer used as it is considered to be an inhumane way of killing rats.23
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5.8 Homisoflavanones Isolated from Hyacinthaceae
A literature search was undertaken to see which homoisoflavanones have been isolated
previously from the southern African Hyacinthaceae. The following tables list the various
homoisoflavanones isolated. The table has been divided (5.8.1-5.8.3) according to the three
different classes of homoisoflavanones.
5.8.1 The 3-benzyl-4-chromanone type of homoisoflavanones
Name R1 ~ R3 R. Rs Ra Plant Source Ref
1. 3,9-dihydro-eucomin OH H OH H OCH3 H Eucomis bicolor Baker 16,31
Eucomis montana Compton 32
Resnova humifusa (Baker) U. & 33
D.M.-D.
2. 7-D-methyl-3,9-dihydro-eucomin OH H OCH3 H OCH3 H Eucomis bico/or Baker 31
Schizocarphus neNOSUS (Burch.) 39
Van der Merwe
3. 3,9-dihydropunctatin OH H OH OCH3 OH H Eucomis comosa (Houtt.) Wehrh. 34
Eucomis pallidiflora Baker 55
4. 7-0-methyl-3,9-dihydropunctalin OH H OCH3 OCH3 OH H Ledebouria cooperi (HookJ.) Jessop 35
Eucomis montana Compton 32
Resnova humifusa (Baker) U. & 33
D.M.-D. 42
Drimiopsis maculata Lindl. & Paxt.
5. 4'-D-methyl-3,9-dihydropunctatin OH H OH OCH3 OCH3 H Eucomis comosa (Houtt.) Wehrh. 16,34
6. 4'-demethyl-5-D-methyl-3,9-dihydro- OCH3 H OH H OH H Eucomis comosa (Houtt.) Wehrh. 16,34
eucomin Eucomis montana Compton 32
7. 3,9-dihydro-autumnalin OH OCH3 OH H OH H Eucomis autumnalis (Mill.) Chitt. 35
Merwilla dracomontana (Hilliard & 37
Burtt) Speta 37
Merwilla plumbea (Lindl.) Speta 38
Schizocarphus neNOSUS (Burch.) 35
Van der Merwe
Ledebouria cooperi (HookJ.) Jessop
8.5,7-dihydroxy-6-methoxy-3-(4'- OH OCH3 OH H OCH3 H Merwilla dracomontana (Hilliard & 37
hydroxybenzyl)-4-chromanone Burtt) Speta
9. 5,7-dihydroxy-3-(3'-hydroxy-4'- OH H OH H OCH3 OH Scilla kraussii Baker 37
methoxybenzyl)-4-chromanone Schizocarphus neNOSUS (Burch.) 38
Van der Merwe 33
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Resnova humifusa (Baker) U. &
D.M.-D.
10. 5,7-dihydroxy-6-methoxy-3-(3'- OH OCHs OH H OCHs OH Merwilla plumbea (Lindl.) Speta 37
hydroxy-4'-methoxybenzyl)-4-chromanone Spetae lachenaliiflora Wetschnig & 35
Pfosser
11. 5,7-dimethoxy-3-(4'-methoxybenzyl)-4- OCHs H OCHs H OCHs H Schizocarphus nervosus (Burch.) 38,39
chromanone Van der Merwe
12. 5"hydroxy-7-methoxy-3-(3'-hydroxy-4'- OH H OCHs H OCHs OH Schizocarphus nervosus (Burch.) 39
methoxybenzyl)-4-chromanone Van der Merwe
13. 5-hydroxy-6,7,8-trimethoxy-3-(4'- OH OCHs OCHs OCHs OH H Veltheimia bracteata Harv. ex. Baker 27
hydroxybenzyl)-4-chromanone
14. 5,8-dihydroxy-6,7-dimethoxy-3-(4'- OH OCHs OCHs OH OH H Veltheimia bracteata Harv. ex. Baker 27
hydroxybenzyl)-4-chromanone
15. 5,7-dihydroxy-3-(4'-hydroxybenzyl)-4- OH H OH H OH H Ledebouria ovatifolia (Baker) Jessop 40
chromanone Eucomis montana Compton 32
Resnova humifusa (Baker) U. & 33
D.M.-D. 42
Drimiopsis maculata Lindl. &Paxt.
16.5 hydroxy-7-methoxy-3-(4'-hydroxy-3'- OH H OCHs H OH OCHs Schizocarphus nervosus (Burch.) 38
methoxybenzyl)-4-chromanone Van der Merwe
17.5-hydroxy-6,7-dimethoxy-3-(4'- OH OCHs OCHs H OH OCHs Schizocarphus nervosus (Burch.) 38
hydroxy-3'-methoxybenzyl)-4-chromanone Van der Merwe
18. 5,7-dihydroxy-3-(3',4'- OH H OH H OCHs OCHs Schizocarphus nervosus (Burch.) 38
dimethoxybenzyl)-4-chromanone Van der Merwe
19. 6-hydroxy-5,7-dimethoxy-3-(4'- OCHs OH OCHs H OH H Schizocarphus nervosus (Burch.) 38
hydroxybenzyl)-4-chromanone Van der Merwe
20. 5,6,7-trimethoxy-3-(4'-hydroxybenzyl)- OCHs OCHs OCHs H OH H Schizocarphus nervosus (Burch.) 38
4-chromanone Van der Merwe
21.8 hydroxy-5,7-dimethoxy-3-(4'- OCHs H OCHs OH OCHs H Schizocarphus nervosus (Burch.) 38
methoxybenzyl)-4-chromanone Van der Merwe
22. 5,7-dimethoxy-3-(4'-hydroxybenzyl)-4- OCHs H OCHs H OH H Schizocarphus nervosus (Burch.) 38
chromanone Van der Merwe 42
Drimiopsis burkei Baker
23. 5,6-dihydroxy-7-methoxy-3-(4'- OH OH OCHs H OH OCHs Scilla zebrina Baker 41
hydroxy-3'-methoxybenzyl)-4-chromanone
24.6-hydroxy-5,7-dimethoxy-3-(4'- OCHs OH OCHs H OH OCHs Scilla zebrina Baker 41,50
hydroxy-3'-methoxybenzyl)-4-chromanone
25.5,7- dihydroxy-3-(4'-hydroxy-3'- OH H OH H OH OCHs Scilla zebrina Baker 41
methoxybenzyl)-4-chromanone Drimia delagoensis (Baker) Jessop 42
26. 7-hydroxy-5,6-dimethoxy-3-(4'- OCHs OCHs OH H OH H Resnova humifusa (Baker) U. & 33
hydroxybenzyl)-4-chromanone D.M.-D.
27.5,6-dihYdroxy-7-methoxy-3-(4'- OH OH OCHs H OH H Drimiopsis maculata Lindl. &Paxt. 42
hydroxybenzyl )-4-chromanone
28.6-hydroxy-5,7-dimethoxy-3-(4'- OCHs OH OCHs H OH H Scilla zebrina Baker 50
hydroxy)-4-chromanone
29. 5-hYdroxy-7-methoxy-3-(4'-hydroxy)-4- OH H OCHs H OH H Lachenalia rubida Jacq. 55
chromanone
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).8.2 The 3-benzyl-3-hydroxy-4-chromanone type of homoisoflavanones
Name R1 R2 ~ ~ Rs Re Plant Source Ref
30. eucomol OH H OH H OCH3 H Eucomis bicolor Baker 4
Merwilla dracomontana (Hilliard & 37
Burtt) Speta 32
Eucomis montana Compton 33
Resnova humifusa (Baker) U. &
D.M.-D.
31. 7-Q-methyleucomol OH H OCH3 H OCH3 H Eucomis bico/or Baker 4
Eucomis montana Compton 32
Omithogalum longibracteatum SO
Jacq.t
32. 3,S,7-trihydroxy-3-(4'- OH H OH H OH H Eucomis montana Compton 32
hydroxybenzyl)-4-chromanone Resnova humifusa (Baker) U. & 33
D.M.-D.
33. 3,7-dihydroxy-S,6-dimethoxy-3- OCH3 OCH3 OH H OH H Eucomis montana Compton 32
(4'-hydroxybenzyl)-4-chromanone
34. 3,S-dihydroxy-3-(4'-hydroxy-3'- OH H OCH3 H OH OCHa Albuca fastigiata Dryand 42
methoxybenzyl)-4-chromanone
5.8.3 The 3-benzylidene-4-chromanone type of homoisoflavanones
Rs
Name R1 R2 ~ Re Rs Plant Source Ref
3S. eucomin OH H OH H OCHa Eucomis bicolor Baker 4
Eucomis montana Compton 32
36.punctatin OH H OH OCHa OH Eucomis comosa (Houtt.) 34
Wehrh.
37.4'-0-methyl-punctatin OH H OH OCH3 OCHa Eucomis autumnalis (Mill.) Chitt. 36
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38. 4'-dimethyl-eucomin OH H OH H OH Eucomis comosa (Houtt.) 34
Wehrh. 38,39
Schizocarphus neNOSUS
(Burch.) Van der Merwe
39.7-Q-methyt-eucomin OCH3 H OH H OCH3 Eucomis bico/or Baker 31
40. autumnalin OH OCH3 OH H OH Eucomis autumnalis (Mill.) Chitt. 36
Schizocarphus neNOSUS. 38
(Burch.) Van der Merwe
41. 5,7-dihydroxy-6-methoxy-3-(4'- OH OCH3 OH H OCH3 Schizocarphus neNOSUS 38
methoxybenzylidene)-4-chromanone (Burch.) Van der Merwe
42. 5-hydroxy-7-methoxy-3-(4'- OH H OCH3 H OH Schizocarphus neNOSUS 38
hydroxybenzylidene)-4-chromanone (Burch.) Van der Merwe
43.5,6,7-trihydroxy-8-methoxy-3-(4'- OH OH OH OCH3 OH Eucomis pallidiflora Baker 55
hydroxybenzylidene)-4-chromanone
5.8.4 The Scillascillin type of homoisoflavanones
R
Name R1 Plant Source Ref
44. 3',5-dihydroxy-4',7-dimethoxyspiro{2H-1-benzopyran-3(4H), 7'- OCH3 Drimiopsis maculata Lindl. 42
bicyclo[4.2.0]octa[1,3,5]-trien)-4-one & Paxt. 35
Eucomis humilis Baker
45. 3',5,7-trihydroxy-4'-methoxyspiro{2H-1-benzopyran-3(4H), 7'- OH Drimiopsis maculata Lindl. 42






5.9 Bufadienolides isolated from Hyacinthaceae
A similar literature search, as conducted for the homoisoflavanones, was done for the
bufadienolides from the Hyacinthaceae. The different bufadienolides have been divided into
six major parent skeletal groups which incorporates all of the compounds.
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R
H 4 OH 6
Name R1 Rz ~ Iti Plant Source Ref
1. physodine A H ~-D-digit GHO H Drimia physodes (Jacq.) Jessop 43
2. physodine B OAc ~-D-glc-(1~4)-Q-(2- GHO H Drimia physodes (Jacq.) Jessop 43
Q-acetyl-a-L-thev)
3. hellebrigenin H H GHO H Drimia altissima (Lt.) Ker Gawl. 44
Drimia depressa (Baker) Jessop 45
4. hellebrigenin 3-Q-~- H P-D-glc GHO H Drimia altissima (Lt.) Ker Gawt. 44
D-glucopyranoside Drimia depressa (Baker) Jessop 45
5. hellebrigenol 3-Q-P- H P-D-glc GHzOH H Drimia depressa (Baker) Jessop 45
D-glucopyranoside
6. bovoruboside H a-L-thev GHO =0 Drimia depressa (Baker) Jessop 46
Bowiea volublis Harv. ex. HookJ. 51
7. bovokryptoside H a-L-thev GHO pOH Drimia depressa (Baker) Jessop 46
Bowiea volublis Harv. ex. HookJ. 51
8 H
7
H 4 H 6
Name R1 Plant Source Ref
8. physodine G P-D-xyl-(1~4)-Q-a-L-rha Drimia physodes (Jacq.) Jessop. 43
9. physodine D P-D-xyl-(1 ~3)-Q-(4' -Q-acetyl-a-L-rha) Drimia physodes (Jacq.) Jessop 43
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Name R1 R2 ~ R.. Plant Source Ref
10.scillirosidin OH OAc OH H Drimia sanguinea (Schinz) 47
Jessop
11. desacetylscillirosidin OH OH OH H Drimia sanguinea (Schinz) 47
Jessop
12. 12J3-hydroxyscillirosidin OH OAc OH OH Drimia sanguinea (Schinz) 47
Jessop 35
Drimia robusta Baker
10.scillirosidin-12-one OH OAc OH =0 Drimia robusta Baker 35
13. 12J3-hydroxy-desacetyl-scillirosidin OH OH OH OH Drimia sanguinea (Schinz) 47
Jessop
14. 12J3-hydroxyscilliroside O-J3-D-glc OAc OH OH Drimia sanguinea (Schinz) 47
Jessop
15. 12J3-hydroxyscillirosidin-3-one -0 OAc OH OH Drimia sanguinea (Schinz) 47
Jessop
16. 12J3-hydroxyscillirubrosidin-3-one -0 H OH OH Drimia sanguinea (Schinz) 47
Jessop
17. scillaren A O-J3-D-glc-(1-+4)-a-L- H H H Drimia sanguinea (Schinz) 48
rha Jessop 49
Drimia indica (Roxb.) Jessop
18. scilliphaeoside O-a-L-rha H H OH Drimia indica (Roxb.) Jessop 49
19. urginin O-a-L-rha-(1 ~3)-[J3- H H H Drimia altissima (Lt.) Ker 50,54
D-glc-(1~4)]-a-L-rha Gawl.
20. proscillaridin A O-a-L-rha H H H Drimia indica (Roxb.) Jessop 49
Drimia robusta Baker 35
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Name RI R2 R3 Rot Rs Plant Source Ref
22. 5a-4,5-dihydro-12~-hydroxy- OH OAc OH OH CH3 Drimia sanguinea (Schinz) 47
scillirosidin Jessop
23. 5a-4,5-dihydroxy-scillaren A O-~-D-glc-(1~4)-n-L- H H H CH3 Drimia sanguinea (Schinz) 48
rha Jessop
24. bovogenin A OH H H H CHO Bowiea volubilis Harv. ex. 51
HookJ.
25. bovoside A* 0-(6'-<leoxy-3'-0- H H H CHO Bowiea volubilis Harv. ex. 51
methyl)-~-D-glc HookJ.
o
Name RI Plant Source Ref
26. scilliglaucosidin/nabogenin OH Drimia altissima (Lf.) Ker Gawl. 44
Bowiea volubilis Harv. ex. HookJ. 51
27. scilliglaucosidin-3-one =0 Drimia altissima (Lf.) Ker Gawl. 44
28. scilliglaucosidin 3~-O-a-L-rhamnopyranoside O-a-L-rha Drimia altissima (Lf.) Ker Gawl. 44
29. scilliglauCQsidin 3~-0-~-D-glucopyranoside O-~-D-glc . Drimia altissima (Lf.) Ker Gawl. 44
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Name Plant Source Ref
30. rubellin Drimia calcarata (Baker) Stedje 52
OH
4 OH 6
Name RI Plant Source Ref
31. 5~-3~, 16~-dihydroxybufa-20.22-dienolide H Drimia depressa (Baker) Jessop 55
32. 5~-16~-dihydroxybufa-20 ,22-dienolide 3~-o-~-D-galactoside o-~-D-gal Drimia depressa (Baker) Jessop 55
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Chapter 6: Extractives from Ledebouria revoJuta
6.1 Introduction
Ledebouria revo/uta (L.t.) Jessop belongs to the subfamily Hyacinthoideae of the Hyacinthaceae
1
•
Members of this family are widely distributed, but are particularly well represented in southern
Africa and in the region stretching from the Mediterranean to south-western Asia.1 There are
approximately forty-six species of Ledebouria Roth in Africa and Asia, thirty-eight of which are
native to South Africa? Ledebouria was formerly included in the genus Scilla L. but has now
been independently placed.
Ledebouria revo/uta (Figure 6.1) is distributed through much of the eastern half of South Africa.3
It occurs in areas of woodland and grassland vegetation.3 The leaves are polymorphic in shape,
fleshiness and markings.3 Flower colour varies from green tinged with pink, to a dark pinkish
purple with the flowers being sometimes scented.3 The bulbs have a purplish-brown outer scale
and are membranous.3
Plants of Ledebouria are extensively used by traditional healers in KwaZulu-Natal, particularly in
enemas and as purgatives for both humans and cattle.4 Ledebouria revo/uta is used by the Sotho
as a charm to drive away lightning, and for the treatment of lumbago.4 Other members of the
genus used traditionally include Ledebouria cooperi (HookJ.) Jessop used by the Sotho women
during pregnancy, and by boys during circumcision rites.4 Ledebouria ovatifo/ia (Baker) Jessop is
used for the treatment of gastro-enteritis and in purgatives for adults.4
Figure 6. 1 Ledebouria revoluta, Photo: N.Crouch
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This is the first reported phytochemical study of this plant. Both the dichloromethane and
methanol extracts of this plant were investigated. This led to the isolation of four
homoisoflavanones (Figure 6. 2). The compounds isolated were 5,7-dihydroxy-3-(4'-
methoxybenzyl)-4-chromanone (compound XV), 5,7-dihydroxy-3-(4'-hydroxybenzyl)-4-
chromanone (compound XVI), 7,8-dimethoxy-5-hydroxy-3-(4'-hydroxyrnethoxybenzyl)-4-














Figure 6. 2 Compounds isolated from Ledebouria revoluta
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6.2 Results and Discussion
6.2.1 Structural Elucidation of Compound XV, 5,7-Dihydroxy-3-{4'-methoxybenzyl)-4-
chromanone (3,9-dihydro-eucomin) (spectra 15.a-k)
HO
Figure 6. 3 Structure of compound XV, 3,9-dihydro-eucomin
Compound XV (Figure 6. 3), was isolated as white needle-like crystals with a melting point of
152-154°C. This compound was found to have a molar mass of 300 g. mor
1
corresponding to a
molecular formula of C17H160 S' From the molecular formula, a double bond equivalence of ten
was deduced.
The proton NMR spectrum of compound XV showed the characteristic splitting pattern of the 2H-
2, H-3 and 2H-9 protons. This was indicative of a 3-benzyl-4-chromanone-type of
homoisoflavanone. Each of the H-2 protons was split by each other and the H-3 proton and this
resulted in a pair of double doublets at OH 4.11 (6.8, 11.5 Hz) and OH 4.25 (4.3, 11.5 Hz) assigned
to the two H-2 protons. The same splitting pattern was displayed by the interaction of H-3 and
the two H-9 protons and the double doublet resonances of the H-9 protons were found at OH 3.15
(4.3,13.7 Hz) and OH 2.70 (10.7,13.7 Hz). The H-3 proton was found to occur as a multiplet at OH
2.78. The proton NMR spectrum also showed the presence of one methoxy group proton
resonance at OH 3.78.
The appearance of an M'SS' system in the proton NMR spectrum with resonances at OH 6.85 (d,
8.6 Hz, H-3', H-5') and OH 7.14 (d, 8.6 Hz, H-2', H-6') was indicative of the presence of two pairs
of equivalent protons on the S ring and this also indicated that the B ring was l' ,4'-disubstituted.
The methoxy group was attached to this ring because of the presence of a base peak of m/z 121
in the mass spectrum which corresponds to a methoxybenzyl / methoxytropylium ion (Scheme 6.
1). The substitution pattern on this ring was confirmed using the NOESY spectrum. The NOESY
spectrum showed a correlation between the methoxy group proton signal at OH 3.78 and the H-3'
and H-S' resonance at OH 6.85. Thus the methoxy group was placed at C-4' on ring B.
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HO
OH 0
m/z 300 m/z 121 m/z 121
Scheme 6. 1 Fragmentation pattern of compound XVS
The substitution pattern on the A-ring could be deduced from the mass, l H NMR and UV spectra.
The appearance of a pair of doublets each integrating to one proton at OH 5.97 (d, 2.1 Hz) and
5.90 (d, 2.1 Hz) due to H-6 and H-8 (as predetermined on biosynthetic grounds) in the proton
NMR spectrum indicated that there were two unsubsituted position on the A ring. The loss of m/z
121 mass units in the mass spectrum indicates that the methoxy group is on ring B and because
of the molecular formula ring A must have 2 hydroxy groups. One hydroxy group was assigned
to the C-7 position due to a bathochromic shift of 40 nm in the UV spectrum when NaOAc was
added.6,7 The other hydroxy group was assigned to the C-5 position due a bathochromic shift of
24 nm in the UV spectrum with AICI3•
6
,7 The downfield signal due to a hydroxy group proton (OH
12.12 (s» was assigned to the proton of the strongly hydrogen-bonded 5-hydroxy group.8 This
was confirmed by the downfield shift of the carbonyl group (oc 198.0) that becomes deshielded
due to the chelating effects with the hydroxy group at C_5.8 The structure was confirmed using
the HMBC spectrum. The HMBC, COSY and NOESY data are provided in Table 6.2.
The infrared data supported the postulated homoisoflavanone structure for compound xv. Peaks
were observed at 3460 cm-1 (O-H stretching), 2927 cm-1 (aliphatic C-H stretching), 1653 cm-1
(C=O stretching), 1514 and 1444 cm-1 (aromatic C=C stretching).
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Table 6.1 CD data for the 3-benzyl-4-chromanone type of homoisoflavones isolated.





















The absolute configuration at C-3 for this compound could be reported as circular dichromism
(CD) experiments were carried out by Prof. D. Ferreira at the University of Mississippi on all four
homoisoflavanones isolated (Table 6.1). The negative Cotton effects between 284 and 298 nm
for the four compounds indicated a 3R absolute configuration for all four compounds.9 This R
configuration gives H-3 as a.
A literature search for the compound indicated that it was 5,7-dihydroxy-3-(4'-methoxybenzyl)-4-
chromanone isolated previously from Eucomis bicolor Baker and Resnova humifusa (Baker)U. &
D.M.-D. (syn. Drimiopis maxima Baker).1O,11 Comparison of the 13C NMR data (Table 6.2) proved
them to be very close indeed and compound XV was identified as 5,7-dihydroxy-3-(4'-
methoxybenzyl)-4-chromanone.
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(ppm) (ppm) (ppm) (C~H)
2a 4.11 (dd, 6.8,11.5 Hz) 2b;3 2b;3
68.95 68.94 3;9a,b
2b 4.25 (dd, 4.3,11.5 Hz) 2a;3 2a;3
2a,b;9a,b;2
3 2.78 (m) 46.82 46.82 2a;9a,b 2a,b;9a,b ,
4 197.95 197.93 2a,b;3;9 a,b
4a 102.66 102.65 5-0H;6;8
5 164.69 164.68 6
6 5.97 (d, 2.1 Hz) 96.61 96.60 5-0H;7-0H;8 5-0H;7-0H
7 164.28 164.26 8
8 5.90 (d, 2.1 Hz) 95.01 94.99 6 7-0H
8a 163.19 163.17 2a;b;6;8
9a 2.70 (dd, 10.7, 13.7 Hz) 3;9a 3;9b;2'/6'
31.97 31.95 2a,b;3
9b 3.15 (dd, 4.3,13.7 Hz) 3;9b 3;9a;2'/6'
1' 129.74 130.06
2'/6' 7.14 (d, 8.6 Hz) 130.14 130.10 3;9a,b;3'/5' 3'/5' 2a;9a;3'/5'






5-0H 12.12 (s) 6
7-0H 5.79 (s) 6;8
4'-OCH3 3.78 (s) 55.29 55.27 3'/5'
*Literature values obtained in CDC13•
11
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6.2.2. Structural Elucidation of Compound XVI, 5,7-Dihydroxy.3-(4'.hydroxybenzyl)-4·
chromanone (spectra 16.a-h)
This compound was isolated as white needle-like crystals.
HO
Figure 6. 4 Structure of compound XVI, S,7-dihydroxy-3-(4'-hydroxybenzyl)-4-chromanone
This compound (Figure 6. 4) also belongs to the 3-benzyl-4-chromanone type of
homoisoflavanones. The resonances observed for 2H-2, H-3 and 2H-9 in the 1H NMR spectrum
were similar to those of compound XVI.
Inspection of the mass spectrum revealed a parent ion at, m/z 286, which corresponded to a
molecular formula of C16H1405, and was consistent with the proposed homoisoflavanone
structure. Strong fragment ions were observed at m/z 107 and 180 due to A-4 fragmentation.
The fragment ion at m/z 180 indicates that ring A had two hydroxy groups and the hydroxybenzyl
I tropylium ion at m/z 107 similarly suggested that the B ring had one hydroxy group as a
substituent. The fragment ion at m/z 153 is formed via the retro-Diels Alder cleavage of the




OH~HOW,0 i t + ~OH d--::OH
~ + A)l- !J
H2C
OH 0 +












Scheme 6. 2 Fragmentation pattern of compound XVI5
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The infra-red data supported the homoisoflavanone structure for compound XVI. Peaks were
observed at 3430 cm-1 (O-H stretching), 2930 cm-1 (aliphatic C-H stretching), 1619 cm-1 (C=O
stretching), and 1521 cm-1 (aromatic C=C stretching).
The aromatic region of the 1H NMR spectrum confirmed the substitution pattern indicated by the
mass spectrum. The aromatic AA'BB' system with resonances at OH 6.99 (d, 8.6 Hz, H-2',H-6'),
OH 6.72 (d, 8.6 Hz, H-3',H-5'), confirmed the substitution pattern of the B ring and was found to be
similar to that of compound XV. The 1H NMR spectrum showed no methoxy group proton
resonances to be present. However, instead of an methoxy group at C-4', one finds the presence
of a hydroxy group. The remaining aromatic signals in the spectrum were a pair of doublet
resonances (integrating to one proton each) at OH 5.84 (d, 2.1 Hz) and 5.90 (d, 2.1 Hz). This
confirmed the type of substituents on the A ring that had been suggested by the mass spectrum.
The substitution pattern was the same as for compound XV. One of the hydroxy groups was
assigned to the C-5 position due to a bathochromic shift (40 nm) in the UV spectrum with AIC13.
6
,7
The other hydroxy group was assigned to the C-? position due to a bathochromic shift (25 nm) in
the UV spectrum when NaOAc was added.6,7
These assignments were confirmed by the HMBC, NOESY and COSY spectra and are listed in
Table 6.3. This compound was found to differ from compound XV only in the substitution of the
B-ring. Instead of a methoxy group, a hydroxy group was found present. A literature search for
the compound indicated that it was 5,?-dihydroxy-3-(4'-hydroxybenzyl)-4-chromanone previously
isolated from Muscari comosum (L.) Mi11. 12,13
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(ppm) (ppm) (ppm) (C--+H)
2a 4.02 (dd, 6.8, 11.5 Hz) 2b;3 2b;3;2'/6'
68.67 70.1 3;9a,b
2b 4.17 (dd, 4.3,11.5 Hz) 2a;3 2a;3;2'/6'
3 2.68 (m) 46.73 48.2 2a,b;9a,b 2a,b;9a,b 2a,b;9a,2'/6
4 197.90 199.4 2a,b;3;8;9a,b;
4a 101.79 102.8 6;8
5 163.01 165.8 6
6 5.90 (d, 2.1 Hz) 96.31 97.1 8
7 166.3 168.2 6;8
8 5.84 (d, 2.1 Hz) 95.11 95.9 6
8a 162.96 164.7 2a;b;8
9a 2.59 (dd, 10.7, 13.7 Hz) 3;9b 2a,b;3;9b;2'/6'
31.98 32.9 2a,b;3;
9b 3.06 (dd, 4.3, 13.7 Hz) 3;9a 9a;2'/6'
1' 128.83 130.2 3;9a,b;3'/5'
2'/6' 6.99 (d, 8.6 Hz) 130.03 131.2 9a,b 3'/5' 2a,b;3;9a,b
3'/5' 6.72 (d, 8.6 Hz) 115.40 116.4 2'/6' 2'/6' 2'/6'
4' 155.2 157.2 3'/5';2'/6'
* Literature values obtained in CD30D.
13
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6.2.3 Structural Elucidation of Compound XVII, 7,S-Oimethoxy-5-hydroxy-3-(4'-
hydroxybenzyl)-4-chromanone (spectra 17.a-h)
Figure 6. 5 Structure of compound XVII, 7,8-dimethoxy-5-hydroxy-3-(4'-hydroxybenzyl)-4-
chromanone
This compound (Figure 6. 5) also belongs to the 3-benzyl-4-chromanone type of
homoisoflavanones. The resonances observed for 2H-2, H-3 and 2H-9 in the l H NMR spectrum
were similar to those of compound XV and XVI. The proton NMR spectrum also showed the
presence of two methoxy group proton resonances at OH 3.76 and OH 3.86.
Inspection of the mass spectrum revealed a parent ion at, m/z 330, which corresponded to a
molecular formula of C18H1806, and was consistent with the proposed homoisoflavanone
structure. Strong fragment ions were observed at m/z 224 and 107 due to A-4 fragmentation.
The fragment ion at m/z 224 indicates that ring A had two methoxy groups and one hydroxyl
group and the hydroxybenzyl / tropylium ion at m/z 107 similarly suggested that the B ring had
one hydroxy group as a substituent. The fragment ion at m/z 153 is formed via the retro-Diels






-.A:4 I + I =/
:::,.,. +:::,.,. - !J
H2COH ° +












Scheme 6. 3 Fragmentation pattern of compound xvns
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The appearance of an AA'BB' system in the proton NMR spectrum with resonances at OH 6.76 (d,
8.6 Hz, H-3', H-5') and OH 7.07 (d, 8.6 Hz, H-2', H-6') was indicative of the presence of two pairs
of equivalent protons on the B ring and this also indicated that the B ring was 1', 4'-disubstituted.
The mass spectrum showed a peak at m/z 107 corresponding to a hydroxybenzyl fragment
indicating the possible presence of a hydroxy group at C-4'.
The substitution pattern on the A-ring could be deduced from the mass, 1H NMR and UV spectra.
The appearance of a singlet integrating to one proton at OH 6.08 (s) (usually due to H-6 or H-8) in
the proton NMR spectrum, indicated that there was only one unsubsituted position on the A ring.
The existence of a peak at m/z 224 in the mass spectrum was evidence of a dimethoxy-
hydroxychromanone fragment ion.5 This implied that the A-ring contained two methoxy groups
and one hydroxy group. One hydroxy group was assigned to the C-5 position due a
bathochromic shift of 27 nm in the UV spectrum with AICI3.
6
.
7 The downfield signal due to a
hydroxy group proton (OH 12.03 (s)) was assigned to the proton of the strongly hydrogen-bonded
5-hydroxy group.8 This was confirmed by the downfield shift of the carbonyl group (oc 198.3) that
becomes deshielded due to the chelating effects with the hydroxy group at C-5.B When NaOAc
was added there was no shift in the UV spectrum and this indicated that no hydroxy group was
found at C-7 instead a methoxy group (OH 3.86) was assigned to C-7. The remaining methoxy
group was assigned to H-8. This assignment was done due to a NOESY correlation existing
between the 5-0H group proton (OH 12.03) and the singlet proton (OH 6.08), thus indicating that
the proton had to be at C-6 and the methoxy group at C-8. The structure was confirmed using
the HMBC spectrum. The HMBC, COSY and NOESY data are provided in Table 6.4.
The infrared spectrum supported the postulated homoisoflavanone structure. Peaks were
observed at 3460 cm'1 (O-H stretching), 2927 cm-1 (aliphatic C-H stretching), 1653 cm,1 (C=O
stretching), 1514 and 1444 cm-1(aromatic C=C stretching).
A literature search for the compound indicated that it was 7,8-dimethoxy-5-hydroxy-3-(4'-
hydroxybenzyl)-4-chromanone chromanone previously isolated from Ledebouria cooperi (Hook.f)
Jessop.14
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Table 6.4: 1H, 13C, HMBC, COSY and NOESY data for 7,8-dimethoxy-5-hydroxy-3-{4'·
hydroxybenzyl)-4-chromanone (CDCI3)
Literature values obtained In CD30D.

















4a 102.22 102.9 5-0H;6
5 160.24 161.1 5-0H;6




8 129.32 129.6 7-0CH3; 7-0CH3










l' 129.32 129.6 3,9a,b;3'/5'
2'/6' 7.07 (d, 8.6 Hz) 130.22 130.8 9a,b;3'/5' 3'/5' 2a;3;9a,b;3'/5'
3'/5' 6.76 (d, 8.6 Hz) 115.55 116.0 2'/6',4'~OCH3 2'/6' 2'/6'
4' 154.71 156.9 3'/5';2'/6'
5-0H 12.03 (s) - 6
7-0CH3 3.86 (s) 56.17 56.3 6 6
8-0CH3 3.76 (s) 61.32 61.1
* . 14
142
Chapter 6: Extractives from Ledebouria revoluta




Figure 6. 6 Structure of compound XVIII, 5,7-dihydroxy-8-methoxy-3-
(4'-hydroxybenzyl)-4-chromanone
Compound XVIII (Figure 6. 6), was isolated as a yellow amorphous material. This compound
was found to have a molar mass of 316 g. mor1 corresponding to a molecular formula of
C17H160 6. From the molecular formula, a double bond equivalence of ten was deduced. This
compound also belongs to the 3-benzyl-4-chromanone type of homoisoflavanones. The
resonances observed for 2H-2, H-3 and 2H-9 in the 1H NMR spectrum were similar to those of
compounds XV, XVI and XVII. The proton NMR spectrum also showed the presence of one
methoxy group proton resonance at OH 3.91.
The appearance of an M'BB' system in the proton NMR spectrum with resonances at OH 6.77
(dd, 8.6, 1.7 Hz, H-3', H-5') and OH 7.01 (dd, 8.1,1.7 Hz, H-2', H-6') was indicative of the presence
of two pairs of equivalent protons on the B ring and this also indicated that the B ring was 1', 4'-
disubstituted. The mass spectrum (Scheme 6. 4) showed a peak at m/z 107 corresponding to a












3 It '9cHO 7 0 CH30 7 OH
:::,... ;:,.. :::,... I
C~ C~+o ~O
OH OH
m/z 182 m/z 183
Scheme 6. 4 Fragmentation pattern of compound XVIII5
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The substitution pattern on the A-ring could be deduced from the mass, 1H NMR and UV spectra.
The appearance of a singlet integrating to one proton at OH 6.12 (s) (usually due to H-6 or H-8) in
the proton NMR spectrum, indicated that there was only one unsubsituted position on the A ring.
The existence of a peak at m/z 209 in the mass spectrum was evidence of a
dihydroxymethoxychromanone fragment ion.5 This implied that the A-ring contained two hydroxy
groups and one methoxy group. One hydroxy group was assigned to the C-5 position due a
bathochromic shift of 27 nm in the UV spectrum with AICI3•
6
,7 The downfield signal due to a
hydroxy group proton (OH 12.03 (s» was assigned to the proton of the strongly hydrogen-bonded
5-hydroxy group.8 This was confirmed by the downfield shift of the carbonyl group (oc 198.3) that
becomes deshielded due to the chelating effects with the hydroxy group at C-5.8 The hydroxy
group was assingned to H-7 due to a bathachromic shift of 36 nm in the UV spectrum with
NaOAc. The methoxy group was assigned to H-8. This assignment was done due to a NOESY
correlation existing between the 5-0H group proton (OH 12.03) and the singlet proton (OH 6.08),
thus indicating that the proton had to be at C-6 and the methoxy group at C-8. The structure was
confirmed using the HMBC spectrum. The HMBC, COSY and NOESY data are provided in
Table 6.5.
The infrared data supported the postulated homoisoflavanone structure. Peaks were observed at
3460 cm,1 (O-H stretching), 2927 cm·1 (aliphatic C-H stretching), 1653 cm·1 (C=O stretching),
1514 and 1444 cm·1 (aromatic C=C stretching).
A literature search for the compound indicated that it was 5,7-dihydroxy-8-methoxy-3-(4'-
hydroxybenzyl)-4-chromanone previously isolated from Eucomis comosa (Houtt.) Wehrh. and
Eucomis pallidiflora Baker.15,16 Comparison of the carbon data proved them to be very close
indeed. 16
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OH Oc HMBC COSY NOESY
(ppm) (ppm) (ppm) (C~H)
2a 4.20 (dd, 6.4,11.5 Hz) 2b;3 3;2b;9a;2'/6'
69.41 69.4 9a,b
2b 4.33 (dd, 3.9, 11.5 Hz) 2a 3;2a;2'/6'
3 2.81 (m) 46.77 46.8 9a 2a 3;9a;2'/6'
4 197.70 197.7 2a,b
4a a 102.4 5-0H;6
5 157.71 157.7 6
6 6.12 (5) 95.87 95.9 5-0H 5-0H
7 160.25 160.2 5-0H;6
8 a 127.6 8-0CH3
8a 152.99 153.0 2a
9a 2.72 (dd, 10.3, 13.2 Hz) 9b 2b;3;9b;2'/6'
31.91 31.9 2'/6'
9b 3.13 (dd, 4.3,13.2 Hz) 9a 2a;3;9a;2'/6'
l' 129.79 129.8 3;3'/5'
2'/6' 7.09 (d, 8.6 Hz) 130.29 130.3 9a,b 3';5'
3;2a,b;9a,b;3'/
5'
3'/5' 6.77 (dd, 8.6 Hz) 115.58 115.6 2'/6' 2';6' 2'/6'
4' 154.47 154.4 3'/5';2'/6'
5-0H 11.74(5) - 6
8-0CH3 3.91 (5) 61.51 61.5
* Literature values obtained in CDC13.
16
a Resonance was too weak to be determined.
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6.3 Experimental
Material of Ledebouria revo/uta (L.f.) Jessop was collected from Long Tom Pass, Mpumalanga,
and a voucher retained (N. Crouch 853, NH).
The bulbs (mass 0.6 kg) were dried, chopped into smaller pieces and extracted successively with
dichloromethane and methanol by agitation on a Labcon Mechanical shaker at 140 rpm. The
extracts obtained were then filtered and the solvent removed under reduced pressure, to give a
dichloromethane extract (5.00 g) and a methanol extract (15.00 g).1H NMR analysis of the crude
methanol extracts showed nothing of interest and the extract was not investigated further.
The dichloromethane extract was loaded onto a 5 cm diameter column and eluted with a step
gradient solvent system collecting 50 ml fractions at a time (100% dichloromethane fractions 1-
20; 5% ethyl acetate in dichloromethane fractions 21-40; 10% ethyl acetate in dichloromethane
fractions 41-60; 20% ethyl acetate in dichloromethane fractions 61-80; 40% ethyl acetate in
dichloromethane fractions 81-100; 100% ethyl acetate in dichloromethane fractions 101-120).
Purification of fractior;ls 7-12 using a 20% ethyl acetate in hexane solvent system afforded
compound XV at a yield of 0.3% (15.7 mg). Purification of fractions 39-43 using a 30% ethyl
acetate in dichloromethane solvent system afforded compounds XVI at a yield of 0.7% (32.5 mg)
and compound XVIII, at a yield of 0.3% (15.0 mg). Purification of fractions 82-89 using a 40%
ethyl acetate in hexane solvent system afforded compound XVII at a yield of 1% (50.3 mg).
6.3.1 Physical data for Compound XV
Name: 5,7-dihydroxy-3-(4' -methoxybenzyl)-4-chromanone
Yield: 15.7 mg
Physical description: white needle-like crystals
Melting Point: 152-154°C (lit. 161_163)10,11
Optical rotation: -2.50 (c, 0.16 in methanol) (value not given in literature)
Mass spectrum: GC-MS: [M+] at m/z 300, C17H160 S requires 300.09974 g. mor1
ElMS m/z: 300, 121
Infrared: v ~:;l cm-
1
: 3460 (O-H stretching), 2927 (C-H stretching), 2868 (C-H stretching), 1653
(C=O stretching), 1514 and 1444 (C=C stretching)
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1H NMR: OH (ppm) CDCI3: Table 6.2
13C NMR: Oc (ppm) CDCI3: Table 6.2
6.3.2 Physical data for Compound XVI
Name: 5,7-dihydroxy-3-(4'-hydroxybenzyl)-4-chromanone
Yield: 32.5 mg
Physical description: white needle-like crystals
Melting point: 97-100°C (lit. 103_104oC)12.13
Optical rotation: -12.38 (c.0.214 in methanol) (lit. -34°, c 0.4 in methanol)12.13
Mass spectrum: GC-MS: [M+] at m/z 286, C1sH140S requires 286.084124 g. mor1
ElMS m/z: 286,180,171,153,133,107
Infrared: v~~l cm-1: 3430 (O-H stretching), 2930 (C-H stretching), 2852 (C-H stretching), 1619
(C=O stretching) and 1521 (C=C stretching)
UV: A~:;12 nm (log c): 214.0 (5.8), 291.0 (5.6)
with AICI3: 331.0
with NaOAc: 316.0
1H NMR: OH (ppm) CDCI3: Table 6.3
13C NMR: Oc (ppm) CDCI3: Table 6.3
6.3.3 Physical data for Compound XVII
Name: 7,8-dimethoxy-5-hydroxy-3-(4'-hydroxybenzyl)-4-chromanone
Yield: 50.3 mg
Physical description: white, amorphous material
Melting point: 121-123°C
Optical Rotation: -19.94 (c, 0.178 in methanol) (lit. -15°, cO.4 in methanol)14
Mass spectrum: HRMS: [M+] at m/z 330.11133, C1sH1S0S requires 330.110339 g. mor1
ElMS mlz: 330,209,181,107
Infrared: v ~~l cm,1: 3460 (O-H stretching), 2927 (C-H stretching), 1653 (C=O stretching) and
1514 and 1414 (aromatic C=C stretching).
UV: A:~12 nm (log c): 356.0 (5.2), 291.0 (5.8)
with AICI3 : 318.0
with NaOAc: 291.0
1H NMR: OH (ppm) CDCI3: Table 6.4
13C NMR: Oc (ppm) CDCI3: Table 6.4
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6.2.4 Physical data for Compound XVIII
Name: 5,7-dihydroxy-8-methoxy-3-(4'-hydroxybenzyl)-4-chromanone
Yield: 15.0 mg
Physical description: yellow amorphous material
Optical rotation: -7.796 (c, 0.186 g in methanol) (lit. -37(dioxin»17
Mass spectrum: GC-MS: [M+] at m/z 316, C17H160 6requires 316.094688 g. mor
1
ElMS m/z: 316,210,209,183,107
Infrared: v ~:~I cm-1: 3380 (O-H stretching), 2922 (C-H stretching), 1637 (C=O stretching) and
1522 (C=C stretching)
UV: A ~,::11 nm (log E): 289.0 (5.5), 206.0 (5.8)
with AICI3: 311.0
with NaOAc]: 325.0
1H NMR: bH (ppm) CDCI3: Table 6.5
13C NMR: be (ppm) CDCI3: Table 6.5
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Chapter 7: Extractives from Drimia macrocentra and
Urginea riparia
7.1 Introduction
Drimia macrocentra (Baker) Jessop (syn. Urginea macrocentra Baker) of the Hyacinthaceae
family (Liliaceae sensu lato) has been placed in the subfamily Urgineoideae. This plant is
commonly called the Natal Slangkop as the leaf/inflorescence resembles an elevated snake's
head. Although for many years its ingestion has been blamed as a cause of mortality in
stock,1,2 no phytochemical analyses have been reported for this species.
Drimia macrocentra (Figure 7.1) is distributed in South Africa along the coast and uplands of
KwaZulu-Natal, extending as far south as the Transkei of the Eastern Cape.1 It grows in
moist or marshy ground at altitudes up to 2685 m.1 The bulbs may attain a diameter of 5 cm,
and are an ovoid shape. The bulbs have very characteristic white outer scales that are fleshy
and brittle.1
This plant is known to the Zulu as ujobo and the bulb is highly esteemed as an anthelmintic
agent.1
Urginea riparia Baker is a poorly understood bulbous species found both in the Midlands and
coastal regions of KwaZulu-Natal and the Transkei of the Eastern Cape. It frequents rocky,
exposed stream and riverside habitats (as suggested by its specific epithet), growing usually
in clumped colonies with its bulbs submerged and leaves erect and emergent. Its relation to
other urgineoids of the Hyacinthaceae remains to be properly elucidated, for at present its
closest relative appears to be Drimia calcarata (Baker) Stedje (syn. Urginea calcarata (Baker)
Hilliard & Burtt) under which it has been synonymised (as syn. Drimia modesta (Baker)
Jessop).3
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Figure 7. 1 Dlustration of Drimia IIUlCrocentra from MitcheUJ
This is the first reported phytochemical study on both Drimia macrocentra and Urginea riparia.
The dichloromethane and methanol extracts of the plant bulbs were investigated. This led to
several bufadienolide - rich fractions in very low concentrations however only two
bufadienolides were isolated (Figure 7. 2). Of the compounds isolated, one (XX) has not
been reported previously. The compounds isolated were rubellin (compound XIX, from
Drimia maaocentra) and riparian (compound xx, from Urginea riparia).
HO•.•.
~










Figure 7. 2 Compounds isolated from Drimia IIUlCrocentra and Urginea riparia
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7.2 Results and Discussion
7.2.1 Structural Elucidation of Compound XIX, Rubellin (spectra 19.a-i)
Figure 7. 3 Structure of compound XIX, rubellin
Rubellin (compound XIX) was isolated as the major constituent from the methanol extract of
Drimia macrocentra. The structure proposed below from the NMR spectra suggested a molar
mass of 620 g. mor1• However the molecular ion peak was not seen in the FAB mass
spectrum but the highest peak at m/z 5861 was seen suggesting the loss of two hydroxy
groups.
The 1H NMR spectrum showed the Characteristic resonances at OH 7.54 (d, 2.6 Hz) (H-21), OH
7.92 (dd, 2.6, 9.7 Hz), H-22) and OH 6.34 (d, 9.7 Hz, H-23), which, together with the presence
of the two methyl group proton resonances at OH 1.09 (s, 3H-18) and OH 1.72 (s, 3H-19),
indicated the presence of a bufadienolide. The C-21 and C-22 resonances showed 3J HMBC
correlations to the resonance at OH 4.08 (t, 8.8 Hz) assigned to H-17. The C-17 resonance, in
turn, showed a 3J HMBC correlation to the methyl resonance at OH 1.09 (s) assigned to 3H-18.
The resonance at Oc 86.69 was ascribed to C-14 on the basis of a 3J HMBC correlation with
the 3H-18 resonance and a hydroxy group was placed at this position by comparison with
literature.4
The 13C NMR spectrum showed the presence of two carbonyl resonances at Oc 164.64 and Oc
214.95. The resonance at Oc 164.46 was assigned to the carbonyl group of the lactone ring
(C-24) as it showed HMBC correlations to the H-21, H-22 and H-23 resonances. The
remaining carbonyl resonance was assigned to C-12 due to a 3J HMBC correlation with the
3H-18 resonance. A further HMBC correlation from C-12 to the resonance at OH 5.21 (d, 12.3
Hz) led to it being assigned to H-11. The corresponding carbon resonance in the HSQC
spectrum was at Oc 73.58 which indicated the presence of a oxygen substituent and a
hydroxy group was placed at this position by comparison with literature.4 The H-11 resonance
T FAB HRMS of compound is currently being completed to confirm the molecular ion
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showed a correlation in the COSY spectrum to the resonance at OH 1.65 (d, 12.3 Hz) which
was assigned to H-9. The C-9 resonance at Oc 54.48 showed a 3J HMBC correlation to the
second methyl group proton resonance (OH 1.72 (s» assigned to 3H-19. The resonance at Qc
41.35 showed HMBC correlations to 3H-19 and H-11 resonances and was assigned to C-10.
A further HMBC correlation were seen between C-10 and to the resonance at OH 5.47 (d, 1.8
Hz), which was seen to correspond to a carbon resonance at Oc 126.98 in the HSQC
spectrum which was assigned to C-4 and enabled the placement of the double bond between
C-4 and C-5. The H-4 resonance showed a correlation in the COSY spectrum to the
resonance at OH 5.47 (d, 1.8 Hz), which had a corresponding carbon resonance at Oc 79.87
and was assigned to H-3. A further correlation in the COSY spectrum between the H-3
resonance and a resonance at OH 5.22 (brs) with a corresponding carbon resonance at OH
72.39 in the HSQC spectrum indicated a further oxygen substituent at C-2. The resonance at
Oc 75.03 was assigned to C-6 on the basis of a 3J HMBC correlation to H-4 and a hydroxy
group was placed at C-6. The stereochemistry of the hydroxy group at C-6 was determined
using the NOESY spectrum: the absence of a NOESY correlation between the 3H-19 and H-6
resonances implied H-6 was not~. The fully substituted carbon resonance at Oc 78.98 was
ascribed to C-8 on the basis of a 3J HMBC correlation with H-6 and a hydroxy group was
placed at C-8.
The stereochemistry at C-11 was determined through the NOESY spectrum. A correlation in
the NOESY spectrum between both the 3H-18 and the 3H-19 methyl group proton signals
and the H-11 resonance indicated H-11 was in a ~ position. Similarly a correlation in the
NOESY spectrum between the 3H-19 methyl group proton singlet resonance and the H-1
resonance at BH 2.86 allowed for the assignment of a ~ orientation to this proton and hence
assignment of the a orientation to the other H-1 resonance at OH 1.40.
The glycone part of the bufadienolide glycoside was found to be a carbohydrate moiety
doubly linked to the aglycone at the C-2 and C-3 positions. The NOESY spectrum showed
this linkage to be a at C-2 and ~ at C-3. The H-1 ~ resonance showed a positive correlation to
the H-2 proton and it was assigned the ~ configuration. The H-2~ resonance showed no
correlation in the NOESY spectrum to the H-3 proton hence H-3 was assigned the a
configuration. The hemiacetal carbon resonance at Bc 98.86 was assigned to C-1', the acetal
(C-3') carbon resonance occurred at Bc 100.21. A methoxy group was attached to C-3' as
shown by a 3J correlation between C-3' and the methoxy group proton resonance. The
resonance at Bc 70.08 was assigned to C-2' on the basis of a 2J correlation to H-1' and further
2J HMBC correlations between C-1' and C-3' and the H-2' proton. The C-2' resonance
showed a further 3J correlation to a resonance at OH 3.67 (d, 1.7 Hz) this was assigned to H-
4'. The corresponding carbon resonance in the HSQC spectrum was at Oc 71.80 implying the
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presence of an oxygen substituent. This substituent was determined to be an hydroxy group
by comparison with literature. In turn, C-4' showed a 3J correlation to a methyl group
resonance at OH 1.23 (d, 6.2 Hz), which was assigned to H-6'. The remaining resonance in
the 13C NMR spectrum was at be 74.83 implying the presence of an oxygen substituent. This
was assigned to C-5'. The HMBC together with by comparison with literature determined C-5'
and C-1' to be linked via an ether linkage.4 The stereochemistry of the various substituents of
the carbohydrate moiety was again determined using the NOESY spectrum in conjunction
with a molecular model. No correlation in the NOESY spectrum were seen between H-3a
and H-1' indicating the orientation of H-1' to be~. A positive correlation in the NOESY
spectrum between H-1'~ and H-2' indicated the orientation of H-2' to be~. The H-2'
resonance showed a correlation with the 3'-methoxy group proton resonance indicating the
orientation of the methoxy group to be~. This implied the H-3' which was also attached to C-
3' was a oriented. The H-3' resonance showed a correlation in the NOESY spectrum to H-S'
indicating it to be a. This resonance, in turn, showed a correlation to H-4'.
The IR spectrum supported the postulated structure. In the IR spectrum peaks were
observed at 3420 cm-1 (O-H stretching), 2923 cm-1 (aliphatic C-H stretching), 1708 cm-1 (C=O
stretching). A literature search for the compound indicated it to be rubellin isolated previously
from Drimia modesta (Baker) Jessop (as Urginea rubella Baker).4 This bufadienolide
glycoside was previously isolated in 1949 but its structure was only elucidated in 1988.4
Comparison of the NMR data proved to be difficult as they were run in different solvents and
one did see discrepancies. The assignments in literature was done without the aid of 20
experiments and will require correcting. Table 7.1 shows the 1H and 13C NMR data together
with the HMBC, COSY and NOESY NMR data.
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Table 7.1: 1H, 13C, HMBC, COSY and NOESY data for rubellin (CD30D)
BH Bc Bc HMBC
COSY NOESYCarbon
(ppm) (ppm) (ppm) (C~H)
10. 1.40 (d, 13.5 Hz) 1P;2 1P;9
47.75 47.33 9;19
1P 2.86 (dd, 3.5,13.5 Hz) 10. 10.;2;19
2 5.22 (brs) 72.39 74.99 10.;3;4 1P;3 1P;19
3 4.55 (dd, 1.8,8.1 Hz) 79.87 73.78 10.,p 2;4 4;5'
4 5.47 (d, 1.8 Hz) 126.98 127.56 2;6 3 3;6
5 146.52 145.16 6;19
6 4.50 (m) 75.03 71.88 4;70. 70.,p 4;7,p
70. 1.54 (dd, 4.6, 7.4 Hz) 6;70. 6;7p
38.67 40.94
7P 2.54 (dd, 4.6, 14.3 Hz) 6;7p 6,70.
8 78.98 78.72 6;7;9
9 1.65 (d, 12.3 Hz) 54.48 48.37 11 ;19 11 10.
10 41.35 38.51 10.;4;9;11 ;19
11 5.21 (brs) 73.58 72.94 9 9 18;19
12 214.95 214.73 9;11;17;18
13 63.84 63.15 160.,p;17;18
14 86.69 86.26 160.,p;17;18
150. 1.74 (m) 15P;160.,P 160.
35.14 34.78





16P 1.76 (dd, 3.5,8.4 Hz) 150.,p;160.;17 15P;160.;22
17 4.08 (t, 8.8 Hz) 42.99 42.64 18;21 160.,P 160.;18;21 ;22
18 1.09 (5) 20.57 18.00 11 ;17;21 ;22
19 1.72(5) 24.12 24.14 19 1P;11
20 123.01 121.43 17;21;23
21 7.54 (d, 2.6 Hz) 151.34 150.87 17;22 22 17;18
22 7.92 (dd, 2.6,9.7 Hz) 148.95 147.32 17;21 21;23 16P;17;18;23
23 6.34 (d, 9.7 Hz) 115.99 115.92 23 22
24 164.46 161.72 21;22;23
l' 5.16 (d,4.8 Hz) . 98.86 98.23 2' 2' 2'
2' 4.39 (d, 4.8 Hz) 70.08 79.23 1';4' l' l'
3' 100.21 99.90 1';2';4;3'-OCH3 5'
4' 3.67 (d, 1.7 Hz) 71.80 70.15 6' 5';6' 5';6'
5' 4.66 (dd, 1.7,6.3 Hz) 74.83 71.80 1';6' 6' 3;4';6'
6' 1.23 (d, 6.3 Hz) 17.94 20.44 5';6' 5' 4';5'
OCH3 3.34 (5) a u
a Peak obscured by solvent.
b Carbon value not given in literature.; * Literature sample run in d6-acetone.
4
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7.2.2 Structural Elucidation of Compound XX, 16J3-Acetoxy-6J3,12J3-deoxyrubellin
(riparian) (spectra 20.a-l)
o
Figure 7. 4 Structure of compound xx, riparian
Compound XX was isolated as white crystals from the methanol extract of Urginea riparia.
The structure derived from the. NMR spectra above required a molecular formula of
C33H42013. However the FAB MS showed a highest peak at m/z 604T corresponding to the
loss of CH2CO fragment. The loss of 42 mass units can occur for acetate groupS.5 This
compound was found to be closely related to rubellin with a acetoxy group occurring atC-16J3,
and lack of hydroxy groups at C-6J3 and C-8J3 which were present in rUbellin.
The 1H NMR spectrum showed the characteristic resonances of the lactone ring of the
bufadienolide skeleton (H-21 , 7.56 (brs), H-22, 8.35 dd (9.9, 2.6 Hz) and H-23, 6.23 d (9.9
Hz). The NMR spectra of compound XX were found to be similar to those rubllein from
Drimia macrocentra. However, the tertiary hydroxy group at C-8, and the secondary hydroxy
group at C-6 were missing from this compound. This compound instead showed the
presence of a acetoxy group at C-16. This deduction was made through a correlation seen in
the COSY spectrum between the H-17u resonance and the resonance at 5.44 (m) which was
assigned to H-16. The carbonyl carbon resonance of the acetate group also showed a 3J
correlation to the H-16 resonance and the acetate group was placed at C-16. This deduction
was further confirmed with the aid of the HMBC spectrum, which showed a 3J correlation from
the C-14 resonance to the H-16 proton resonance at OH 5.44 (m). The stereochemistry was
determined by use of the NOESY spectrum and a model. A positive correlation was seen in
the NOESY spectrum between the H-17a resonance and the H-16 resonance implying H-16
was a. A correlation in the COSY spectrum between the H~9 resonance at OH 1.44 (m) and
the resonance at OH 2.23 (m) led to the assignment of H-8. A correlation in the NOESY
spectrum between the 3H-19 and the H-11 resonances indicated that H-11 was in the J3
orientation. A correlation in the NOESY spectrum between the H-11 J3 and the H-8
T FAB HRMS is currently being done to confirm molecular formula.
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resonances indicated that H-8 was in the ~ orientation. The aglycone was assigned to be a
carbohydrate moiety as in the previous compound (compound XIX).
The infrared spectrum and ultraviolet spectrum confirmed the postulated structure. Peaks
were observed at 3418 cm-' (O-H stretching). 2935 cm-' (aliphatic C-H stretching) and 1706
cm-' (C=O stretching).
A literature search for the compound was undertaken and it was found to be a novel structure.
It was named riparian. Table 7.2 showed the HMBC, COSY and NOESY data.
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10. 1.92 (d, 13.4 Hz) 1P;2 1P;11
45.54 19
1P 3.18 (d, 13.4 Hz) 10.;2 1a.; 19
2 5.66 (brs) 72.53 4 1a.,p;3 19
3 4.85 (d, 7.7 Hz) 79.17 1';2 1;2;4 4
4 5.41 (5) 122.56 3 3
5 144.42 19
6 2.41 (d, 11.7 Hz) 28.92 7 7
7 1.12 (m) 29.93 6;8 6;8
8 2.23 (m) 41.07 19 7;9 7;11
9 1.44 (m)a 53.95 11 ;19 8;11
10 41.28 1;4;19




15 1.98 (m) 40.34 16 16 16
16 5.44 (m) 73.55 15;17 15;17 15;17
17 4.67 (d, 8.8 Hz) 47.19 15;18 16 16;18;21
18 1.09 (5) 17.73 17;21;22
19 1.22 (5) 19.90 9;19 1P;2;11
20 116.38 17;21;23
21 7.56 (brs) 152.94 17 22 17;18
22 8.35 (dd, 9.9, 2.6 Hz) u 17;21 21;23 18;23
23 6.23 (d, 9.9 Hz) 113.37 22 22
24 161.63 21;23
l' 5.71 (d, 4.8 Hz) 98.81 2' 2'; 3 2'
2' 5.21 (d, 4.8 Hz) 69.75 ·1';4' l' l'
3' 100.33 1';2';4';3'-OCH3
4' 4.01 (5) 71.66 6' 5' 5';6';3'-OCH3
5' 4.97 (d, 6.3 Hz) 73.90 6';1' 4';6' 4';6'
6' 1.46 (d, 6.3 Hz) 18.44 5' 4';5'
3'-OCH3 3.47 (5) 48.29 4'
16-.QOCH3 169.78 16;16-CO.QH3
16-CO.QH3 1.58 (5) 20.60
aPeak obscured.
b Under solvent peak.
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7.3 Experimental
The plant material of Urginea riparia Baker was collected from Lupitana Gorge in the Transkei
and a voucher specimen retained (Crouch, Styles and Van den Bergh 921, NU).
The bulbs (3 kg) were dried. chopped into smaller pieces and extracted successively with
dichloromethane and methanol by agitation on a Labcon Mechanical shaker at 140 rpm for 24
hours. The extracts obtained were then filtered and the solvent removed under reduced
pressure to yield a dichloromethane extract (1.20 g) and methanol extract (15.00 g). Analysis
of the crude methanol extract resulted in no compounds being isolated from this extract.
The dichloromethane extract was loaded onto a 2 cm diameter column and eluted with a step
.. gradient solvent system collecting 100 ml fractions (100% dichloromethane fractions 1-3; 10%
ethyl acetate in dichloromethane fractions 4-17; 20% ethyl acetate in dichloromethane
fractions 18-25; 50% ethyl acetate in dichloromethane fractions 26-40; 100% ethyl acetate in
dichloromethane fractions 41-51). Purification of fractions 26-40 using a 20% ethyl acetate in
dichloromethane solvent system afforded partially pure compound XX. Final purification was
obtained using a Sephadex column eluted with 100% methanol to afford compound XX at a
yield of 1.1 % (13 mg).
Drimia macrocentra (Baker) Jessop (syn. Urginea macrocentra Baker) was collected at
Bushman's Nek, in the KwaZulu-Natal Drakensberg, and a voucher specimen retained a (N.
Crouch, NH 938).
The bulbs (0.65 kg) were dried, chopped into smaller pieces and extracted successively with
dichloromethane and methanol by agitation on a Labcon Mechanical shaker at 140 rpm. The
extracts obtained were then filtered and the solvent removed under reduced pressure. A
dichloromethane extract (3.00 g) and methanol extract (27.00 g) were obtained. TLC analysis
of the dichloromethane and methanol extracts showed that they were very similar and they
were combined.
The extract was loaded onto a 5 cm diameter column and eluted with a step gradient solvent
system collecting 50 ml fractions (100% dichloromethane fractions 1-3; 5% ethyl acetate in
dichloromethane fractions 4-14; 10% ethyl acetate in dichloromethane fractions 15-27; 50%
ethyl acetate in dichloromethane fractions 28-63; 5% methanol in dichloromethane fractions
64-83; 10% methanol in dichloromethane fractions 84-107). Purification of fractions 64-83
using a 2% methanol in dichloromethane solvent system afforded partially pure compound
XIX. Final purification was obtained using a Sephadex column eluted with 100% methanol
and afforded compound XIX at a yield of 0.3% (15 mg).
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7.3.1 Physical data for Compound XIX
Name: rubellin
Yield: 15 mg
Physical description: yellow gum
Optical rotation: sample was too little to obtain a stable reading.
Mass spectrum: [M+] not seen, C31H4Q013 requires 620.246982 g. mor1
ElMS m/z: 586, 530, 458, 373, 191, 149, 129, 109
Infrared: V;:;I cm-1: 3420 (O-H stretching), 2923 (C-H stretching), 1708 (C=O stretching)
1H NMR: OH (ppm) CD30D: Table 7.1
13C NMR: Oc (ppm) CD30D: Table 7.1
7.3.2 Physical data for Compound XX
Name: riparian
Yield: 13 mg
Physical description: brownish gum
Optical rotation: +18.18 (c, 0.022 in methanol)
Mass spectrum: [M+] not seen, C33H42013 requires 646.262542 g. mor1
ElMS: 604 [M+-CH2COY, 430,390,191,149,136,123
Infrared: V;:;I cm-1: 3418 (O-H stretching), 2935 (C-H stretching), 1706 (C=O stretching)
1H NMR: OH (ppm) CsDsN: Table 7.2
13C NMR: Oc (ppm) CsDsN: Table 7.2
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Chapter 8: Screening Results and Conclusion
The various compounds isolated in the current study were screened in the cancer, anti-
oxidant and inflammatory cell line screens. These cell lines were chosen due to their
availability at the time of the study.
8.1 Anti-cancer Screening
The anti-cancer bioassays were undertaken at the CSIR Bio/Chemtek laboratories in Pretoria
under the supervision of Dr. V. Maharaj.
The three cell line prescreening method, which was developed by the National Cancer
Institute (USA), was used in testing compounds isolated for anticancer activity. The three cell
line prescreen identifies a large proportion of the compounds that would be inactive in multi-
dose 60 cell line screening.1 Computer modeling indicates that approximately 50% of
compounds can be eliminated by this prescreen without a significant decrease in the ability to
identify active agents, while increasing the throughput and efficiency of the main cancer
screen with limited loss of information.1 The three cell lines utilized were MCF7 (breast),
TK10 (renal) and UACC62 (melanoma).
These results are presented as dose-response curves for each sub panel (melanoma, breast,
renal). The dose-response curve is a plot of the PG (percent growth) against the
concentration for each cell line. The response parameters Glso (50% growth inhibition), TGI
(total growth inhibition) and LC50 (lethal concentration killing 50%), are interpolated values
from these graphs representing the concentrations at which PG is +50, 0 and -50
respectively. Table 8.1 gives the TGI values for compounds tested.
Table 8.1. Cancer Screening Results
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IV








Inactive in renal cell line
Inactive in all three cell lines
Inactive in all three cell lines
20 (melanoma)


















Compounds I, IV, VI, XIV (Figure 8. 1-4) were all inactive in the three cell lines tested.
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1.00802
Figure 8. 1 Dose-response curves of compound I
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Figure 8. 3 Dose-response curve of compound VI
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6.25E+OO 1.25E+01 2.50E+01 5.00E+01 1.00E+02
Extract concentration (IJglm)
Figure 8. 4 Dose-response curves of compound XIV
Compound ill (Figure 8. 5) showed TGI values of approximately 55 ppm in the melanoma
and breast cell lines and approximately 60 ppm in the renal cell lines. These results indicate
that compound ID has weak anti-cancer activity.
__ eellline 1 (Renal)
__ Cell One 2 (MeIa~a)













6.25E+00 1.25E+01 2.50E+01 5.00E+01 1.00E+02
Extract concentration (pg/RII)
Figure 8. 5 Dose-response curves of compound ID
Compound V (Figure 8. 6) showed TGI values of < 6.25 ppm in the melanoma cell line and
approximately 39 ppm and 100 ppm activity in the renal and breast cell lines respectively.
These results indicate moderate to weak anti-cancer activity. The different graphical profiles
of the three different cancer cell lines against compound V indicate the possibility of
compound V being non - cytotoxic. All cells being killed at very similar concentration values
and at very low concentrations is indicative of cytotoxicity.
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__ Celf line 1 (Renal)
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Extract concentration (lJglmI)
Figure 8. 6 Dose--response CUIVes of compound V
Compound vn (Figure 8. 7) showed TGI values of 20 ppm in the melanoma cell line only and


















-.Ir- Gel/line 3 (Bl9aSt)
Figure 8. 7 Dose--response CUIVes of compound vn
Compound xm (Figure 8. 8) showed TGI values of 100 ppm in the breast and melanoma
cell lines and was inactive in the renal cell line. These results indicate very weak anti-cancer
activity.
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Figure 8. 8 Dose-response curves for compound xm
Compound XX (Figure 8. 9) showed TGI values of <3.5 ppm in the renal, <7 ppm in the
breast and <10.5 ppm in the melanoma cell line. These results indicate moderate anti-cancer
activity. The different graphical profiles of the three cell lines against' compound XX indicate
the possibility of its being non-cytotoxic. All cells being killed at very similar concentration
values and at very low concentrations is indicative of cytotoxicity. However bufadienolide
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Figure 8. 9 Dose-response curves of compound XX
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8.2 Anti-oxidant Screening
The anti-oxidant bioassays were carried out at the CSIR Bio/Chemtek laboratories in Pretoria
under the supervision of Or V. Maharaj.
The OPPH (2,2-diphenyl-1-'picrylhydrazyl radical) method was used to determine the
antioxidant activity. This test has become widely used since its publication in 2000.
2
It
involves the measurement of the disappearance of OPPHo into the reduced form (DPPH-H):
OPPHO (purple) + (AH)n~ OPPH-H (yellow) + (AO)n
Usually the colour change from purple to yellow is evaluated by measuring the disappearance
of the purple colour at 515 nm but it can also be recorded by monitoring the appearance of
the yellow product.
Each sample (35 !!I. 100 ppm) was added to a well in an ELlSA plate. which contains 315 !!I
of 90 !!M DPPH dissolved in methanol. The plate was covered in aluminum foil and left to
stand at room temperature for 1 hour. The radical scavenging capacities of the samples were
determined by using a 340 ATC ELlSA Plate Reader to measure the disappearance of OPPH
at 515 nm.
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Figure 8. 10 Anti-oxidant activity of compounds tested at a concentration of 100 ppm
The anti-oxidant activity results were found to be low (Table 8.2 and Figure 8. 10) at 100
ppm, except for compound xvm which showed a 97.48% decolourisation of the DPPH
radical. Further tests, varying the concentration of compound xvm (5,7-dihydroxy-8-
methoxy-3-(4'-hydroxybenzyl)-4-chromanone) were conducted.
170
Chapter 8: Screening results and Conclusion





Figure 8. 11 Dose-response curve of compound xvm in antioxidant assay
As the concentration of the compound (Figure 8. 11) is decreased the anti-oxidant activity
decreases. A more desirable result would have seen the anti-oxidant actiVity remain high at
lower concentrations for compound xvm. This was not observed (Figure 8. 11), and further
tested were not undertaken.
8.3 Anti-Inflammatory Screening
The anti-inflammatory activity screening involved the use of microsomal cells and the
enzymes, cyclooxygenase (COX-1 and COX-2). Enzyme assays are especially useful in
evaluating the effects of traditional remedies for inflammation and pain related to the
production of prostaglandins. 4 COX-1 and COX-2 are the enzymes responsible, in the
arachidonic acid cascade, for the formation of prostaglandins. Non-steroidal, anti-
inflammatory drugs (NSAIDS) act by inhibiting the activity of COx. The COX assay is an
example of a mechanism-based assay that uses enzymes to detect inhibitors of inflammation.
This bioassay tests for the presence of NSAlDS by measuring the degree of inhibition of COX
enzyme activity. The percentage inhibition is measured against indomethacin as a positive
control.
The COX-1 and 2 bioassays as well as the microsomal cell tests were carried out by a
colleague, Karen du Toit at the University of KwaZulu-Natal, Pietermaritzburg, under the
supervision of Prof. J. van Staden.
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Figure 8. 12 Anti-inflammatory activity of compounds tested
The results for the microsomal cell tests were good (Figure 8. 12). However the results for
COX-1 and COX-2 inhibition were low compared to the control. The control used was
indomethacin, which had an inhibition of 70%. By changing the functional group at C-5 from a
hydroxy group (compound XXIll) to a methoxy group (compound XXIV) the percentage
inhibition dropped by 24% for the microsomal cell and the actiVity in the COX-1 assay
decreased from 31% to OOAl activity for XXIV. Compound XVL which had three hydroxy
substituents on the structure, showed good inhibition of COX-1.
8.4 Conclusion
Twenty one compounds were isolated during this study, ten compounds were isolated for the
first time and four plants (possibly five) were also studied phytochemically for the first time.
Two representatives of the Amaryllidaceae were investigated. The phytochemistry of
Brunsvigia nata/ensis was studied for the first time and yielded four compounds. two novel
alkaloids, one flavanoid and a novel ceramide type of compound (Figure 8.13). This is the


















Figure 8. 13 Compounds isolated from Brunsvigia natalensis
The study on Crinum stuhlmannii was undertaken as a previous one by Nair et al.5 reported
on material collected from a region (Natal Midlands) not likely to fall within the natural
distribution of this species. As the botanical voucher proved untraceable, an attempt was
made to verify the earlier report. Secondly, a comparative study of the bulbs and seeds was
carried out to identify organ-specific production of chemical constituents in an amaryllid. This
led to the isolation of eleven alkaloids (V-XIV) (Figure 8. 14). 6-Hydroxycrinamine and
·Iycorine were the only two constituents common to the current and earlier study. In the
previous study Nair et al.5 isolated a novel alkaloid named delagoenine in their study of the
bulbs, which at that stage was the only reported crinane type alkaloid possess a hydroxy
group at C-12. In the current study the N-methyl derivative of delagoenine (Compound XIII)
was isolated which leads one to conclude that possibly the bulbs studied in the previous study
were in fact the same. In the present study, the only constituent common to bulbs and seeds
of C. stuhlmannii was 6-hydroxycrinamine and this was isolated in fairly large yields from both
sources. Notably, none of the novel alkaloids (stuhlmanine A, S, C, 0 or N-methyl
delagoenine), were isolated from both sources, indicating that these constituents are organ-
specific.
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Figure 8.14 Compounds isolated from Crinum stuhlmannii
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Representatives of two of the southern African Hyacinthaceae sub-families were investigated











Figure 8. 15 Compounds isolated from Ledebouria revoluta
Drimia macrocentra and Urginea riparia (Urgineoideae) yielded one bufadienolide glycoside













Figure 8. 16 Compounds isolated from Drimia macrocentra and Urginea riparia
The compounds isolated were also tested for activity in cancer, anti-oxidant and anti-
inflammatory cell lines. None showed significant actiVity warranting further analysis.
The stUdy of natural product chemistry however is still motivated by the potential discovery of
new drugs that could be developed for use in clinical medicine.
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Spectrum La: lH NMR spectrum of compound I (COCls)
Spectrum lob: lSC NMR spectrum of compound I (COCls)
Spectrum I.c: HSQC spectrum of compound I (COCls)
Spectrum I.d: HMBC spectrum of compound I (COCls)
Spectrum I.e: COSY spectrum of compound I (COCls)
Spectrum 1.f: NOESY spectrum of compound I (COCls)
Spectrum log: Mass spectra of compound I
Spectrum 1.h: Infrared spectrum of compound I
Spectrum I.i: CO spectrum of compound I
Compound 11:
Spectrum 2.a: lH NMR spectrum of compound IT (COCls)
Spectrum 2.b: lSC NMR spectrum of compound IT (COCls)
Spectrum 2.c: HSQC spectrum of compound IT (COCls)
Spectrum 2.d: HMBC spectrum of compound IT (COCls)
Spectrum 2.e: COSY spectrum of compound IT (COCls)
Spectrum 2.f: NOESY spectrum of compound IT (COCls)
Spectrum 2.g: Mass spectrum of compound II
Spectrum 2.h: Infrared spectrum of compound IT
Spectrum 2.i: CD spectrum of compound IT
Compound ill:
Spectrum 3.a: lH NMR spectrum of compound III (COCls)
Spectrum 3.b: l H NMR spectrum of compound III (COsOO)
Spectrum 3.c: 13C NMR spectrum of compound III (COCI3)
Spectrum 3.d: AOEPT spectrum of compound III (COCls)
Spectrum 3.e: HSQC spectrum of compound ITI (COCls)
Spectrum 3.f: HMBC spectrum of compound III (COCI3)
Spectrum 3.g: COSY spectrum of compound III (COCls)
Spectrum 3.h: NOESY spectrum of compound III (COCls)
Spectrum 3.i: Mass spectrum of compound III
Spectrum 3.j: Infrared spectrum of compound III
































Spectrum 4.a: 1H NMR spectrum of compound IV (COCls)
Spectrum 4.b: 1H NMR spectrum of compound IV (CDsOD)
Spectrum 4.c: 1SC NMR spectrum of compound IV (CDCIs)
Spectrum 4,d: ADEPT spectrum of compound IV (CDCls)
Spectrum 4.e: HSQC spectrum of compound IV (CDCls)
Spectrum 4.1: HMBC spectrum of compound IV (COCls)
Spectrum 4.9: COSY spectrum of compound IV (COCls)
Spectrum 4.h: NOESY spectrum of compound IV (COCls)
Spectrum 4.i: Mass spectrum of compound IV
Spectrum 4.j: Infrared spectrum of compound IV
Compound V:
Spectrum 5.a: 1H NMR spectrum of compound V (C50SN)
Spectrum 5.b: 1SC NMR spectrum of compound V (CsOsN)
Spectrum 5.c: HSQC spectrum of compound V (CsDsN)
Spectrum 5.d HMBC spectrum of compound V (CsDsN)
Spectrum 5.e: COSY spectrum of compound V (CsDsN)
Spectrum 5.1: NOESY spectrum of compound V (CsOsN)
Spectrum 5.9: Mass spectrum of compound V
Spectrum 5.h: Infrared spectrum of compound V
Compound VI:
Spectrum 6.a: 1H NMR spectrum of compound VI (CDCIs)
Spectrum 6.b: 1SC NMR spectrum of compound VI (COCls)
Spectrum 6.c: HSQC spectrum of compound VI (COCls)
Spectrum 6.d: HMBC spectrum of compound VI (COCls)
Spectrum 6.e: COSY spectrum of compound VI (COCIs)
Spectrum 6.1: NOESY spectrum of compound VI (COCls)
Spectrum 6.9: Mass spectrum of compound VI
Spectrum 6.h: Infrared spectrum of compound VI
Compound VII:
Spectrum 7.a: 1H NMR spectrum of compound vn (CDsOD)
Spectrum 7.b: 1SC NMR spectrum of compound VII (COsOO)
Spectrum 7.c: ADEPT spectrum of compound VII (COsOD)
































Spectrum 7.e: HMBC spectrum of compound VII (COCla)
Spectrum 7.1: COSY spectrum of compound VII (COaOD)
Spectrum 7.g: NOESY spectrum of compound VII (CDaOD)
Spectrum 7.h: Mass spectrum of compound VII
Spectrum 7.i: Infrared spectrum of compound VII
Spectrum 7.j: CD spectrum of compound VII
Compound VIII:
Spectrum8.a: 1H NMR spectrum of compound VIII (COCla)
Spectrum 8.b: 1aC NMR spectrum of compound VIII (CDCla)
Spectrum 8.c: AOEPT spectrum of compound ID (CDCla)
Spectrum 8.d: HSQC spectrum of compound VIII (COCla)
Spectrum 8.e: HMBC spectrum of compound VIII (CDCla)
Spectrum 8.f: COSY spectrum of compound VIII (COCla)
Spectrum 8.g: NOESY spectrum of compound VIII (CDCla)
Spectrum 8.h: Mass spectrum of compound VIII
Spectrum 8.i: Infrared spectrum of compound VIII
Spectrum 8.j: CD spectrum of compound VID
Compound IX:
Spectrum 9.a: 1H NMR spectrum of compound IX (CD300)
Spectrum 9.b: 1aC NMR spectrum of compound IX (CDaOO)
Spectrum 9.c: HSQC spectrum of compound IX(COaOD)
Spectrum 9.d: HMBC spectrum of compound IX (COaOD)
Spectrum 9.e: COSY spectrum of compound IX (COaOD)
Spectrum 9.1: NOESY spectrum of compound IX (CDaOD)
Spectrum 9.g: Mass spectrum of compound IX
Spectrum 9.h: Infrared spectrum of compound IX
Spectrum 9.i: CO spectrum of compound IX
Compound X:
Spectrum lO.a: 1H NMR spectrum of compound X (CDaOD)
Spectrum lO.b: 1aC NMR spectrum of compound X (CDaOD)
Spectrum lO.c: HSQC spectrum of compound X(CDaOD)
Spectrum lO.d: HMBC spectrum of compound X (CDaOD)
Spectrum IO.e: COSY spectrum of compound X (CDaOD)

































Spectrum 10.g: Mass spectrum of compound X
Spectrum 1O.h: Infrared spectrum of compound X
Spectrum 10.i: CO spectrum of compound X
Compound XI:
Spectrum l1.a: 1H NMR spectrum of compound XI (C0300)
Spectrum 11.b: 13C NMR spectrum of compound XI (COsOO)
Spectrum 11.c: ADEPT spectrum of compound XI (C0300)
Spectrum 11.d: HSQC spectrum of compound XI (COsOO)
Spectrum 11.e: HMBC spectrum of compound XI (COsOO)
Spectrum 11.1: COSY spectrum of compound XI (COsOO)
Spectrum 11.g: NOESY spectrum of compound XI (COsOO)
Spectrum 11.h: Mass spectrum of compound XI
Spectrum 11.i: Infrared spectrum of compound XI
Spectrum 11.j: CD spectrum of compound XI
Compound xn:
. Spectrum 12.a: 1H NMR spectrum of compound XII (CDCls)
Spectrum 12.b: 13C NMR spectrum of compound XII (COCI3)
Spectrum 12.c: ADEPT spectrum of compound XII (COCls)
Spectrum 12.d: HSQC spectrum of compound XII (COCls)
Spectrum 12.e: HMBC spectrum of compound xn (COCls)
Spectrum 12.1: COSY spectrum of compound XII (COCI3)
Spectrum 12.g: NOESY spectrum of compound XII (COCI3)
Spectrum 12.h: Mass spectra of compound XII
Spectrum 12.i: Infrared spectrum of compound XII
Spectrum 12.j: CD spectrum of compound XII
Compound Xill:
Spectrum 13.a: 1H NMR spectrum of compound XIII (COCls)
Spectrum 13.b: 1SC NMR spectrum of compound XIII (CDCls)
Spectrum 13.c: HSQC spectrum of compound XIII (CDCI3)
Spectrum 13.d: HMBC spectrum of compound XIII (CDCI3)
Spectrum 13.e: COSY spectrum of compound XIII (COCls)
Spectrum 13.1: NOESY spectrum of compound XIII (COCls)
Spectrum 13.g: Mass spectra of compound XIII

































Spectrum 13.i: CO spectrum of compound XIII
Compound XIV:
Spectrum 14.a: 1H NMR spectrum of compound XIV (COCI3)
Spectrum 14.b: 13C NMR spectrum of compound XIV (COCls)
Spectrum 14.c: ADEPT spectrum of compound XIV (COCI3)
Spectrum 14.d: HSQC spectrum of compound XIV (COCI3)
Spectrum 14.e: HMSC spectrum of compound XIV (COCI3)
Spectrum 14.1: COSY spectrum of compound XIV (COCI3)
Spectrum 14.g: NOESY spectrum of compound XIV (COCI3)
Spectrum 14.h: Mass spectra of compound XIV
Spectrum 14.i: Infrared spectrum of compound XIV
Spectrum 14.j: CO spectrum of compound XIV
Compound XV:
Spectrum 15.a: 1H NMR spectrum of compound XV (COCI3)
Spectrum 15.b: 13C NMR spectrum of compound XV (COCI3)
Spectrum 15.c: HSQC spectrum of compound XV (CDCI3)
Spectrum 15.d: HMSC spectrum of compound XV (COCI3)
Spectrum 15.e: COSY spectrum of compound XV (COCI3)
Spectrum 15.1: NOESY spectrum of compound XV (COCI3)
Spectrum 15.g: Mass spectrum of compound XV
Spectrum 15.h: Infrared spectrum of compound XV
Spectrum 15.i: UV spectrum of compound XV
Spectrum 15.j: UV spectrum of compound XV with NaOAc
Spectrum 15.k: UV spectrum of compound XV with AICI3
Compound XVI:
Spectrum 16.a: 1H NMR spectrum of compound XVI (COCI3)
Spectrum 16.b: 13C NMR spectrum of compound XVI (COCI3)
Spectrum 16.c: HSQC spectrum of compound XVI (COCI3)
Spectrum 16.d: HMSC spectrum of compound XVI (COCI3)
Spectrum 16.e: COSY spectrum of compound XVI (COCI3)
Spectrum 16.1: NOESY spectrum of compound XVI (COCI3)
Spectrum 16.g: Mass spectrum of compound XVI
Spectrum 16.h: Infrared spectrum of compound XVI
Spectrum 16.i: UV spectrum of compound XV


































Spectrum 16.k: UV spectrum of compound XVI with AICI3
Compound XVII:
Spectrum 17.a: 1H NMR spectrum of compound XVII (CDCI3)
Spectrum l7.b: 13C NMR spectrum of compound XVII (CDCI3)
Spectrum 17.c: HSQC spectrum of compound XVII (CDCI3)
Spectrum 17.d: HMBC spectrum Of compound XVII (CDCI3)
Spectrum 17.e: COSY spectrum of compound XVII (CDCI3)
Spectrum 17.f: NOESY spectrum of compound XVII (CDCI3)
Spectrum 17.9: Mass spectra of compound XVII
Spectrum 17.h: Infrared spectrum of compound XVII
Spectrum 17.i: UV spectrum of compound XVII
Spectrum 17.j: UV spectrum of compound XVII with NaOAc
Spectrum 17.k: UV spectrum of compound XVII with AICI3
Compound XVIII:
Spectrum 18.a: 1H NMR spectrum of compound XVIII (CDCI3)
Spectrum 18.b: 13C NMR spectrum of compound XVIII (CDCI3)
Spectrum 18.c: HSQC spectrum of compound XVIII (CDCI3)
Spectrum 18.d: HMBC spectrum of compound XVIII (CDCI3)
Spectrum 18.e: COSY spectrum of compound XVIII (CDCI3)
Spectrum 18.f: NOESY spectrum of compound XVIII (CDCI3)
Spectrum 18.9: Mass spectrum of compound XVIII
Spectrum 18.h: Infrared spectrum of compound XVIII
Spectrum 18.i: UV spectrum of compound XVIII
Spectrum 18.j: UV spectrum of compound XVIII with NaOAc
Spectrum 18.k: UV spectrum of compound XVIII with AICI3
Compound XIX:
Spectrum 19.a: 1H NMR spectrum of compound XIX (CD30D)
Spectrum 19.b: 13C NMR spectrum of compound XIX «CD30D)
Spectrum 19.c: ADEPT spectrum of compound XIV (CD30D)
Spectrum 19.d: HSQC spectrum of compound XIX (CD30D)
Spectrum 19.e: HMBC spectrum of compound XIX (CD30D)
Spectrum 19.f: COSY spectrum of compound XIX (CD30D)
Spectrum 19.9: NOESY spectrum of compound XIX (CD30D)

































Spectrum 19.i: Infrared spectrum of compound XIX
Compound XX:
Spectrum 20.a: 1H NMR sp.ectrum of compound XX (CsDsN)
Spectrum 20.b: 13C NMR spectrum of compound XX (CsDsN)
Spectrum 19.c: ADEPT spectrum of compound XIV (CsDsN)
Spectrum 20.d: HSQC spectrum of compound XX (CsDsN)
Spectrum 20.e: HMBC spectrum of compound XX (CsDsN)
Spectrum 20.1: COSY spectrum of compound XX ((CsDsN)
Spectrum 20.g: NOESY spectrum of compound XX (CsDsN)
Spectrum 20.h: Mass spectrum of compound XX
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10..... SPECTRUM l.f: NOESY spectrum of compound I (CDCh)
SCAN GRAPH. Aagging:Low Resolution M'z. Filtar:[lntO.3%.].




































Fig 1 Low resolution mass spectrum of sample.
SCAN GRAPH. Aagging:High Rasolution M'z. Highlighting:Base Peak.
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SPECTRUM 2.3: In NMR spectrum of compound II (CDC!J)
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SPECTRUM 2.e: COSY spectrum of compound 11 (CDC!J)
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SPECTRUM 2.g: Mass spectrum of compound IT
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SPECTRUM 3.a: lH NMR spectrum of compound III (CDCh)
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SPECTRUM 3.b: lH NMR spectrum of compound III (CD30D)
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SPECTRUM 3.c: l3C NMR spectrum of compound III (CDCI3)
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SPECTRUM 3.d: ADEPT spectrum of compound III (CDC!})
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SPECTRUM 3.f: HMBC spectrum of compound III (CDC!J)
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SPECTRUM 4.c: DC NMR spectrul11 of compound IV (CDCI3)
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SPECTRUM S.d: HMBC spectrum of compound V (CsDsN)
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SPECTRUM 7.e: HMBC spectrum of compound VII (CD30D)
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SPECTRUM 8.e: HMBC spectrum of compound VIII (CDCI3)
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SPECTRUM S.h: Mass spectrum of compound VIII'
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Spectrum lO.g: Mass spectra of compound X
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Fig 1 High resolution mass spectrum of sample.
ATOMIC COMPOSITION REPORT (MANUAL)
Selected isotopes:
Symbol Min Max V'cy Name
H 0 30 1 Hydrogen-1
C 0 30 4 Carbon-12
o 0 7 2 Oxygen-16
N 0 1 3 Nitrogen-14
Allowable error =minimum of 20;0 ppm, 10.0 mmu.
Mass Calculated ppm mmu Formula
329.11249 329.11777 16.0 5.3 H17.C22.03
a~,O;'fi'~4:2·1Y.'f9.$O:::t~51>5' A9,2.···1Q:,tti~H!~01~lfaiP5;;f\j
330.12827 -18.0 -5.9 H16.C25.N
***** End of Atomic Composition Report *****
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SPECTRUM 12.b: 13C NMR spectrum of compound XII (CDCb)
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SCAN GRAPH. Aagging=Low Resolution M'z. Filler=llntO.3%.].














































Fig 1 Low resolution mass spectrum of sample.
SCAN GRAPH. Aagging:High Resolution M'z. Highlighting=Base Peak.
100 Scan 17#1 :54 • 21 #2:21. Sub=4#0:26 - 6#0:39. Entries=297. Base /Nz=66.01524. 100% Inl.=0.04882. Cl. POS.
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SPECTRUM 13.b: l3C NMR spectrum of compound XIII (CDCb)
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SCAN GRAPH. Flagging=Low Resolution !Nz












































Fig 1 Low resolution mass spectrum of sample.
SCAN GRAPH. Aagging=High Resolution !Nz HighHghting=Base Peak.










































Spectrum 13.g: Mass spectra of compound XIII
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SPECTRUM 14.d: HSQC spectrum of compound XIV (CDC13)
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Fig 1 Low resolution mass spectrum of sample.
SCAN GRAPH. Aagging=High Resolution M'z. Highlighting=Base Peak.

















































Fig 2 High resolution mass spectrum of sample.
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SPECTRUM 15.e: COSY spectrum of compound XV (CDCh)
.,-r-..,-··-T-r'-'.......,-- 1 I
4 3












































r--r-"-I--'~ I 'I '1--.---r-T--l·I,--,-,------,--r-,-,-,--~'-~--,------,---,-..-~





































o ,~~ ,:tl~t~11 J)~~I,I~J~!:I j~!1 1~\97215 ~4~2~2~! l 33~, ~56,37~, ~~2421 ~~.2 16~~8~, 51~~~01 "








I I I I , I I I I I I I r-rr'-'-rr'-r-l'j-.,-r-'--("""-1'-·"_·",-T-I-"'r-r--I'-'-·1-'-1-t---I I I I. 'I I I l-r-




















___~.... ~~ .~ .________________ I







l I \\\,'1.6 i
I
1 I \-
j' ! - \
I I \.
1.0 -j I \ /
I) \, / \
O.5f \ ,/ \
().0-I-----~-------- ---~--
L r--_---------- ----------·_-_·_---------r -- --- -- ---------------1--------------,
200 300 400 500
VVavelength (nm)





------ ----- ----- j-- - - - ----.- --------- ----T --------~
200 300 400 600
\lVavelength (nm)




1.6 ·1 g,\ \ ~
1/1 I ['\' ''1 0
..0 I 1 ' I 0
-< 1'°11 \\ (\ 1. '1 \\ \/-,
_~~ \\ v \
0.5 \ / //\\ \
\\-'::~-"'-'/'---'~"""-'
O
·.0' -. --"-~-- --------.... --- ..












-r- I I I i i I I I '-----r-- I i 1-: I,-----r---- I 1 t-..----,---:-,-·t·--,-.,-,---,-· 1 i I i ---.--------T 1 ~-,·-r---·"---'--~
9 8 7 6 5 4 3 2 1 ppm








i t f ! I i i I I i i I I I I I I i I I I i I I I r-r-r-I 1 I I , I I I '·-rr··,--,-r-rt-rr-,-r--,---,-'-,--I---,--,---,·--"fI-,.-r-r-r-l.......---r--r-~.,.,--,--,-.---r--T~-,~ I I 1""- 1 i-'-l""J
ZOO 180 160 140 120 100 130 60 40 20 ppm
SPECTRUM 16.b: l3C NMR spectrum of compound XVI (CDC!J)
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SPECTRUM 17.d: HMBC spectrum of compound XVII (CDCh)
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SCAN GRAPH. Flagging=Low Resolution M'z.




































Fi 1 Low resolution mass $ . ectrum of sam le.
SCAN GRAPH. Flagging=High Resolution M'z. Highlighting=Base Peak.
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SPECTRUM 18.e: COSY spectrum of compound XVIII (CDCb)
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SPECTRUM 19.h: Mass spectrum of compound XIX
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SPECTRUM 20.i: Infrared spectrum of compound XX
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